WO2022058580A1 - Microbiocidal compounds - Google Patents

Microbiocidal compounds Download PDF

Info

Publication number
WO2022058580A1
WO2022058580A1 PCT/EP2021/075770 EP2021075770W WO2022058580A1 WO 2022058580 A1 WO2022058580 A1 WO 2022058580A1 EP 2021075770 W EP2021075770 W EP 2021075770W WO 2022058580 A1 WO2022058580 A1 WO 2022058580A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
methyl
formula
compounds
compound
Prior art date
Application number
PCT/EP2021/075770
Other languages
French (fr)
Inventor
Stefano RENDINE
Matthias Weiss
Simon Williams
Thomas James HOFFMAN
Original Assignee
Syngenta Crop Protection Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Crop Protection Ag filed Critical Syngenta Crop Protection Ag
Priority to BR112023004833A priority Critical patent/BR112023004833A2/en
Publication of WO2022058580A1 publication Critical patent/WO2022058580A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00—Fungicides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/50—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids the nitrogen atom being doubly bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring

Definitions

  • the present invention relates to microbiocidal oxime derivatives, e.g., as active ingredients, which have microbiocidal activity, in particular, fungicidal activity.
  • the invention also relates to agrochemical compositions which comprise at least one of the oxime derivatives, to processes of preparation of these compounds and to uses of the oxime derivatives or compositions in agriculture or horticulture for controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, preferably fungi.
  • a compound of formula (I) wherein Y is CH or N; X is O or NH; R 1 is selected from the group consisting of hydrogen, halogen, C 1 -C 4 alkyl and C 1 -C 4 alkoxy; R 2 is selected from the group consisting of hydrogen, C 1 -C 8 alkyl, C 3 -C 6 alkenyl, C 3 -C 6 alkynyl, cyanoC 1 - C 6 alkyl-, C 1 -C 6 haloalkyl, C 3 -C 6 haloalkenyl, hydroxyC 2 -C 6 alkyl-, C 1 -C 4 alkoxyC 2 -C 6 alkyl-, C 1 - C 4 haloalkoxyC 2 -C 6 alkyl-, C 1 -C 4 alkoxyC 2 -C 4 alkoxyC 2 -C 6 alkyl-, C 2 -C 6 alkenyloxyC 2
  • an agrochemical composition comprising a fungicidally effective amount of a compound of formula (I) and an agrochemically- acceptable diluent or carrier.
  • Such an agricultural composition may further comprise at least one additional active ingredient.
  • a method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms wherein a fungicidally effective amount of a compound of formula (I), or a composition comprising this compound as active ingredient, is applied to the plants, to parts thereof or the locus thereof.
  • a compound of formula (I) as a fungicide.
  • the use may exclude methods for the treatment of the human or animal body by surgery or therapy.
  • halogen or “halo” refers to fluorine (fluoro), chlorine (chloro), bromine (bromo) or iodine (iodo), preferably fluorine, chlorine or bromine.
  • cyano means a -CN group.
  • hydroxyl or “hydroxy” means an -OH group.
  • amino means an -NH 2 group.
  • C 1 -C 8 alkyl refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing no unsaturation, having from one to eight carbon atoms, and which is attached to the rest of the molecule by a single bond.
  • C 1 -C 4 alkyl is to be construed accordingly.
  • C 1 -C 8 alkyl examples include, but are not limited to, methyl, ethyl, n-propyl, 1- methylethyl (iso-propyl), n-butyl, and 1-dimethylethyl (t-butyl).
  • cyanoC 1 -C 6 alkyl- refers to a C 1 -C 6 alkyl radical as generally defined above substituted by one or more cyano groups.
  • hydroxyC 2 -C 6 alkyl- refers to a C 2 -C 6 alkyl radical as generally defined above substituted by one or more hydroxy groups.
  • C 1 -C 4 alkoxy refers to a radical of the formula -ORa where Ra is a C 1 -C 4 alkyl radical as generally defined above.
  • Examples of C 1 -C 4 alkoxy include, but are not limited to, methoxy, ethoxy, propoxy, iso-propoxy and t-butoxy.
  • C 1 -C 4 alkoxyC 2 -C 6 alkyl- refers to radical of the formula R a -O-R b - where R a is a C 1 -C 4 alkyl radical as generally defined above, and Rb is a C 2 -C 6 alkylene radical as generally defined above.
  • C 1 -C 6 haloalkyl refers to a C 1 -C 6 alkyl radical, as generally defined above, substituted by one or more of the same or different halogen atoms.
  • Examples of C 1 -C 6 haloalkyl include, but are not limited to chloromethyl, fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl and 2,2,2- trifluoroethyl.
  • C 1 -C 4 haloalkoxy refers to a C 1 -C 4 alkoxy group, as defined above, substituted by one or more of the same or different halogen atoms.
  • C 1 -C 4 haloalkoxy examples include, but are not limited to, fluoromethoxy, difluoromethoxy, fluoroethoxy, trifluoromethoxy and trifluoroethoxy.
  • C 1 -C 4 haloalkoxyC 2 -C 6 alkyl- refers to radical of the formula Ra-O-Rb- where Ra is a C 1 -C 4 haloalkyl radical as generally defined above, and Rb is a C 2 -C 6 alkylene radical as generally defined above.
  • C 3 -C 6 alkenyl refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing at least one double bond that can be of either the (E)- or (Z)-configuration, having from three to six carbon atoms, which is attached to the rest of the molecule by a single bond.
  • Examples of C 3 -C 6 alkenyl include, but are not limited to, prop-1-enyl, allyl (prop-2-enyl) and but-1-enyl.
  • C 3 -C 6 alkynyl refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from three to six carbon atoms, and which is attached to the rest of the molecule by a single bond.
  • Examples of C 3 -C 6 alkynyl include, but are not limited to, prop-1-ynyl and propargyl (prop-2-ynyl).
  • C 1 -C 6 alkylcarbonyl refers to a radical of the formula -C(O)Ra where Ra is a C 1 -C 6 alkyl radical as generally defined above.
  • C 1 -C 3 alkylcarbonyl is to be construed accordingly.
  • the term "C 1 -C 6 alkylcarbonylC 1 -C 6 alkyl-" refers to radical of the formula Ra-C(O)-Rb- where Ra is a C 1 -C 6 alkyl radical as generally defined above, and Rb is a C 1 -C 6 alkylene radical as generally defined above.
  • C 1 -C 4 alkoxyC 2 -C 4 alkoxy- refers to radical of the formula Ra-O-Rb-O- where Ra is a C 1 -C 4 alkyl radical as generally defined above, and Rb is a C 2 -C 4 alkyl radical as generally defined above.
  • aminoC 2 -C 6 alkyl- refers to a C 2- C 6 alkyl radical as generally defined above substituted by one or more amino groups.
  • N-C 1 -C 4 alkylamino refers to a radical of the formula RaNH- wherein Ra is a C 1 -C 4 alkyl radical as generally defined above.
  • N,N-diC 1 -C 4 alkylamino refers to a radical of the formula R a (R b )N- wherein R a and R b are the same or different C 1 -C 4 alkyl radicals as generally defined above.
  • C 1 -C 6 alkylcarbonyloxy refers to a radical of the formula - OC(O)Ra wherein Ra is a C 1 -C 6 alkyl radical as generally defined above.
  • C 1 -C 6 alkylcarbonyloxyC 2 -C 6 alkyl- refers to a radical of the formula Ra-C(O)O- Rb- where Ra is a C 1 -C 6 alkyl radical as generally defined above, and Rb is a C 2 -C 6 alkylene radical as generally defined above.
  • C 1 -C 6 alkoxycarbonylC 1 -C 6 alkyl- refers to a radical of the formula Rb-OC(O)- Ra- where R a is a C 1 -C 6 alkyl radical as generally defined above, and Rb is a C 1 -C 6 alkyl radical as generally defined above.
  • C 1 -C 6 alkylsulfanyl refers to a radical of the formula -SR a wherein R a is a C 1 - C 6 alkyl radical as generally defined above.
  • C 1 -C 6 alkylsulfinyl refers to a radical of the formula -S(O)Ra wherein Ra is a C 1 -C 6 alkyl radical as generally defined above.
  • C 1 -C 6 alkylsulfonyl refers to a radical of the formula -S(O) 2 R a wherein R a is a C 1 -C 6 alkyl radical as generally defined above.
  • C 1 -C 4 alkoxyiminoC 2 -C 4 alkyl- refers to a C 1 -C 4 alkoxyimino radical as defined above attached to the rest of the molecule by a C 2 -C 4 alkylene radical as generally defined above.
  • C 3 -C 6 cycloalkyl refers to a stable, monocyclic ring radical which is saturated or partially unsaturated and contains 3 to 6 carbon atoms.
  • C 3 - C 4 cycloalkyl is to be construed accordingly.
  • Examples of C 3 -C 6 cycloalkyl include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
  • the term "C 3 -C 6 cycloalkylC 1 -C 3 alkyl-" refers to a C 3 -C 6 cycloalkyl ring as defined above attached to the rest of the molecule by a C 1 -C 3 alkylene radical as defined above.
  • the term "C 3 - C 4 cycloalkylC 1 -C 2 alkyl-” is to be construed accordingly.
  • C 3 -C 6 cycloalkylC 1 -C 3 alkyl- examples include, but are not limited to cyclopropylmethyl- and cyclobutylethyl-.
  • phenylC 1 -C 3 alkyl- refers to a phenyl ring attached to the rest of the molecule by a C 1 -C 3 alkylene radical as generally defined above.
  • heterocyclyl or “heterocyclic” refers to a stable 3- to 6-membered non-aromatic monocyclic ring radical which comprises 1, 2, or 3 heteroatoms individually selected from nitrogen, oxygen and sulfur.
  • heterocyclyl radical may be bonded to the rest of the molecule via a carbon atom or heteroatom.
  • heterocyclyl include, but are not limited to, pyrrolinyl, pyrrolidyl, tetrahydrofuryl, tetrahydrothienyl, tetrahydrothiopyranyl, piperidyl, piperazinyl, tetrahydropyranyl, dihydroisoxazolyl, dioxolanyl, morpholinyl or ⁇ -lactamyl.
  • heterocyclylC 1 -C 3 alkyl- refers to a heterocyclyl ring as defined above attached to the rest of the molecule by a C 1 -C 3 alkylene radical as generally defined above.
  • heteroaryl refers to a 5- or 6-membered monocyclic aromatic ring which comprises 1, 2, 3 or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur.
  • the heteroaryl radical may be bonded to the rest of the molecule via a carbon atom or heteroatom.
  • heteroaryl examples include, furyl, pyrrolyl, imidazolyl, thienyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, tetrazolyl, pyrazinyl, pyridazinyl, pyrimidyl or pyridyl.
  • heteroarylC 1 -C 3 alkyl- refers to a heteroaryl ring as defined above attached to the rest of the molecule by a C 1 -C 3 alkylene radical as generally defined above.
  • the compound of formula (I) may exist as E and/or Z isomers.
  • a compound of formula (I) can be drawn in at least 4 different isomeric forms as shown below.
  • the individual isomers, or intermediates depicted below or in reaction schemes 1 to 21 may interconvert in solid state, in solution, or under exposure to light.
  • the presence of one or more possible asymmetric carbon atoms in a compound of formula (I) means that the compounds may occur in chiral isomeric forms, i.e., enantiomeric or diastereomeric forms. Also atropisomers may occur as a result of restricted rotation about a single bond.
  • Formula (I) is intended to include all those possible isomeric forms and mixtures thereof.
  • the present invention includes all those possible isomeric forms and mixtures thereof for a compound of formula (I).
  • formula (I) is intended to include all possible tautomers (including lactam-lactim tautomerism and keto-enol tautomerism) where present.
  • the present invention includes all possible tautomeric forms for a compound of formula (I).
  • the compounds of formula (I) according to the invention are in free form, in covalently hydrated form, or in salt form, e.g., an agronomically usable or agrochemically acceptable salt form.
  • N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds.
  • Y is CH or N.
  • Y is CH.
  • X is O or NH.
  • X is O.
  • R 1 is selected from the group consisting of hydrogen, halogen, C 1 -C 4 alkyl and C 1 -C 4 alkoxy.
  • R 1 is selected from the group consisting of hydrogen, halogen and C 1 -C 4 alkyl. More preferably, R 1 is selected from the group consisting of hydrogen, chloro, fluoro and C 1 -C 4 alkyl. Even more preferably, R1 is selected from the group consisting of hydrogen, fluoro and methyl. Even more preferably still, R 1 is hydrogen or methyl. Most preferably, R 1 is hydrogen.
  • R 2 is selected from the group consisting of hydrogen, C 1 -C 8 alkyl, C 3 -C 6 alkenyl, C 3 -C 6 alkynyl, cyanoC 1 - C 6 alkyl-, C 1 -C 6 haloalkyl, C 3 -C 6 haloalkenyl, hydroxyC 2 -C 6 alkyl-, C 1 -C 4 alkoxyC 2 -C 6 alkyl-, C 1 - C 4 haloalkoxyC 2 -C 6 alkyl-, C 1 -C 4 alkoxyC 2 -C 4 alkoxyC 2 -C 6 alkyl-, C 2 -C 6 alkenyloxyC 2 -C 6 alkyl-, C 2 - C 6 alkynyloxyC 2 -C 6 alkyl-, aminoC 2 -C 6 alkyl-, N-C 1 -C 4 alkylaminoC 2 -C 6 alkyl-, N,
  • R 2 is selected from the group consisting of C 1 -C 8 alkyl, C 3 -C 6 alkenyl, C 3 -C 6 alkynyl, cyanoC 1 - C 6 alkyl-, C 1 -C 6 haloalkyl, hydroxyC 2 -C 6 alkyl-, C 1 -C 4 alkoxyC 2 -C 6 alkyl-, C 1 -C 4 haloalkoxyC 2 -C 6 alkyl-, C 1 - C 6 alkylcarbonyloxyC 2 -C 6 alkyl-, C 1 -C 4 alkoxyiminoC 2 -C 4 alkyl-, C 3 -C 6 cycloalkyl and C 3 -C 6 cycloalkylC 1 - C 3 alkyl-, wherein said C 3 -C 6 cycloalkyl or C 3 -C 6 cycloalkylC 1 -C 3 alkyl- are optionally substitute
  • R 2 is selected from the group consisting of C 1 -C 8 alkyl and C 3 -C 6 alkynyl. Even more preferably, R 2 is selected from the group consisting of C 1 -C 4 alkyl and C 3 -C 6 alkynyl. Even more preferably still, R 2 is selected from the group consisting of methyl, ethyl and propargyl. R 3 is selected from the group consisting of methyl, ethyl, propyl, iso-propyl, chloro, fluoro, cyano, difluoromethyl, trifluoromethyl, oxo, hydroxy, methoxy, ethoxy, difluoromethoxy, and cyclopropyl.
  • R 3 is selected from the group consisting of methyl, ethyl, propyl, iso-propyl, chloro, fluoro, difluoromethyl, trifluoromethyl and cyclopropyl. More preferably, R 3 is selected from the group consisting of methyl, chloro, fluoro and trifluoromethyl. Even more preferably, R 3 is chloro or fluoro.
  • a 1 is CH 2 or O. Preferably, A 1 is CH 2 .
  • a 2 is a direct bond, CH 2 , or CH 2 CH 2 .
  • a 2 is CH 2 or CH 2 CH 2 . Most preferably A 2 is CH 2 .
  • a 1 and A 2 are CH 2 .
  • Y is CH;
  • X is O;
  • R 1 is selected from the group consisting of hydrogen, fluoro and methyl;
  • R 2 is selected from the group consisting of C 1 -C 8 alkyl, C 3 -C 6 alkenyl, C 3 -C 6 alkynyl, cyanoC 1 -C 6 alkyl-, C 1 - C 6 haloalkyl, hydroxyC 2 -C 6 alkyl-, C 1 -C 4 alkoxyC 2 -C 6 alkyl-, C 1 -C 4 haloalkoxyC 2 -C 6 alkyl-, C 1 - C 6 alkylcarbonyloxyC 2 -C 6 alkyl-, C 1 -C 4 alkoxyiminoC 2 -C 4 alkyl-, C 3 -C 6 cycloalkyl and C 3 -C 6 cycloalkylC 1 - C 3 alkyl-
  • Y is CH; X is O; R 1 is hydrogen; R 2 is selected from the group consisting of C 1 -C 8 alkyl and C 3 -C 6 alkynyl; A 1 is CH 2 ; and A 2 is CH 2 .
  • Y is CH; X is O; R 1 is hydrogen; R 2 is selected from the group consisting of C 1 -C 4 alkyl and C 3 -C 6 alkynyl (preferably, methyl, ethyl and propargyl); A 1 is CH 2 ; and A 2 is CH 2 .
  • the compound according to formula (I) is selected from the group consisting of compounds 1.1 to 1.6 listed in table T1 below.
  • an intermediate of formula (IIa) wherein, Y is CH; X is O; R 1 is selected from the group consisting of hydrogen, halogen and C 1 -C 4 alkyl (preferably, hydrogen, fluoro and methyl, more preferably hydrogen); A 1 is CH 2 ; and A 2 is CH 2 ;
  • a compound of formula (IIa) as defined herein in a process for the manufacture of a compound of formula (I) as defined herein.
  • the compounds of formula (I) according to the invention may be useful for combating phytopathogenic fungi (e.g Alternaria alternata, Phakopsora pachyrhizi, Plasmopara viticola, Sclerotinia sclerotiorum or Septoria tritici also known as Mycosphaerella graminicola) containing a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone).
  • phytopathogenic fungi e.g Alternaria alternata, Phakopsora pachyrhizi, Plasmopara viticola, Sclerotinia sclerotiorum or Septoria tritici also known as Mycosphaerella graminicola
  • Qo inhibitors e.g strobilurins such as
  • the compounds of formula (I) according to the invention may be useful for combating phytopathogenic fungi (e.g Alternaria alternata, Plasmopara viticola, Sclerotinia sclerotiorum or Septoria tritici also known as Mycosphaerella graminicola) containing a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone), wherein the mutation is G143A.
  • phytopathogenic fungi e.g Alternaria alternata, Plasmopara viticola, Sclerotinia sclerotiorum or Septoria tritici also known as Mycosphaerella graminicola
  • Qo inhibitors e.g strobilurins such as azoxystrobin, pyraclostrobin and tri
  • the compounds of formula (I) according to the invention may be useful for combating phytopathogenic fungi (e.g Phakopsora pachyrhizi) containing a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone), wherein the mutation is F129L.
  • phytopathogenic fungi e.g Phakopsora pachyrhizi
  • Qo inhibitors e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone
  • the compounds of formula (I) according to the invention may be useful for combating phytopathogenic fungi (e.g Phakopsora pachyrhizi) containing a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone), wherein the mutation is Y132C.
  • phytopathogenic fungi e.g Phakopsora pachyrhizi
  • Qo inhibitors e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone
  • the invention also relates to a method of controlling or preventing infestation by phytopathogenic fungi in a plant (e.g Alternaria alternate, Phakopsora pachyrhizi Plasmopara viticola, Sclerotinia sclerotiorum or Septoria tritici also known as Mycosphaerella graminicola, preferably Phakopsora pachyrhizi), wherein said phytopathogenic fungi contains a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobliurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone), said method comprising applying to the plant, to parts thereof or the locus thereof, a fungicidally effective amount of a compound of formula (I) (including any one of compounds 1.1 to 1.6).
  • a plant e.g Alternaria alternate, Phakopsora pachy
  • the level of resistance and therefore the impact on the performance of the fungicide can be measured by the use of a 'Resistance Factor' (RF).
  • RF EC50 value of the resistant strain/EC50 value of the sensitive strain.
  • resistant fungal strains In order to obtain resistant fungal strains, a researcher is to locate a host crop and geographical region where the relevant resistance had been reported in literature. Leaf samples infected by the target disease are then collected from the locations/host crops and sent to a laboratory, where pure cultures would be isolated. The resistant phenotype of the fungal cultures is determined either by conducting a full dose response bioassay and comparing the bioassay results to similar bioassay results for a known susceptible strain of the same species. Alternatively the resistance genotype of the fungal strain can be determined by molecular techniques (e.g. qPCR) if the resistance mechanism for the relevant species is known.
  • molecular techniques e.g. qPCR
  • the compounds of formula (I) according to the invention can be made as shown in the following schemes 1 to 21, wherein Y, X, R 1 , R 2 , R 3 , A 1 and A 2 are as defined for a compound of formula (I), unless otherwise stated.
  • Compounds of formula (I) can be prepared from compounds of formula (II) by treatment with hydroxylamines of formula (III), or an appropriate salt thereof, optionally in the presence of a base such as sodium acetate or an acid such as acetic acid and in solvents such as ethanol, methanol or water at temperatures between 20°C and 100°C.
  • compounds of formula (I) can be prepared from compounds of formula (I-I) by treatment with an alkylating agent such of formula (IV) wherein R 2 is as described for formula (I) and R 3a is an appropriate leaving group (e.g. Cl, Br, I, OTs), optionally in the presence of a base such as sodium hydride, potassium tertbutoxide or potassium carbonate, in a solvent such as dimethylformamide or tetrahydrofuran, at temperatures between 0°C and 100°C.
  • an alkylating agent such of formula (IV) wherein R 2 is as described for formula (I) and R 3a is an appropriate leaving group (e.g. Cl, Br, I, OTs)
  • a base such as sodium hydride, potassium tertbutoxide or potassium carbonate
  • solvent such as dimethylformamide or tetrahydrofuran
  • Compounds of formula (II) can be prepared from compounds of formula (V), wherein M is a metalloid species (e.g. MgCl, ZnCl, B(OH)2 or BPin), by reaction with a compound of formula (VI), where R 4 is a halogen or pseudohalogen (e.g. Br, I, OTf), in the presence of a suitable catalyst such as palladium diacetate and optionally a supporting ligand (e.g. CatCXiumA®) and base (e.g.
  • Pd(dppf)Cl2 Pd(dppf)Cl2) and base (e.g. potassium phosphate) in solvents such as 1,4-dioxane, dimethylformamide or toluene at temperatures between 20°C and 100°C.
  • solvents such as 1,4-dioxane, dimethylformamide or toluene at temperatures between 20°C and 100°C.
  • Compounds of formula (VII) are either commercially available or compounds of formula (VII) wherein A 1 and A 2 are CH 2 can be prepared from compounds of formula (VIII) using an activating agent, such as SOCl2, in a suitable solvent such as DMF or DCM, followed by introduction of a Lewis acid, such aluminium trichloride, under an atmosphere of ethylene at pressures between 0 and 20 bar and temperatures between 20°C and 120°C.
  • an activating agent such as SOCl2
  • a suitable solvent such as DMF or DCM
  • a Lewis acid such aluminium trichloride
  • a base such as sodium acetate or an acid such as acetic acid
  • solvents such as ethanol, methanol or water at temperatures between 20°C and 100°C.
  • compounds of formula (I) can be obtained by condensation with hydroxylamine or a salt thereof, optionally in the presence of a base such as sodium acetate or an acid such as acetic acid and in solvents such as ethanol or methanol at temperatures between 20°C and 100°C followed by methylation with a reagent such dimethyl sulfate or methyl iodide in the presence of a base, such as potassium tertbutoxide, in a suitable solvent such as THF.
  • a base such as sodium acetate or an acid such as acetic acid
  • solvents such as ethanol or methanol
  • Compounds of formula (IX) can be prepared from compounds of formula (X), where R 5 is Br or I, preferably I, by treatment with methylamine in the presence of a suitable catalyst such as PEPPSI TM -IPr and a base such as potassium carbonate, in an appropriate solvent (e.g. 1,4-dioxane or dimethylformamide) under an atmosphere of carbon monoxide at pressures between 0 and 20 bar and temperatures between 20°C and 120°C.
  • a suitable catalyst such as PEPPSI TM -IPr and a base such as potassium carbonate
  • an appropriate solvent e.g. 1,4-dioxane or dimethylformamide
  • a suitable organometallic species e.g. iPrMgCl.LiCl, n-BuLi, or t-BuLi
  • a suitable solvent e.g. tetrahydrofuran or diethyl ether
  • compounds of formula (IX) wherein X is NH can be prepared from compounds of formula (IX), wherein X is O, via selective amidation using methylamine, or a suitable salt thereof, optionally in the presence of an activating agent, such as diethylaluminum chloride, in a suitable solvent such as tolune.
  • an activating agent such as diethylaluminum chloride
  • compounds of formula (I) can be prepared from compounds of formula (XI), wherein M is a metalloid species (e.g.
  • R 4 is a halogen or pseudohalogen (e.g. Br, I, OTf), in the presence of a suitable catalyst such as palladium acetate and optionally a supporting ligand (e.g. CatCXiumA®) and base (e.g. potassium phosphate) in a suitable solvent such as 1,4-dioxane, DMF, or toluene at temperatures between 20°C - 150°C.
  • a suitable catalyst such as palladium acetate and optionally a supporting ligand (e.g. CatCXiumA®) and base (e.g. potassium phosphate) in a suitable solvent such as 1,4-dioxane, DMF, or toluene at temperatures between 20°C - 150°C.
  • a suitable solvent such as 1,4-dioxane, DMF, or toluene
  • Compounds of formula (XI) wherein M is a metalloid species can be prepared from compounds of formula (X) wherein R 5 is a halogen or pseudohalogen (e.g. I, Br, Cl, OTf) by treatment with a suitable reagent (e.g. bis-pinacolatodiboron) optionally in the presence of a suitable catalyst (e.g. Pd(dppf)Cl2) and base (e.g. potassium phosphate) in a solvent such as 1,4-dioxane, dimethylformamide or toluene at temperatures between 20°C-150°C.
  • a suitable reagent e.g. bis-pinacolatodiboron
  • a suitable catalyst e.g. Pd(dppf)Cl2
  • base e.g. potassium phosphate
  • compounds of formula (XI), wherein M is a metal species can be prepared from compounds of formula (X), where R 5 is Cl, Br or I, via metal-halogen exchange with a suitable organometallic species (e.g. iPrMgCl.LiCl, n-BuLi, or EtZnCl), in a suitable solvent (e.g. tetrahydrofuran or diethyl ether), and at temperatures between -78°C and 25°C.
  • a suitable organometallic species e.g. iPrMgCl.LiCl, n-BuLi, or EtZnCl
  • a suitable solvent e.g. tetrahydrofuran or diethyl ether
  • compounds of formula (I) wherein Y is N can be obtained from compounds of formula (XII) via addition of tertbutyl nitrite in a suitable solvent, such as toluene, and optionally in the presence of a base, such as potassium tert-butoxide followed by the addition of a methylating reagent such as methyl iodie or dimethylsulfate at a suitable temperature range between 20°C and 50°C.
  • a suitable solvent such as toluene
  • a base such as potassium tert-butoxide
  • a methylating reagent such as methyl iodie or dimethylsulfate
  • a minor nitrone byproduct of formula (XIII) may form and it can be converted to compounds of formula (I) via treatment with N-methyl hydroxylamine or a salt thereof, optionally in the presence of a base and in a suitable solvent such as DMSO, MeCN, or DMF at temperatures between 50°C and 100°C.
  • a suitable solvent such as DMSO, MeCN, or DMF at temperatures between 50°C and 100°C.
  • compounds of formula (XV) wherein Y is N can be obtained from compounds of formula (XIV) via addition of an oxidant, such as tert-butyl nitrite in a suitable solvent, such as toluene, and optionally in the presence of a base, such as potassium tert-butoxide followed by the addition of a methylating reagent such as methyl iodie or dimethylsulfate at suitable temperatures between 20°C and 50°C.
  • an oxidant such as tert-butyl nitrite
  • a suitable solvent such as toluene
  • a base such as potassium tert-butoxide
  • a methylating reagent such as methyl iodie or dimethylsulfate
  • a minor nitrone byproduct of formula (XVI) may form which can be converted to a compound of formula (XV) via treatment with N-methyl hydroxylamine or a salt thereof, optionally in the presence of a base and in a suitable solvent such as DMSO, MeCN, or DMF at temperatures between 50°C and 100°C.
  • a suitable solvent such as DMSO, MeCN, or DMF at temperatures between 50°C and 100°C.
  • Compounds of formula (II) can be obtained from compounds of formula (XV), via intoduction of a suitable acid, such as trifluoroacetic acid or para-tolulsulfonic acid, in a suitable solvent, such as acetone and water. This is shown in scheme 15 and for related examples see Current Organocatalysis 2018, 5, 196-200 or Journal of Organic Chemistry, 2006, 71, 4956-4964.
  • Compounds of formula (XVII) can be obtained from compounds of formula (VII), via introductionwith ethylene glycol in the presence of a suitable acid, such as camphorsulfonic acid or para-tolylsulfonic acid, in a suitable solvent, such as toluene or methyl orthoester at temperatures between 20°C and 50°C. This is shown in scheme 17 and for related examples see WO2006044293.
  • Compounds of formula (XVIII) wherein M is a metalloid species (e.g. B(OH)2, BPin) can be prepared from compounds of formula (XVII) wherein R 5 is a halogen or pseudohalogen (e.g.
  • a suitable metallating agent e.g. bis-pinacolatodiboron
  • a suitable catalyst e.g. Pd(dppf)Cl 2
  • base e.g. potassium phosphate
  • M is a metalloid species such as (e.g.
  • ZnCl, MgCl, Li can be prepared from compounds of formula (XVII), where R 5 is Cl, Br or I, via metal-halogen exchange with a suitable organometallic species (e.g. iPrMgCl.LiCl, n-BuLi, or EtZnCl), in a suitable solvent (e.g. tetrahydrofuran or diethyl ether), and at a temperature between -78°C.
  • a suitable organometallic species e.g. iPrMgCl.LiCl, n-BuLi, or EtZnCl
  • a suitable solvent e.g. tetrahydrofuran or diethyl ether
  • Compounds of formula (XV), can be obtained from compounds of formula (XIV), by treatment with a base such as sodium methoxide and a formylating agent such as methyl formate followed by methylation with a reagent such dimethyl sulfate in the presence of a base such as K2CO3 or via introduction of ortho methylester in the presence of an acid such as H2SO4.
  • a base such as sodium methoxide and a formylating agent such as methyl formate followed by methylation with a reagent such dimethyl sulfate in the presence of a base such as K2CO3 or via introduction of ortho methylester in the presence of an acid such as H2SO4.
  • a suitable catalyst such as palladium acetate and optionally a supporting ligand (e.g. CatCXiumA®) and base (e.g. potassium phosphate) in a suitable solvent such as 1,4-dioxane, DMF or toluene at temperatures between 20°C- 150°C.
  • a suitable catalyst such as palladium acetate and optionally a supporting ligand (e.g
  • compounds of formula (XIX) wherein X is NH can be prepared from compounds of formula (XIX) wherein X is O, via selective amidation using methylamine, or a suitable salt thereof, optionally in a one pot fashion and optionally in the presence of a base.
  • a suitable salt thereof optionally in a one pot fashion and optionally in the presence of a base.
  • Such conversions may also take place after use, e. g. in the treatment of plants in the treated plant, or in the harmful fungus to be controlled.
  • the compounds of formula (I) of the present invention have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
  • the compounds of formula (I) can be used in the agricultural sector and related fields of use, e.g., as active ingredients for controlling plant pests or on non-living materials for the control of spoilage microorganisms or organisms potentially harmful to man.
  • the novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe.
  • the compounds of formula (I) can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later, e.g., from phytopathogenic microorganisms.
  • the present invention further relates to a method for controlling or preventing infestation of plants or plant propagation material and/or harvested food crops susceptible to microbial attack by treating plants or plant propagation material and/or harvested food crops wherein an effective amount a compound of formula (I) is applied to the plants, to parts thereof or the locus thereof.
  • fungicide as used herein means a compound that controls, modifies, or prevents the growth of fungi.
  • fungicidally effective amount where used means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all deviation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection.
  • compounds of formula (I) as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings, for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil.
  • the propagation material can be treated with a composition comprising a compound of formula (I) before planting: seed, for example, can be dressed before being sown.
  • the active compounds of formula (I) can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation.
  • the composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing.
  • the invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.
  • the compounds of formula (I) can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene management.
  • the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint.
  • the compounds of formula (I) are for example, effective against fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses.
  • fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses are for example: Absidia corymbifera, Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, Botryosphaeria spp. including B. dothidea, B. obtusa, Botrytis spp. comprising B. cinerea, Candida spp.
  • C. albicans including C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Cephaloascus fragrans, Ceratocystis spp, Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp, Claviceps purpurea, Coccidioides immitis, Cochliobolus spp, Colletotrichum spp. including C.
  • Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P. philippinensis and P. sorghi, Peronospora spp, Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp, Phoma spp, Phomopsis viticola, Phytophthora spp.
  • P. infestans Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P.
  • the compounds of formula (I) may be used for example on turf, ornamentals, such as flowers, shrubs, broad-leaved trees or evergreens, for example conifers, as well as for tree injection, pest management and the like.
  • target crops and/or useful plants to be protected typically comprise perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St.
  • perennial and annual crops such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries
  • cereals for example barley, maize (corn), millet, oats
  • Augustine grass and Zoysia grass herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.
  • herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme
  • legumes for example beans, lentils, peas and soya beans
  • useful plants is to be understood as also including useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol-pyrovyl- shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering.
  • herbicides like bromoxynil or classes of herbicides
  • EPSPS (5-enol-pyrovyl- shikimate-3-phosphate-synthase) inhibitors
  • GS glutamine synthetase
  • PPO protoporphyrinogen-oxidase
  • imazamox by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola).
  • crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I ⁇ and LibertyLink®.
  • Useful plants is to be understood as also including useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
  • YieldGard ⁇ (maize variety that expresses a CryIA(b) toxin); YieldGard Rootworm ⁇ (maize variety that expresses a CryIIIB(b1) toxin); YieldGard Plus ⁇ (maize variety that expresses a CryIA(b) and a CryIIIB(b1) toxin); Starlink ⁇ (maize variety that expresses a Cry9(c) toxin); Herculex I ⁇ (maize variety that expresses a CryIF(a2) toxin and the enzyme phosphinothricine N- acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B ⁇ (cotton variety that expresses a CryIA(c) toxin); Bollgard I ⁇ (cotton variety that expresses a CryIA(c) toxin); Boll
  • crops is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
  • Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as ⁇ - endotoxins, e.g.
  • Vip vegetative insecticidal proteins
  • Vip e.g. Vip1, Vip2, Vip3 or Vip3A
  • insecticidal proteins of bacteria colonising nematodes for example Photorhabdus spp.
  • Xenorhabdus spp. such as Photorhabdus luminescens, Xenorhabdus nematophilus
  • toxins produced by animals such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins
  • toxins produced by fungi such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins
  • agglutinins proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors
  • ribosome- inactivating proteins (RIP) such as ricin, maize-RIP, abrin, luffin, saporin or bryodin
  • steroid metabolism enzymes such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecd
  • ⁇ -endotoxins for example Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1, Vip2, Vip3 or Vip3A
  • Vip vegetative insecticidal proteins
  • Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701).
  • Truncated toxins for example a truncated Cry1Ab, are known.
  • modified toxins one or more amino acids of the naturally occurring toxin are replaced.
  • preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G- recognition sequence is inserted into a Cry3A toxin (see WO 03/018810).
  • Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0374753, WO93/07278, WO95/34656, EP-A-0427529, EP-A-451878 and WO 03/052073.
  • transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
  • CryI-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0367 474, EP-A-0401979 and WO 90/13651.
  • the toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects.
  • Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera).
  • Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard ⁇ (maize variety that expresses a Cry1Ab toxin); YieldGard Rootworm ⁇ (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus ⁇ (maize variety that expresses a Cry1Ab and a Cry3Bb1 toxin); Starlink ⁇ (maize variety that expresses a Cry9C toxin); Herculex I ⁇ (maize variety that expresses a Cry1Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B ⁇ (cotton variety that expresses a Cry1Ac toxin); Bollgard I
  • transgenic crops are: 1. Bt11 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1Ab toxin. Bt11 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 2. Bt176 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St.
  • This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence.
  • the preparation of such transgenic maize plants is described in WO 03/018810.
  • MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9.
  • MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects. 5.
  • NK603 ⁇ MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a Cry1Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.
  • the compounds of formula (I) (including any one of compounds 1.1 to 1.6) or fungicidal compositions according to the present invention comprising a compound of formula (I) may be used in controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi (such as Phakopsora pachyrhizi) on soy bean plants.
  • transgenic soybean plants expressing toxins for example insecticidal proteins such as delta-endotoxins, e.g. Cry1Ac (Cry1Ac Bt protein).
  • toxins for example insecticidal proteins such as delta-endotoxins, e.g. Cry1Ac (Cry1Ac Bt protein).
  • this may include transgenic soybean plants comprising event MON87701 (see U.S. Patent No. 8,049,071 and related applications and patents, as well as WO 2014/170327 A1 (eg, see paragraph [008] reference to Intacta RR2 PRO TM soybean)), event MON87751 (US. Patent Application Publication No. 2014/0373191) or event DAS- 81419 (U.S. Patent No.8632978 and related applications and patents).
  • event MON87701 see U.S. Patent No. 8,049,071 and related applications and patents, as well as WO 2014/170327 A1 (eg, see paragraph [008] reference
  • transgenic soybean plants may comprise event SYHT0H2 - HPPD tolerance (U.S. Patent Application Publication No. 2014/0201860 and related applications and patents), event MON89788 - glyphosate tolerance (U.S. Pat. No.7,632,985 and related applications and patents), event MON87708 - dicamba tolerance (U.S. Patent Application Publication No. US 2011/0067134 and related applications and patents), event DP-356043-5 - glyphosate and ALS tolerance (U.S. Patent Application Publication No. US 2010/0184079 and related applications and patents), event A2704-12 - glufosinate tolerance (U.S. Patent Application Publication No.
  • event DAS-40278-9 - tolerance to 2,4- dichlorophenoxyacetic acid and aryloxyphenoxypropionate see WO 2011/022469, WO 2011/022470, WO 2011/022471, and related applications and patents
  • event 127 - ALS tolerance WO 2010/080829 and related applications and patents
  • event GTS 40-3-2 - glyphosate tolerance event DAS-68416-4- 2,4-dichlorophenoxyacetic acid and glufosinate tolerance
  • event FG72 - glyphosate and isoxaflutole tolerance event BPS-CV127-9 - ALS tolerance and GU262 - glufosinate tolerance or event SYHT04R - HPPD tolerance.
  • the compounds of formula (I) may be used in controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi (such as Phakopsora pachyrhizi) on soy bean plants.
  • phytopathogenic diseases especially phytopathogenic fungi (such as Phakopsora pachyrhizi)
  • soy bean plants there are known in the scientific literature certain Elite soybean plant varieties where R-gene stacks, conferring a degree of immunity or resistance to specific Phakopsora pachyrhizi, have been been introgressed in the plant genome, see for example: “Fighting Asian Soybean Rust”, Langenbach C, et al, Front Plant Science 7(797) 2016).
  • An elite plant is any plant from an elite line, such that an elite plant is a representative plant from an elite variety.
  • elite soybean varieties that are commercially available to farmers or soybean breeders include: AG00802, A0868, AG0902, A1923, AG2403, A2824, A3704, A4324, A5404, AG5903, AG6202 AG0934; AG1435; AG2031; AG2035; AG2433; AG2733; AG2933; AG3334; AG3832; AG4135; AG4632; AG4934; AG5831; AG6534; and AG7231 (Asgrow Seeds, Des Moines, Iowa, USA); BPR0144RR, BPR 4077NRR and BPR 4390NRR (Bio Plant Research, Camp Point, Ill., USA); DKB17- 51 and DKB37-51 (DeKalb Genetics, DeKalb, Ill., USA); DP 4546 RR, and DP 7870 RR (Delta & Pine Land Company, Lubbock,
  • the compounds of formula (I) (including any one of compounds 1.1 to 1.6), or fungicidal compositions according to the present invention comprising a compound of formula (I), are used to control Phakopsora pachyrhizi, (including fungicidally-resistant strains thereof, as outlined herein) on Elite soybean plant varieties where R-gene stacks, conferring a degree of immunity or resistance to specific Phakopsora pachyrhizi, have been been introgressed in the plant genome. Numerous benefits may be expected to ensue from said use, e.g.
  • Fungicidal-resistant strains of Phakopsora pachyrhizi have been reported in the scientific literature, with strains resistant to one or more fungicides from at least each of the following fungicidal mode of action classes being observed: sterol demethylation-inhibitors (DMI), quinone-outside-inhibitors (QoI) and succinate dehydrogenase inhibitors (SDHI).
  • DMI sterol demethylation-inhibitors
  • QoI quinone-outside-inhibitors
  • SDHI succinate dehydrogenase inhibitors
  • the compounds of formula (I) (including any one of compounds 1.1 to 1.6), or fungicidal compositions according to the present invention comprising a compound of formula (I), are used to control Phakopsora pachyrhizi which are resistant to one or more fungicides from any of the following fungicidal MoA classes: sterol demethylation-inhibitors (DMI), quinone-outside-inhibitors (QoI) and succinate dehydrogenase inhibitors (SDHI).
  • locus as used herein means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil.
  • plants refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits.
  • plant propagation material is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes.
  • seeds in the strict sense
  • Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned.
  • plant propagation material is understood to denote seeds.
  • the compounds of formula (I) may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently Formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances.
  • compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.
  • Suitable carriers and adjuvants e.g. for agricultural use, can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers.
  • Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended.
  • Such formulations include anti-settling agents and dispersing agents and may further include a wetting agent to enhance activity as well an anti-foam and a crystal growth inhibitor.
  • these concentrates are diluted in water and normally applied as a spray to the area to be treated.
  • the amount of active ingredient may range from 0.5% to 95% of the concentrate.
  • Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers. The particles contain the active ingredient retained in a solid matrix.
  • Typical solid matrices include fuller’s earth, kaolin clays, silicas and other readily wet organic or inorganic solids.
  • Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent.
  • Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other non-volatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated.
  • the amount of active ingredient may range from 0.5% to 95% of the concentrate.
  • Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required.
  • Typical carriers for granular Formulations include sand, fuller’s earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound.
  • Granular Formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins.
  • Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers.
  • Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates. Encapsulated droplets are typically 1 to 50 microns in diameter.
  • the enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound.
  • Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores.
  • Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter.
  • Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring. Examples of such materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust and granular carbon.
  • Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene-butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates.
  • Other useful formulations for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents.
  • Pressurised sprayers wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used.
  • Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl formamide, dimethyl sulfoxide, 1,4
  • Water is generally the carrier of choice for the dilution of concentrates.
  • suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller’s earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin.
  • a broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application. These agents, when used, normally comprise from 0.1% to 15% by weight of the formulation.
  • Typical surface active agents include salts of alkyl sulfates, such as diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub.18 ethoxylate; alcohol-alkylene oxide addition products, such as tridecyl alcohol-C.sub.
  • soaps such as sodium stearate
  • alkylnaphthalenesulfonate salts such as sodium dibutylnaphthalenesulfonate
  • dialkyl esters of sulfosuccinate salts such as sodium di(2-ethylhexyl) sulfosuccinate
  • sorbitol esters such as sorbitol oleate
  • quaternary amines such as lauryl trimethylammonium chloride
  • polyethylene glycol esters of fatty acids such as polyethylene glycol stearate
  • block copolymers of ethylene oxide and propylene oxide and salts of mono and dialkyl phosphate esters.
  • compositions of the invention include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti- foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents.
  • biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention.
  • these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank.
  • These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides and/or plant growth regulators.
  • Pesticidal agents are referred to herein using their common name are known, for example, from "The Pesticide Manual", 15th Ed., British Crop Protection Council 2009.
  • the compositions of the invention may also be applied with one or more systemically acquired resistance inducers (“SAR” inducer). SAR inducers are known and described in, for example, United States Patent No.
  • the compounds of formula (I) are normally used in the form of agrochemical compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds.
  • further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants. They can also be selective herbicides or non-selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation.
  • the compounds of formula (I) may be used in the form of (fungicidal) compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of formula (I) or of at least one preferred individual compound as defined herein, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants.
  • the invention therefore provides a composition, preferably a fungicidal composition, comprising at least one compound formula (I) an agriculturally acceptable carrier and optionally an adjuvant.
  • An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use. Agricultural carriers are well known in the art.
  • composition may comprise at least one or more pesticidally-active compounds, for example an additional fungicidal active ingredient in addition to the compound of formula (I).
  • the compound of formula (I) may be the sole active ingredient of a composition or it may be admixed with one or more additional active ingredients such as a pesticide, fungicide, synergist, herbicide or plant growth regulator where appropriate.
  • An additional active ingredient may, in some cases, result in unexpected synergistic activities.
  • Suitable additional active ingredients include the following: acycloamino acid fungicides, aliphatic nitrogen fungicides, amide fungicides, anilide fungicides, antibiotic fungicides, aromatic fungicides, arsenical fungicides, aryl phenyl ketone fungicides, benzamide fungicides, benzanilide fungicides, benzimidazole fungicides, benzothiazole fungicides, botanical fungicides, bridged diphenyl fungicides, carbamate fungicides, carbanilate fungicides, conazole fungicides, copper fungicides, dicarboximide fungicides, dinitrophenol fungicides, dithiocarbamate fungicides, dithiolane fungicides, furamide fungicides, furanilide fungicides, hydrazide fungicides, imidazole fungicides, mercury fungicides, morpholine fung
  • suitable additional active ingredients also include the following: 3-difluoromethyl-1-methyl- 1H-pyrazole-4-carboxylic acid (9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)- amide , 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid methoxy-[1-methyl-2-(2,4,6- trichlorophenyl)-ethyl]-amide , 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid (2- dichloromethylene-3-ethyl-1-methyl-indan-4-yl)-amide (1072957-71-1), 1-methyl-3-difluoromethyl-1H- pyrazole-4-carboxylic acid (4'-methylsulfanyl-biphenyl-2-yl)-amide, 1-methyl-3-difluoromethyl-4H- pyrazole-4-
  • the compounds of the invention may also be used in combination with anthelmintic agents.
  • anthelmintic agents include, compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives as described in EP- 357460, EP-444964 and EP- 594291.
  • Additional anthelmintic agents include semisynthetic and biosynthetic avermectin/milbemycin derivatives such as those described in US-5015630, WO-9415944 and WO-9522552. Additional anthelmintic agents include the benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, parbendazole, and other members of the class. Additional anthelmintic agents include imidazothiazoles and tetrahydropyrimidines such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel.
  • Additional anthelmintic agents include flukicides, such as triclabendazole and clorsulon and the cestocides, such as praziquantel and epsiprantel.
  • flukicides such as triclabendazole and clorsulon
  • cestocides such as praziquantel and epsiprantel.
  • the compounds of the invention may be used in combination with derivatives and analogues of the paraherquamide/marcfortine class of anthelmintic agents, as well as the antiparasitic oxazolines such as those disclosed in US-5478855, US- 4639771 and DE-19520936.
  • the compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents as described in WO 96/15121 and also with anthelmintic active cyclic depsipeptides such as those described in WO 96/11945, WO 93/19053, WO 93/25543, EP 0626375, EP 0382173, WO 94/19334, EP 0382173, and EP 0503538.
  • the compounds of the invention may be used in combination with other ectoparasiticides; for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like; neonicotinoids such as imidacloprid and the like.
  • ectoparasiticides for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like; neonicotinoids such as imidacloprid and the like.
  • terpene alkaloids for example those described in International Patent Application Publication Numbers WO 95/19363 or WO 04/72086, particularly the compounds disclosed therein.
  • Organophosphates acephate, azamethiphos, azinphos-ethyl, azinphos- methyl, bromophos, bromophos-ethyl, cadusafos, chlorethoxyphos, chlorpyrifos, chlorfenvinphos, chlormephos, demeton, demeton-S-methyl, demeton-S-methyl sulphone, dialifos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosthiazate, hep
  • Carbamates alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801, isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m-cumenylbutyryl(methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717.
  • Pyrethroids acrinathin, allethrin, alphametrin, 5-benzyl-3-furylmethyl (E) -(1 R)-cis-2,2-dimethyl-3-(2- oxothiolan-3-ylidenemethyl)cyclopropanecarboxylate, bifenthrin, beta -cyfluthrin, cyfluthrin, a- cypermethrin, beta -cypermethrin, bioallethrin, bioallethrin((S)-cyclopentylisomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, cyhalothrin, cythithrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, ethofenprox, fenfluthrin, fenpropathrin,
  • Arthropod growth regulators a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron, buprofezin, diofenolan, hexythiazox, etoxazole, chlorfentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide; c) juvenoids: pyriproxyfen, methoprene (including S-methoprene), fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen.
  • antiparasitics acequinocyl, amitraz, AKD-1022, ANS-118, azadirachtin, Bacillus thuringiensis, bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG-505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloden, diafenthiuron, DBI-3204, dinactin, dihydroxymethyldihydroxypyrrolidine, dinobuton, dinocap, endosulfan, ethiprole, ethofenprox, fenazaquin, flumite, MTI- 800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, flufenzine, flufenprox, fluproxyfen, halofenprox, hydr
  • Biological agents Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, virus and fungi.
  • Bactericides chlortetracycline, oxytetracycline, streptomycin.
  • Such mixtures include (wherein “I” represents a compound of formula (I)): a compound selected from the group of substances consisting of petroleum oils + I, 1,1-bis(4-chloro-phenyl)-2-ethoxyethanol + I, 2,4-dichlorophenyl benzenesulfonate + I, 2-fluoro-N-methyl-N-1-naphthylacetamide + I, 4-chlorophenyl phenyl sulfone + I, acetoprole + I, aldoxycarb + I, amidithion + I, amidothioate + I, amiton + I, amiton hydrogen oxalate + I, amitraz + I, aramite + I, arsenous oxide + I, azobenzene + I, azothoate + I, benomyl + I, benoxa-fos + I, benzyl benzoate + I, bixafen + I, brofenval
  • the compounds in this paragraph may be prepared from the methods described in WO 2017/055473, WO 2017/055469, WO 2017/093348 and WO 2017/118689; 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4- triazol-1-yl)propan-2-ol + I (this compound may be prepared from the methods described in WO 2017/029179); 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol + I (this compound may be prepared from the methods described in WO 2017/029179); 3-[2-(1- chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile + I (this compound may be prepared from the methods described in WO 2016/156290); 3-[2-(
  • the designation is not a "common name”, the nature of the designation used instead is given in round brackets for the particular compound; in that case, the IUPAC name, the IUPAC/Chemical Abstracts name, a "chemical name”, a “traditional name”, a “compound name” or a “develoment code” is used or, if neither one of those designations nor a "common name” is used, an "alternative name” is employed.
  • “CAS Reg. No” means the Chemical Abstracts Registry Number.
  • the active ingredient mixture of the compounds of formula (I) and an active ingredient as described above are preferably in a mixing ratio of from 100:1 to 1:6000, especially from 50:1 to 1:50, more especially in a ratio of from 20:1 to 1:20, even more especially from 10:1 to 1:10, very especially from 5:1 and 1:5, special preference being given to a ratio of from 2:1 to 1:2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1:1, or 5:1, or 5:2, or 5:3, or 5:4, or 4:1, or 4:2, or 4:3, or 3:1, or 3:2, or 2:1, or 1:5, or 2:5, or 3:5, or 4:5, or 1:4, or 2:4, or 3:4, or 1:3, or 2:3, or 1:2, or 1:600, or 1:300, or 1:150, or 1:35, or 2:35, or 4:35, or 1:75, or 2:75, or 4:75, or 1:6000, or 1:3000, or 1:1500
  • the mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
  • the mixtures comprising a compound of formula (I) and one or more active ingredients as described above can be applied, for example, in a single “ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a “tank-mix”, and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days.
  • compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.
  • auxiliaries such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides
  • compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • Another aspect of the invention is related to the use of a compound of formula (I) or of a preferred individual compound as defined herein, of a composition comprising at least one compound of formula (I) or at least one preferred individual compound as above-defined, or of a fungicidal or insecticidal mixture comprising at least one compound of formula (I) or at least one preferred individual compound as above-defined, in admixture with other fungicides or insecticides as described above, for controlling or preventing infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms.
  • useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms.
  • a further aspect of the invention is related to a method of controlling or preventing an infestation of plants, e.g., useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g., harvested food crops, or of non-living materials by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials.
  • useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g., harvested food crops, or of non-living materials by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms
  • a compound of formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts
  • Controlling or preventing means reducing infestation by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated.
  • a preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, or insects which comprises the application of a compound of formula (I), or an agrochemical composition which contains at least one of said compounds, is foliar application. The frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen or insect.
  • the compounds of formula (I) can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field.
  • the compounds of formula I may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
  • a formulation e.g.
  • compositions containing the compound of formula (I), and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of formula (I), may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
  • extenders for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
  • Advantageous rates of application are normally from 5g to 2kg of active ingredient (a.i.) per hectare (ha), preferably from 10g to 1kg a.i./ha, most preferably from 20g to 600g a.i./ha.
  • convenient dosages are from 10mg to 1g of active substance per kg of seeds.
  • a composition comprising a compound of formula (I) according to the present invention is applied either preventative, meaning prior to disease development or curative, meaning after disease development.
  • compositions of the invention may be employed in any conventional form, for example in the form of a twin pack, a powder for dry seed treatment (DS), an emulsion for seed treatment (ES), a flowable concentrate for seed treatment (FS), a solution for seed treatment (LS), a water dispersible powder for seed treatment (WS), a capsule suspension for seed treatment (CF), a gel for seed treatment (GF), an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK
  • compositions may be produced in conventional manner, e.g. by mixing the active ingredients with appropriate formulation inerts (diluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects).
  • appropriate formulation inerts diiluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects.
  • conventional slow release formulations may be employed where long lasting efficacy is intended.
  • Particularly formulations to be applied in spraying forms such as water dispersible concentrates (e.g. EC, SC, DC, OD, SE, EW, EO and the like), wettable powders and granules, may contain surfactants such as wetting and dispersing agents and other compounds that provide adjuvancy effects, e.g.
  • a seed dressing formulation is applied in a manner known per se to the seeds employing the combination of the invention and a diluent in suitable seed dressing formulation form, e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds.
  • suitable seed dressing formulation form e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds.
  • seed dressing formulations are known in the art.
  • Seed dressing formulations may contain the single active ingredients or the combination of active ingredients in encapsulated form, e.g.
  • the formulations include from 0.01 to 90% by weight of active agent, from 0 to 20% agriculturally acceptable surfactant and 10 to 99.99% solid or liquid formulation inerts and adjuvant(s), the active agent consisting of at least the compound of formula (I) optionally together with other active agents, particularly microbiocides or conservatives or the like.
  • Concentrated forms of compositions generally contain in between about 2 and 80%, preferably between about 5 and 70% by weight of active agent.
  • Application forms of formulation may for example contain from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight of active agent. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ diluted formulations.
  • Tables 1.1 to 1.7 below illustrate the compounds of the invention.
  • the skilled person would understand that the compounds of formula (I) may exist as E and/or Z isomers as described herein before. Where mentioned the specific geometric configuration is not considered to be limiting.
  • Tables 1.2 to 1.7 discloses 61 individual compounds of the formula (I) in which A 1 , A 2 , X, Y, and R 1 are as specifically defined in Tables 1.2 to 1.7, which refer to Table 1 wherein R 2 is specifically defined.
  • Table 1
  • Table 1.2 This table discloses 61 specific compounds of the formula (I) wherein A 1 and A 2 are CH 2 , X is O, Y is CH, R 1 is methyl, and R 2 is as defined above in the Table 1.
  • Table 1.3 This table discloses 61 specific compounds of the formula (I) wherein A 1 and A 2 are CH 2 , X is O, Y is CH, R 1 is fluoro, and R 2 is as defined above in the Table 1.
  • Table 1.4 This table discloses 61 specific compounds of the formula (I) wherein A 1 is CH 2 , A 2 is CH 2 CH 2 , X is O, Y is CH, R 1 is hydrogen, and R 2 is as defined above in the Table 1.
  • Table 1.5 This table discloses 61 specific compounds of the formula (I) wherein A 1 and A 2 are CH 2 , X is O, Y is CH, R 1 is methoxy, and R 2 is as defined above in the Table 1.
  • Table 1.6 This table discloses 61 specific compounds of the formula (I) wherein A 1 and A 2 are CH 2 , X is O, Y is N, R 1 is hydrogen, and R 2 is as defined above in the Table 1.
  • Table 1.7 This table discloses 61 specific compounds of the formula (I) wherein A 1 and A 2 are CH 2 , X is NH, Y is N, R 1 is hydrogen, and R 2 is as defined above in the Table 1. EXAMPLES The Examples which follow serve to illustrate the invention.
  • the compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm, 0.8 ppm or 0.2 ppm.
  • Compounds of formula (I) may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against diseases that are caused by fungi or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile (including improved crop tolerance), improved physico- chemical properties, or increased biodegradability).
  • LC/MS Liquid Chromatography Mass Spectrometry and the description of the apparatus and the methods is as follows: Method A: Spectra were recorded on a Mass Spectrometer from Waters Corporation (SQD, SQDII or QDA Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive and negative ions), Capillary: 0.8-3.00 kV, Cone: 5-30 V, Source Temperature: 120-150°C, Desolvation Temperature: 350-600°C, Cone Gas Flow: 50-150 l/h, Desolvation Gas Flow: 650-1000 l/h, Mass range: 50 to 900 Da and an Acquity UPLC from Waters Corporation: Binary pump, heated column compartment , diode-array detector and ELSD.
  • enantiomerically pure final compounds may be obtained from racemic materials as appropriate via standard physical separation techniques, such as reverse phase chiral chromatography, or through stereoselective synthetic techniques, eg, by using chiral starting materials.
  • Formulation Examples Wettable powders a) b) c) Active ingredient [compound of Formula (I)] 25 % 50 % 75 % sodium lignosulfonate 5 % 5 % - sodium lauryl sulfate 3 % - 5 % sodium diisobutylnaphthalenesulfonate - 6 % 10 % phenol polyethylene glycol ether - 2 % - (7-8 mol of ethylene oxide) highly dispersed silicic acid 5 % 10 % 10 % Kaolin 62 % 27 % - The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.
  • Powders for dry seed treatment a) b) c) Active ingredient [compound of Formula (I)] 25 % 50 % 75 % light mineral oil 5 % 5 % 5 % highly dispersed silicic acid 5 % 5 % - Kaolin 65 % 40 % - Talcum - - 20 % The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
  • Emulsifiable concentrate active ingredient [compound of Formula (I)] 10 % octylphenol polyethylene glycol ether 3 % (4-5 mol of ethylene oxide) calcium dodecylbenzenesulfonate 3 % castor oil polyglycol ether (35 mol of ethylene oxide) 4 % Cyclohexanone 30 % xylene mixture 50 % Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.
  • Dusts a) b) c) Active ingredient [compound of Formula (I)] 5 % 6 % 4 % Talcum 95 % - - Kaolin - 94 % - mineral filler - - 96 % Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed. Extruder granules Active ingredient [compound of Formula (I)] 15 % sodium lignosulfonate 2 % Carboxymethylcellulose 1 % Kaolin 82 % The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.
  • Coated granules Active ingredient [compound of Formula (I)] 8 % polyethylene glycol (mol. wt.200) 3 % Kaolin 89 % The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.
  • Suspension concentrate Active ingredient [compound of Formula (I)] 40 % propylene glycol 10 % nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6 % Sodium lignosulfonate 10 % Carboxymethylcellulose 1 % Silicone oil (in the form of a 75 % emulsion in water) 1 % Water 32 %
  • the finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • Active ingredient [compound of Formula (I)] 40 % propylene glycol 5 % copolymer butanol PO/EO 2 % tristyrenephenole with 10-20 moles EO 2 % 1,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 % monoazo-pigment calcium salt 5 % Silicone oil (in the form of a 75 % emulsion in water) 0.2 % Water 45.3 % The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • Acetic acid (19.9 mL, 344 mmol, 2.00 equiv.) was then introduced dropwise at room temperature and the resulting suspension was stirred for 22 hours.
  • Triethyl amine (72.2 mL, 516 mmol, 3.00 equiv.) was then added dropwise while keeping the temperature constant with a water bath. The brown solution was stirred for 3 hours.
  • a mixture of saturated aqueous Na2S2O3 and saturated aqueous NaHCO 3 was then added, the layers were separated, and the aqueous layer was extracted with dichloromethane.
  • Step 2 Preparation of 8-bromo-N-ethoxy-tetralin-2-imine To a mixture of 8-bromotetralin-2-one (3.00 g, 13.3 mmol, 1.00 equiv.) in ethanol (20 mL) was added O- ethylhydroxylamine hydrochloride (4.02 g, 40.0 mmol, 3.00 equiv.) followed by sodium acetate (3.31 g, 40.0 mmol, 3.00 equiv.). The resulting reaction mixture was stirred at room temperature for 18 hours, then diluted with EtOAc and water, and extracted with EtOAc.
  • Step 3 Preparation of methyl N-ethoxy-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) tetralin-2-imine
  • 8-bromo-N-ethoxy-tetralin-2-imine (0.75 g, 2.80 mmol, 1.00 equiv.) in dioxane (5.60 mL) was added potassium acetate (0.55 g, 5.60 mmol, 2.00 equiv.) and bis(pinacolato)diboron (1.43 g, 5.60 mmol, 2.00 equiv.).
  • Step 4 Preparation of methyl (E)-2-(3-ethoxyiminotetralin-5-yl)-3-methoxy-prop-2-enoate
  • N-ethoxy-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)tetralin-2-imine 400 mg, 1.27 mmol, 1.00 equiv.
  • dioxane 12.7 mL
  • water 0.63 mL
  • methyl (Z)-2-iodo-3-methoxy- prop-2-enoate 460 mg, 1.90 mmol, 1.50 equiv.
  • cesium carbonate (831 mg, 2.54 mmol, 2.00 equiv.) followed by addition of cataCXium-A-Pd-G3 (195 mg, 0.25 mmol, 0.20 equiv.).
  • Step 2 Preparation of methyl (E)-3-methoxy-2-(3-oxotetralin-5-yl)prop-2-enoate
  • 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)tetralin-2-one (1.00 g, 3.67 mmol, 1.00 equiv.) in dioxane (36.7 mL) and water (1.84 mL) was added methyl (Z)-2-iodo-3-methoxy-prop-2- enoate (1.33 g, 5.51 mmol, 1.50 equiv.), cesium carbonate (2.41 g, 7.35 mmol, 2.00 equiv.), followed by cataCXium-A-Pd-G3 (563 mg, 0.73 mmol, 0.20 equiv.).
  • Step 3 Preparation of methyl (E)-3-methoxy-2-(3-prop-2-ynoxyiminotetralin-5-yl)prop-2-enoate
  • methanol 4.00 mL
  • O-prop-2-ynylhydroxylamine hydrochloride 100 mg, 0.92 mmol, 3.00 equiv.
  • sodium acetate 7.6.4 mg, 0.92 mmol, 3.00 equiv.
  • Example B Biological examples/test methods: Glomerella lagenarium syn. Colletotrichum lagenarium (anthracnose of cucurbits): Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 °C and the inhibition of growth was determined photometrically after 72 hrs at 620nm.
  • the test plates were incubated at 24°C and the inhibition of growth was determined photometrically after approximately 5-6 days at 620nm.
  • the following compounds gave at least 80% control of Mycosphaerella arachidis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.2, 1.3, 1.4 Phakopsora pachyrhizi (Soybean rust): Soybean leaf disks are placed on agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf disks are inoculated with a spore suspension of the fungus.

Abstract

Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.

Description

Microbiocidal Compounds The present invention relates to microbiocidal oxime derivatives, e.g., as active ingredients, which have microbiocidal activity, in particular, fungicidal activity. The invention also relates to agrochemical compositions which comprise at least one of the oxime derivatives, to processes of preparation of these compounds and to uses of the oxime derivatives or compositions in agriculture or horticulture for controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, preferably fungi. According to the present invention, there is provided a compound of formula (I):
Figure imgf000002_0001
wherein Y is CH or N; X is O or NH; R1 is selected from the group consisting of hydrogen, halogen, C1-C4alkyl and C1-C4alkoxy; R2 is selected from the group consisting of hydrogen, C1-C8alkyl, C3-C6alkenyl, C3-C6alkynyl, cyanoC1- C6alkyl-, C1-C6haloalkyl, C3-C6haloalkenyl, hydroxyC2-C6alkyl-, C1-C4alkoxyC2-C6alkyl-, C1- C4haloalkoxyC2-C6alkyl-, C1-C4alkoxyC2-C4alkoxyC2-C6alkyl-, C2-C6alkenyloxyC2-C6alkyl-, C2- C6alkynyloxyC2-C6alkyl-, aminoC2-C6alkyl-, N-C1-C4alkylaminoC2-C6alkyl-, N,N-diC1-C4alkylamino C2- C6alkyl-, C1-C6alkylcarbonylC1-C6alkyl-, C1-C6alkoxycarbonylC1-C6alkyl-, C1-C6alkylcarbonyloxyC2- C6alkyl-, N-C1-C4alkylaminocarbonylC1-C6alkyl-, N,N-diC1-C4alkylaminocarbonylC1-C6alkyl-, C1- C6alkylsulfanylC1-C6alkyl-, C1-C6alkylsulfinylC1-C6alkyl-, C1-C6alkylsulfonylC1-C6alkyl-, C1- C4alkoxyiminoC2-C4alkyl-, C3-C6cycloalkyl, C3-C6cycloalkylC1-C3alkyl-, phenyl, heterocyclyl, heteroaryl, phenylC1-C3alkyl-, heterocyclylC1-C3alkyl- and heteroarylC1-C3alkyl-, wherein said C3-C6cycloalkyl, C3- C6cycloalkylC1-C3alkyl-, phenyl, heterocyclyl, heteroaryl, phenylC1-C3alkyl-, heterocyclylC1-C3alkyl- or heteroarylC1-C3alkyl- are optionally substituted where feasible by 1 or 2 R3 substituents, which may be the same or different, and wherein said heterocyclyl is a 3- to 6- membered non-aromatic ring which comprises 1 or 2 heteroatoms individually selected from nitrogen, oxygen and sulfur, and said heteroaryl is a 5-or 6-membered monocyclic aromatic ring which comprises 1, 2, 3 or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur; R3 is selected from the group consisting of methyl, ethyl, propyl, iso-propyl, chloro, fluoro, cyano, difluoromethyl, trifluoromethyl, oxo, hydroxy, methoxy, ethoxy, difluoromethoxy, and cyclopropyl; A1 is CH2 or O; A2 is a direct bond, CH2, or CH2CH2; or an agronomically acceptable salt thereof; or an N-oxide thereof. It has been found that the novel compounds of formula (I) have, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi. According to a second aspect of the invention, there is provided an agrochemical composition comprising a fungicidally effective amount of a compound of formula (I) and an agrochemically- acceptable diluent or carrier. Such an agricultural composition may further comprise at least one additional active ingredient. According to a third aspect of the invention, there is provided a method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a fungicidally effective amount of a compound of formula (I), or a composition comprising this compound as active ingredient, is applied to the plants, to parts thereof or the locus thereof. According to a fourth aspect of the invention, there is provided the use of a compound of formula (I) as a fungicide. According to this particular aspect of the invention, the use may exclude methods for the treatment of the human or animal body by surgery or therapy. As used herein, the term "halogen" or “halo” refers to fluorine (fluoro), chlorine (chloro), bromine (bromo) or iodine (iodo), preferably fluorine, chlorine or bromine. As used herein, cyano means a -CN group. As used herein, the term “hydroxyl” or “hydroxy” means an -OH group. As used herein, amino means an -NH2 group. As used herein, oxo means an =O group (eg, as in a carbonyl (C=O) group). As used herein, the term "C1-C8alkyl" refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing no unsaturation, having from one to eight carbon atoms, and which is attached to the rest of the molecule by a single bond. C1-C4alkyl is to be construed accordingly. Examples of C1-C8alkyl include, but are not limited to, methyl, ethyl, n-propyl, 1- methylethyl (iso-propyl), n-butyl, and 1-dimethylethyl (t-butyl). As used herein, the term “cyanoC1-C6alkyl-” refers to a C1-C6alkyl radical as generally defined above substituted by one or more cyano groups. As used herein, the term “hydroxyC2-C6alkyl-” refers to a C2-C6alkyl radical as generally defined above substituted by one or more hydroxy groups. As used herein, the term "C1-C4alkoxy" refers to a radical of the formula -ORa where Ra is a C1-C4alkyl radical as generally defined above. Examples of C1-C4alkoxy include, but are not limited to, methoxy, ethoxy, propoxy, iso-propoxy and t-butoxy. As used herein, the term " C1-C4alkoxyC2-C6alkyl-" refers to radical of the formula Ra-O-Rb- where Ra is a C1-C4alkyl radical as generally defined above, and Rb is a C2-C6alkylene radical as generally defined above. As used herein, the term "C1-C6haloalkyl" refers to a C1-C6alkyl radical, as generally defined above, substituted by one or more of the same or different halogen atoms. Examples of C1-C6haloalkyl include, but are not limited to chloromethyl, fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl and 2,2,2- trifluoroethyl. As used herein, the term "C1-C4haloalkoxy" refers to a C1-C4alkoxy group, as defined above, substituted by one or more of the same or different halogen atoms. Examples of C1-C4haloalkoxy include, but are not limited to, fluoromethoxy, difluoromethoxy, fluoroethoxy, trifluoromethoxy and trifluoroethoxy. As used herein, the term " C1-C4haloalkoxyC2-C6alkyl-" refers to radical of the formula Ra-O-Rb- where Ra is a C1-C4haloalkyl radical as generally defined above, and Rb is a C2-C6alkylene radical as generally defined above. As used herein, the term "C3-C6alkenyl" refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing at least one double bond that can be of either the (E)- or (Z)-configuration, having from three to six carbon atoms, which is attached to the rest of the molecule by a single bond. Examples of C3-C6alkenyl include, but are not limited to, prop-1-enyl, allyl (prop-2-enyl) and but-1-enyl. As used herein, the term "C3-C6alkynyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from three to six carbon atoms, and which is attached to the rest of the molecule by a single bond. Examples of C3-C6alkynyl include, but are not limited to, prop-1-ynyl and propargyl (prop-2-ynyl). As used herein, the term "C1-C6alkylcarbonyl" refers to a radical of the formula -C(O)Ra where Ra is a C1-C6alkyl radical as generally defined above. C1-C3alkylcarbonyl is to be construed accordingly. As used herein, the term " C1-C6alkylcarbonylC1-C6alkyl-" refers to radical of the formula Ra-C(O)-Rb- where Ra is a C1-C6alkyl radical as generally defined above, and Rb is a C1-C6alkylene radical as generally defined above. As used herein, the term "C1-C4alkoxyC2-C4alkoxy-" refers to radical of the formula Ra-O-Rb-O- where Ra is a C1-C4alkyl radical as generally defined above, and Rb is a C2-C4alkyl radical as generally defined above. As used herein, the term “aminoC2-C6alkyl-” refers to a C2-C6alkyl radical as generally defined above substituted by one or more amino groups. As used herein, the term “N-C1-C4alkylamino” refers to a radical of the formula RaNH- wherein Ra is a C1-C4alkyl radical as generally defined above. As used herein, the term “N,N-diC1-C4alkylamino” refers to a radical of the formula Ra(Rb)N- wherein Ra and Rb are the same or different C1-C4alkyl radicals as generally defined above. As used herein, the term "C1-C6alkylcarbonyloxy" refers to a radical of the formula - OC(O)Ra wherein Ra is a C1-C6alkyl radical as generally defined above. As used herin, the term " C1-C6alkylcarbonyloxyC2-C6alkyl-" refers to a radical of the formula Ra-C(O)O- Rb- where Ra is a C1-C6alkyl radical as generally defined above, and Rb is a C2-C6alkylene radical as generally defined above. As used herein, the term "C1-C6alkoxycarbonylC1-C6alkyl- " refers to a radical of the formula Rb-OC(O)- Ra- where Ra is a C1-C6alkyl radical as generally defined above, and Rb is a C1-C6alkyl radical as generally defined above. As used herein, the term “C1-C6alkylsulfanyl” refers to a radical of the formula -SRa wherein Ra is a C1- C6alkyl radical as generally defined above. As used herein, the term “C1-C6alkylsulfinyl” refers to a radical of the formula -S(O)Ra wherein Ra is a C1-C6alkyl radical as generally defined above. As used herein, the term “C1-C6alkylsulfonyl” refers to a radical of the formula -S(O)2Ra wherein Ra is a C1-C6alkyl radical as generally defined above. As used herein, the term “C1-C4alkoxyimino” refers to a radical of the formula (=NORa) where Ra is a C1- C4alkyl radical as generally defined above. As used herein, the term " C1-C4alkoxyiminoC2-C4alkyl-" refers to a C1-C4alkoxyimino radical as defined above attached to the rest of the molecule by a C2-C4alkylene radical as generally defined above. As used herein, unless explicitly stated otherwise, the term "C3-C6cycloalkyl" refers to a stable, monocyclic ring radical which is saturated or partially unsaturated and contains 3 to 6 carbon atoms. C3- C4cycloalkyl is to be construed accordingly. Examples of C3-C6cycloalkyl include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. As used herein, the term "C3-C6cycloalkylC1-C3alkyl-" refers to a C3-C6cycloalkyl ring as defined above attached to the rest of the molecule by a C1-C3alkylene radical as defined above. The term "C3- C4cycloalkylC1-C2alkyl-" is to be construed accordingly. Examples of C3-C6cycloalkylC1-C3alkyl- include, but are not limited to cyclopropylmethyl- and cyclobutylethyl-. As used herein, the term “phenylC1-C3alkyl-” refers to a phenyl ring attached to the rest of the molecule by a C1-C3alkylene radical as generally defined above. As used herein, unless explicitly stated otherwise, the term "heterocyclyl" or "heterocyclic" refers to a stable 3- to 6-membered non-aromatic monocyclic ring radical which comprises 1, 2, or 3 heteroatoms individually selected from nitrogen, oxygen and sulfur. The heterocyclyl radical may be bonded to the rest of the molecule via a carbon atom or heteroatom. Examples of heterocyclyl include, but are not limited to, pyrrolinyl, pyrrolidyl, tetrahydrofuryl, tetrahydrothienyl, tetrahydrothiopyranyl, piperidyl, piperazinyl, tetrahydropyranyl, dihydroisoxazolyl, dioxolanyl, morpholinyl or δ-lactamyl. As used herein, the term "heterocyclylC1-C3alkyl-" refers to a heterocyclyl ring as defined above attached to the rest of the molecule by a C1-C3alkylene radical as generally defined above. As used herein, unless explicitly stated otherwise, the term "heteroaryl" refers to a 5- or 6-membered monocyclic aromatic ring which comprises 1, 2, 3 or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur. The heteroaryl radical may be bonded to the rest of the molecule via a carbon atom or heteroatom. Examples of heteroaryl include, furyl, pyrrolyl, imidazolyl, thienyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, tetrazolyl, pyrazinyl, pyridazinyl, pyrimidyl or pyridyl. As used herein, the term "heteroarylC1-C3alkyl-" refers to a heteroaryl ring as defined above attached to the rest of the molecule by a C1-C3alkylene radical as generally defined above. The compound of formula (I) may exist as E and/or Z isomers. This invention covers all such isomers and mixtures thereof in all proportions. For example a compound of formula (I) can be drawn in at least 4 different isomeric forms as shown below. Moreover, the individual isomers, or intermediates depicted below or in reaction schemes 1 to 21 may interconvert in solid state, in solution, or under exposure to light.
Figure imgf000007_0001
The presence of one or more possible asymmetric carbon atoms in a compound of formula (I) means that the compounds may occur in chiral isomeric forms, i.e., enantiomeric or diastereomeric forms. Also atropisomers may occur as a result of restricted rotation about a single bond. Formula (I) is intended to include all those possible isomeric forms and mixtures thereof. The present invention includes all those possible isomeric forms and mixtures thereof for a compound of formula (I). Likewise, formula (I) is intended to include all possible tautomers (including lactam-lactim tautomerism and keto-enol tautomerism) where present. The present invention includes all possible tautomeric forms for a compound of formula (I). In each case, the compounds of formula (I) according to the invention are in free form, in covalently hydrated form, or in salt form, e.g., an agronomically usable or agrochemically acceptable salt form. N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book “Heterocyclic N-oxides” by A. Albini and S. Pietra, CRC Press, Boca Raton 1991. The following list provides definitions, including preferred definitions, for substituents Y, X, R1, R2, R3, A1 and A2 with reference to the compounds of formula (I) according to the invention. For any one of these substituents, any of the definitions given below may be combined with any definition of any other substituent given below or elsewhere in this document. Y is CH or N. Preferably, Y is CH. X is O or NH. Preferably, X is O. R1 is selected from the group consisting of hydrogen, halogen, C1-C4alkyl and C1-C4alkoxy. Preferably, R1 is selected from the group consisting of hydrogen, halogen and C1-C4alkyl. More preferably, R1 is selected from the group consisting of hydrogen, chloro, fluoro and C1-C4alkyl. Even more preferably, R1 is selected from the group consisting of hydrogen, fluoro and methyl. Even more preferably still, R1 is hydrogen or methyl. Most preferably, R1 is hydrogen. R2 is selected from the group consisting of hydrogen, C1-C8alkyl, C3-C6alkenyl, C3-C6alkynyl, cyanoC1- C6alkyl-, C1-C6haloalkyl, C3-C6haloalkenyl, hydroxyC2-C6alkyl-, C1-C4alkoxyC2-C6alkyl-, C1- C4haloalkoxyC2-C6alkyl-, C1-C4alkoxyC2-C4alkoxyC2-C6alkyl-, C2-C6alkenyloxyC2-C6alkyl-, C2- C6alkynyloxyC2-C6alkyl-, aminoC2-C6alkyl-, N-C1-C4alkylaminoC2-C6alkyl-, N,N-diC1-C4alkylaminoC2- C6alkyl-, C1-C6alkylcarbonylC1-C6alkyl-, C1-C6alkoxycarbonylC1-C6alkyl-, C1-C6alkylcarbonyloxyC2- C6alkyl-, N-C1-C4alkylaminocarbonylC1-C6alkyl-, N,N-diC1-C4alkylaminocarbonylC1-C6alkyl-, C1- C6alkylsulfanylC1-C6alkyl-, C1-C6alkylsulfinylC1-C6alkyl-, C1-C6alkylsulfonylC1-C6alkyl-, C1- C4alkoxyiminoC2-C4alkyl-, C3-C6cycloalkyl, C3-C6cycloalkylC1-C3alkyl-, phenyl, heterocyclyl, heteroaryl, phenylC1-C3alkyl-, heterocyclylC1-C3alkyl- and heteroarylC1-C3alkyl-, wherein said C3-C6cycloalkyl, C3- C6cycloalkylC1-C3alkyl-, phenyl, heterocyclyl, heteroaryl, phenylC1-C3alkyl-, heterocyclylC1-C3alkyl- or heteroarylC1-C3alkyl- are optionally substituted where feasible by 1 or 2 R3 substituents, which may be the same or different, and wherein said heterocyclyl is a 3- to 6- membered non-aromatic ring which comprises 1 or 2 heteroatoms individually selected from nitrogen, oxygen and sulfur, and said heteroaryl is a 5-or 6-membered monocyclic aromatic ring which comprises 1, 2, 3 or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur. Preferably, R2 is selected from the group consisting of C1-C8alkyl, C3-C6alkenyl, C3-C6alkynyl, cyanoC1- C6alkyl-, C1-C6haloalkyl, hydroxyC2-C6alkyl-, C1-C4alkoxyC2-C6alkyl-, C1-C4haloalkoxyC2-C6alkyl-, C1- C6alkylcarbonyloxyC2-C6alkyl-, C1-C4alkoxyiminoC2-C4alkyl-, C3-C6cycloalkyl and C3-C6cycloalkylC1- C3alkyl-, wherein said C3-C6cycloalkyl or C3-C6cycloalkylC1-C3alkyl- are optionally substituted where feasible by 1 or 2 R3 substituents, which may be the same or different. More preferably, R2 is selected from the group consisting of C1-C8alkyl and C3-C6alkynyl. Even more preferably, R2 is selected from the group consisting of C1-C4alkyl and C3-C6alkynyl. Even more preferably still, R2 is selected from the group consisting of methyl, ethyl and propargyl. R3 is selected from the group consisting of methyl, ethyl, propyl, iso-propyl, chloro, fluoro, cyano, difluoromethyl, trifluoromethyl, oxo, hydroxy, methoxy, ethoxy, difluoromethoxy, and cyclopropyl. Preferably, R3 is selected from the group consisting of methyl, ethyl, propyl, iso-propyl, chloro, fluoro, difluoromethyl, trifluoromethyl and cyclopropyl. More preferably, R3 is selected from the group consisting of methyl, chloro, fluoro and trifluoromethyl. Even more preferably, R3 is chloro or fluoro. A1 is CH2 or O. Preferably, A1 is CH2. A2 is a direct bond, CH2, or CH2CH2. Preferably, A2 is CH2 or CH2CH2. Most preferably A2 is CH2. Preferably, A1 and A2 are CH2. Preferably, in a compound according to formula (I) of the invention; Y is CH; X is O; R1 is selected from the group consisting of hydrogen, fluoro and methyl; R2 is selected from the group consisting of C1-C8alkyl, C3-C6alkenyl, C3-C6alkynyl, cyanoC1-C6alkyl-, C1- C6haloalkyl, hydroxyC2-C6alkyl-, C1-C4alkoxyC2-C6alkyl-, C1-C4haloalkoxyC2-C6alkyl-, C1- C6alkylcarbonyloxyC2-C6alkyl-, C1-C4alkoxyiminoC2-C4alkyl-, C3-C6cycloalkyl and C3-C6cycloalkylC1- C3alkyl-, wherein said C3-C6cycloalkyl or C3-C6cycloalkylC1-C3alkyl- are optionally substituted where feasible by 1 or 2 R3 substituents, which may be the same or different; R3 is selected from the group consisting of methyl, chloro, fluoro and trifluoromethyl; A1 is CH2; and A2 is CH2. More preferably, in a compound according to formula (I) of the invention; Y is CH; X is O; R1 is hydrogen; R2 is selected from the group consisting of C1-C8alkyl and C3-C6alkynyl; A1 is CH2; and A2 is CH2. Even more preferably, in a compound according to formula (I) of the invention; Y is CH; X is O; R1 is hydrogen; R2 is selected from the group consisting of C1-C4alkyl and C3-C6alkynyl (preferably, methyl, ethyl and propargyl); A1 is CH2; and A2 is CH2. In an even more preferred embodiment, the compound according to formula (I) is selected from the group consisting of compounds 1.1 to 1.6 listed in table T1 below. According to the invention there is also provided an intermediate of formula (IIa), wherein, Y is CH;
Figure imgf000010_0001
X is O; R1 is selected from the group consisting of hydrogen, halogen and C1-C4alkyl (preferably, hydrogen, fluoro and methyl, more preferably hydrogen); A1 is CH2; and A2 is CH2; According to the invention there is also provided the use of a compound of formula (IIa) as defined herein, in a process for the manufacture of a compound of formula (I) as defined herein. In one embodiment, the compounds of formula (I) according to the invention (including any one of compounds 1.1 to 1.6) may be useful for combating phytopathogenic fungi (e.g Alternaria alternata, Phakopsora pachyrhizi, Plasmopara viticola, Sclerotinia sclerotiorum or Septoria tritici also known as Mycosphaerella graminicola) containing a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone). In a further embodiment, the compounds of formula (I) according to the invention (including any one of compounds 1.1 to 1.6) may be useful for combating phytopathogenic fungi (e.g Alternaria alternata, Plasmopara viticola, Sclerotinia sclerotiorum or Septoria tritici also known as Mycosphaerella graminicola) containing a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone), wherein the mutation is G143A. In a further embodiment, the compounds of formula (I) according to the invention (including any one of compounds 1.1 to 1.6) may be useful for combating phytopathogenic fungi (e.g Phakopsora pachyrhizi) containing a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone), wherein the mutation is F129L. In another embodiment, the compounds of formula (I) according to the invention (including any one of compounds 1.1 to 1.6) may be useful for combating phytopathogenic fungi (e.g Phakopsora pachyrhizi) containing a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobilurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone), wherein the mutation is Y132C. In another embodiment, the invention also relates to a method of controlling or preventing infestation by phytopathogenic fungi in a plant (e.g Alternaria alternate, Phakopsora pachyrhizi Plasmopara viticola, Sclerotinia sclerotiorum or Septoria tritici also known as Mycosphaerella graminicola, preferably Phakopsora pachyrhizi), wherein said phytopathogenic fungi contains a mutation in the mitochondrial cytochrome b conferring resistance to Qo inhibitors (e.g strobliurins such as azoxystrobin, pyraclostrobin and trifloxystrobin or fenamidone or famoxadone), said method comprising applying to the plant, to parts thereof or the locus thereof, a fungicidally effective amount of a compound of formula (I) (including any one of compounds 1.1 to 1.6). The level of resistance and therefore the impact on the performance of the fungicide can be measured by the use of a 'Resistance Factor' (RF). The resistance factor can be calculated by dividing the concentration of a fungicide that provides a set level of disease control (i.e.50 percent) for the 'resistant' fungal strain with the concentration of the same fungicide that provides the same level of disease control for the 'susceptible' strain of the same fungal species (RF = EC50 value of the resistant strain/EC50 value of the sensitive strain). Although there are no set rules, three categories can be defined: 1) RF ≥ 50 = resistant strain, 2) 5 ≤ RF < 50 = less sensitive strain (shift in sensitivity), and 3) RF < 5 = sensitive strain. In order to obtain resistant fungal strains, a researcher is to locate a host crop and geographical region where the relevant resistance had been reported in literature. Leaf samples infected by the target disease are then collected from the locations/host crops and sent to a laboratory, where pure cultures would be isolated. The resistant phenotype of the fungal cultures is determined either by conducting a full dose response bioassay and comparing the bioassay results to similar bioassay results for a known susceptible strain of the same species. Alternatively the resistance genotype of the fungal strain can be determined by molecular techniques (e.g. qPCR) if the resistance mechanism for the relevant species is known. The compounds of formula (I) according to the invention can be made as shown in the following schemes 1 to 21, wherein Y, X, R1, R2, R3, A1 and A2 are as defined for a compound of formula (I), unless otherwise stated. Compounds of formula (I), can be prepared from compounds of formula (II) by treatment with hydroxylamines of formula (III), or an appropriate salt thereof, optionally in the presence of a base such as sodium acetate or an acid such as acetic acid and in solvents such as ethanol, methanol or water at temperatures between 20°C and 100°C. This is shown in scheme 1 and related examples of such transformations are described in Organic Letters, 2011, 13, 540-542, or Organic Letters, 2013, 14, 272-
Figure imgf000012_0001
Alternatively compounds of formula (I), can be prepared from compounds of formula (I-I) by treatment with an alkylating agent such of formula (IV) wherein R2 is as described for formula (I) and R3a is an appropriate leaving group (e.g. Cl, Br, I, OTs), optionally in the presence of a base such as sodium hydride, potassium tertbutoxide or potassium carbonate, in a solvent such as dimethylformamide or tetrahydrofuran, at temperatures between 0°C and 100°C. This is shown in scheme 2 and related examples of such transformations are described in Bioorganic and Medicinal Chemistry Letters, 2010, 18, 8642-8659.
Figure imgf000012_0002
Compounds of formula (II) can be prepared from compounds of formula (V), wherein M is a metalloid species (e.g. MgCl, ZnCl, B(OH)2 or BPin), by reaction with a compound of formula (VI), where R4 is a halogen or pseudohalogen (e.g. Br, I, OTf), in the presence of a suitable catalyst such as palladium diacetate and optionally a supporting ligand (e.g. CatCXiumA®) and base (e.g. potassium phosphate) in a suitable solvent such as 1,4-dioxane, dimethylformamide or toluene at temperatures between 20°C and 100°C. This is shown in scheme 3 and related examples of such transformations are described in Tetrahedron, 2011, 67, 624-635 and Advanced Synthesis and Catalysis, 2017, 359, 3865-3879.
Figure imgf000013_0001
Compounds of formula (V) can be prepared from compounds of formula (VII) wherein R5 is a halogen or pseudohalogen (e.g. Br, I, OTf) by treatment with a suitable metallating agent (e.g. bis- pinacolatodiboron, (Bpin)2)) optionally in the presence of a suitable catalyst (e.g. Pd(dppf)Cl2) and base (e.g. potassium phosphate) in solvents such as 1,4-dioxane, dimethylformamide or toluene at temperatures between 20°C and 100°C. This is shown in scheme 4 and related examples are given in Journal of Medicinal Chemistry, 2018, 61, 5623-5642 or Journal of Medicinal Chemistry, 2013, 56, 5514- 5540.
Figure imgf000013_0002
Compounds of formula (VII) are either commercially available or compounds of formula (VII) wherein A1 and A2 are CH2 can be prepared from compounds of formula (VIII) using an activating agent, such as SOCl2, in a suitable solvent such as DMF or DCM, followed by introduction of a Lewis acid, such aluminium trichloride, under an atmosphere of ethylene at pressures between 0 and 20 bar and temperatures between 20°C and 120°C. Compounds of formula (VIII) are commercial or can be prepared by known methods. This is shown in scheme 5 and related examples are described in J. Med. Chem.1993, 36, 2485-2493.
Figure imgf000014_0001
Compounds of formula (I) wherein Y = N can be prepared from compounds of formula (IX) by condensation with N-methyl hydroxylamine or a salt thereof, optionally in the presence of a base such as sodium acetate or an acid such as acetic acid and in solvents such as ethanol, methanol or water at temperatures between 20°C and 100°C. Alternatively, compounds of formula (I) can be obtained by condensation with hydroxylamine or a salt thereof, optionally in the presence of a base such as sodium acetate or an acid such as acetic acid and in solvents such as ethanol or methanol at temperatures between 20°C and 100°C followed by methylation with a reagent such dimethyl sulfate or methyl iodide in the presence of a base, such as potassium tertbutoxide, in a suitable solvent such as THF. This is shown in scheme 6 and related examples are described in WO2001012585, US5856573, Organic & Biomolecular Chemistry, 2011, 9, 6895-6898 and Journal of Medicinal Chemistry, 2000, 43, 560-568.
Figure imgf000014_0002
Compounds of formula (IX) can be prepared from compounds of formula (X), where R5 is Br or I, preferably I, by treatment with methylamine in the presence of a suitable catalyst such as PEPPSI™-IPr and a base such as potassium carbonate, in an appropriate solvent (e.g. 1,4-dioxane or dimethylformamide) under an atmosphere of carbon monoxide at pressures between 0 and 20 bar and temperatures between 20°C and 120°C. Such transformations are shown in scheme 7 and related examples are described in RSC Advances, 2014, 4, 48177-48190 and Organic Letters, 2009, 11, 1321- 1324. Alternatively, compounds of formula (IX), wherein X = O, can be prepared from compounds of formula (X), wherein R5 is Cl, Br or I, via metal-halogen exchange with a suitable organometallic species (e.g. iPrMgCl.LiCl, n-BuLi, or t-BuLi), in a suitable solvent (e.g. tetrahydrofuran or diethyl ether), and at a temperature between -78°C and 25°C followed by the addition of dimethyl oxalate, optionally in one pot fashion. Furthermore, compounds of formula (IX) wherein X is NH can be prepared from compounds of formula (IX), wherein X is O, via selective amidation using methylamine, or a suitable salt thereof, optionally in the presence of an activating agent, such as diethylaluminum chloride, in a suitable solvent such as tolune. For related examples, see: Chem., Int. Ed., 2017, 56, 12770; ‘The Preparation of Organolithium Reagents and Intermediates’ Leroux, F., et al Wiley, New York. 2004. Such transformations are shown in scheme 7.
Figure imgf000015_0001
Compounds of formula (X) wherein R5 = halogen can be prepared from compounds of formula (VII) by treatment with hydroxylamines of formula (III) or an appropriate salt thereof, optionally in the presence of a base such as sodium acetate or an acid such as acetic acid in solvents such as ethanol, methanol or water at temperatures between 20°C and 100°C. This is shown in scheme 8 and related examples of such transformations are described in Organic Letters, 2011, 13, 540-542 or Organic Letters, 2013, 14, 272-275.
Figure imgf000015_0002
Alternatively compounds of formula (I) can be prepared from compounds of formula (XI), wherein M is a metalloid species (e.g. ZnCl, MgCl, Li), by reaction with a species of formula (VI), where R4 is a halogen or pseudohalogen (e.g. Br, I, OTf), in the presence of a suitable catalyst such as palladium acetate and optionally a supporting ligand (e.g. CatCXiumA®) and base (e.g. potassium phosphate) in a suitable solvent such as 1,4-dioxane, DMF, or toluene at temperatures between 20°C - 150°C. This is shown in scheme 9 and related examples of such transformations are described in Tetrahedron, 2011, 67, 624- 635 and Advanced Synthesis and Catalysis, 2017, 359, 3865-3879.
Figure imgf000016_0001
Compounds of formula (XI) wherein M is a metalloid species (e.g. B(OH)2, BPin), can be prepared from compounds of formula (X) wherein R5 is a halogen or pseudohalogen (e.g. I, Br, Cl, OTf) by treatment with a suitable reagent (e.g. bis-pinacolatodiboron) optionally in the presence of a suitable catalyst (e.g. Pd(dppf)Cl2) and base (e.g. potassium phosphate) in a solvent such as 1,4-dioxane, dimethylformamide or toluene at temperatures between 20°C-150°C. This is shown in scheme 10 and related examples are given in Journal of Medicinal Chemistry, 2018, 61, 5623 - 5642 or Journal of Medicinal Chemistry, 2013, 56, 5514-5540. Alternatively, compounds of formula (XI), wherein M is a metal species (e.g. MgCl, Li, ZnCl) can be prepared from compounds of formula (X), where R5 is Cl, Br or I, via metal-halogen exchange with a suitable organometallic species (e.g. iPrMgCl.LiCl, n-BuLi, or EtZnCl), in a suitable solvent (e.g. tetrahydrofuran or diethyl ether), and at temperatures between -78°C and 25°C. Such transformations are shown in scheme 10.
Figure imgf000016_0002
Compounds of formula (I), can be obtained from compounds of formula (XII), by treatment with a base such as sodium methoxide and a formylating agent such as methyl formate followed by methylation with a reagent such dimethyl sulfate in the presence of a base such as K2CO3, or alternatively via introduction of ortho methylester in the presence of an acid such as TiCl4 or H2SO4, This is shown in scheme 11 and for related examples see WO2001012585, WO2009064031 or Organic Letters, 2016, 18, 6344-6347.
Figure imgf000017_0001
Compounds of formula (XII), wherein X is O, can be obtained from compounds of formula (X), wherein R5 is a halogen via metal-catalyzed decarboxylative cross-coupling with suitable malonic ester derivatives. For related examples see Tetrahedron, 68, 2012, 2113-2120. This is shown in scheme 12. Additionally, compounds of formula (XII) wherein X is NH can be prepared from compounds of formula (XII) wherein X is O via selective amidation using methylamine, or a suitable salt thereof, optionally in a one pot fashion and optionally in the presence of a base.
Figure imgf000017_0002
Moreover, compounds of formula (I) wherein Y is N, can be obtained from compounds of formula (XII) via addition of tertbutyl nitrite in a suitable solvent, such as toluene, and optionally in the presence of a base, such as potassium tert-butoxide followed by the addition of a methylating reagent such as methyl iodie or dimethylsulfate at a suitable temperature range between 20°C and 50°C. During this reaction a minor nitrone byproduct of formula (XIII) may form and it can be converted to compounds of formula (I) via treatment with N-methyl hydroxylamine or a salt thereof, optionally in the presence of a base and in a suitable solvent such as DMSO, MeCN, or DMF at temperatures between 50°C and 100°C. For related examples see WO2016055404.This is shown in scheme 13.
Figure imgf000018_0001
Moreover, compounds of formula (XV) wherein Y is N, can be obtained from compounds of formula (XIV) via addition of an oxidant, such as tert-butyl nitrite in a suitable solvent, such as toluene, and optionally in the presence of a base, such as potassium tert-butoxide followed by the addition of a methylating reagent such as methyl iodie or dimethylsulfate at suitable temperatures between 20°C and 50°C. During this reaction a minor nitrone byproduct of formula (XVI) may form which can be converted to a compound of formula (XV) via treatment with N-methyl hydroxylamine or a salt thereof, optionally in the presence of a base and in a suitable solvent such as DMSO, MeCN, or DMF at temperatures between 50°C and 100°C. This is shown in scheme 14 and for related examples see WO2016055404.
Figure imgf000018_0002
Compounds of formula (II), can be obtained from compounds of formula (XV), via intoduction of a suitable acid, such as trifluoroacetic acid or para-tolulsulfonic acid, in a suitable solvent, such as acetone and water. This is shown in scheme 15 and for related examples see Current Organocatalysis 2018, 5, 196-200 or Journal of Organic Chemistry, 2006, 71, 4956-4964.
Figure imgf000019_0001
Compounds of formula (XIV), wherein X is O, can be obtained from compounds of formula (XVII), via metal-catalyzed decarboxylative cross-coupling with malonic ester. For related examples see Tetrahedron, 68, 2012, 2113-2120. This is shown in scheme 16. Additionally, compounds of formula (XIV) wherein X is NH can be directly prepared from compounds of formula (XIV) wherein X is O via selective amidation using methylamine, or a suitable salt thereof, optionally in a one pot fashion and optionally in the presence of a base.
Figure imgf000019_0002
Compounds of formula (XVII), can be obtained from compounds of formula (VII), via introductionwith ethylene glycol in the presence of a suitable acid, such as camphorsulfonic acid or para-tolylsulfonic acid, in a suitable solvent, such as toluene or methyl orthoester at temperatures between 20°C and 50°C. This is shown in scheme 17 and for related examples see WO2006044293.
Figure imgf000019_0003
Compounds of formula (XVIII) wherein M is a metalloid species (e.g. B(OH)2, BPin), can be prepared from compounds of formula (XVII) wherein R5 is a halogen or pseudohalogen (e.g. Br, Cl, OTf) by treatment with a suitable metallating agent (e.g. bis-pinacolatodiboron) optionally in the presence of a suitable catalyst (e.g. Pd(dppf)Cl2) and base (e.g. potassium phosphate) in a solvent such as 1,4- dioxane, dimethylformamide or toluene at temperatures between 20°C-150°C. This is shown in scheme 18 and related examples are given in Journal of Medicinal Chemistry, 2018, 61, 5623 - 5642 or Journal of Medicinal Chemistry, 2013, 56, 5514-5540. Alternatively, compounds of formula (XVIII), M is a metalloid species such as (e.g. ZnCl, MgCl, Li), can be prepared from compounds of formula (XVII), where R5 is Cl, Br or I, via metal-halogen exchange with a suitable organometallic species (e.g. iPrMgCl.LiCl, n-BuLi, or EtZnCl), in a suitable solvent (e.g. tetrahydrofuran or diethyl ether), and at a temperature between -78°C. This is shown in scheme 18 and for related examples, see: Chem., Int. Ed., 2017, 56, 12770; ‘The Preparation of Organolithium Reagents and Intermediates’ Leroux, F., et al Wiley, New York.2004.
Figure imgf000020_0001
Compounds of formula (XV), can be obtained from compounds of formula (XIV), by treatment with a base such as sodium methoxide and a formylating agent such as methyl formate followed by methylation with a reagent such dimethyl sulfate in the presence of a base such as K2CO3 or via introduction of ortho methylester in the presence of an acid such as H2SO4. This is shown in scheme 19 and for related examples see WO2009064031 or Organic Letters, 2016, 18, 6344-6347.
Figure imgf000020_0002
Alternatively compounds of formula (XV) can be prepared from compounds of formula (XVIII), wherein M is a metalloid species (e.g. Li, ZnCl, MgCl, B(OH)2, BPin), by reaction with a species of formula (VI), where R4 is a halogen or pseudohalogen (e.g. Br, I, OTf), in the presence of a suitable catalyst such as palladium acetate and optionally a supporting ligand (e.g. CatCXiumA®) and base (e.g. potassium phosphate) in a suitable solvent such as 1,4-dioxane, DMF or toluene at temperatures between 20°C- 150°C. This is shown in scheme 20 and related examples of such transformations are described in Tetrahedron, 2011, 67, 624-635 and Advanced Synthesis and Catalysis, 2017, 359, 3865-3879.
Figure imgf000021_0001
Compounds of formula (XIX), wherein X = O, can be prepared from compounds of formula (XVIII) via introduction of dimethyl oxalate in a suitable solvent (e.g. tetrahydrofuran or diethyl ether), and at a temperature between -78°C and 25°C. Such transformations are shown in scheme 21. Furthermore, compounds of formula (XIX) wherein X is NH can be prepared from compounds of formula (XIX) wherein X is O, via selective amidation using methylamine, or a suitable salt thereof, optionally in a one pot fashion and optionally in the presence of a base. For related examples, see: Chem., Int. Ed., 2017, 56, 12770; ‘The Preparation of Organolithium Reagents and Intermediates’ Leroux, F., et al Wiley, New York.2004.
Figure imgf000021_0002
If the synthesis yields mixtures of isomers, a separation is generally not necessarily required because in some cases the individual isomers can be interconverted during work-up for use or during application (e. g. under the action of light, acids or bases). Such conversions may also take place after use, e. g. in the treatment of plants in the treated plant, or in the harmful fungus to be controlled. As already indicated, surprisingly, it has now been found that the compounds of formula (I) of the present invention have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi. The compounds of formula (I) can be used in the agricultural sector and related fields of use, e.g., as active ingredients for controlling plant pests or on non-living materials for the control of spoilage microorganisms or organisms potentially harmful to man. The novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and can be used for protecting numerous cultivated plants. The compounds of formula (I) can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later, e.g., from phytopathogenic microorganisms. The present invention further relates to a method for controlling or preventing infestation of plants or plant propagation material and/or harvested food crops susceptible to microbial attack by treating plants or plant propagation material and/or harvested food crops wherein an effective amount a compound of formula (I) is applied to the plants, to parts thereof or the locus thereof. It is also possible to use compounds of formula (I) as fungicide. The term “fungicide” as used herein means a compound that controls, modifies, or prevents the growth of fungi. The term “fungicidally effective amount” where used means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all deviation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection. It may also be possible to use compounds of formula (I) as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings, for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil. The propagation material can be treated with a composition comprising a compound of formula (I) before planting: seed, for example, can be dressed before being sown. The active compounds of formula (I) can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation. The composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing. The invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated. Furthermore, the compounds of formula (I) can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene management. In addition, the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint. The compounds of formula (I) are for example, effective against fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses. These fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses are for example: Absidia corymbifera, Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, Botryosphaeria spp. including B. dothidea, B. obtusa, Botrytis spp. inclusing B. cinerea, Candida spp. including C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Cephaloascus fragrans, Ceratocystis spp, Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp, Claviceps purpurea, Coccidioides immitis, Cochliobolus spp, Colletotrichum spp. including C. musae, Cryptococcus neoformans, Diaporthe spp, Didymella spp, Drechslera spp, Elsinoe spp,Epidermophyton spp, Erwinia amylovora, Erysiphe spp. including E. cichoracearum, Eutypa lata, Fusarium spp. including F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cingulate, Guignardia bidwellii, Gymnosporangium juniperi- virginianae, Helminthosporium spp, Hemileia spp, Histoplasma spp. including H. capsulatum, Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp, Monilinia spp, Mucor spp, Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp, Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P. philippinensis and P. sorghi, Peronospora spp, Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp, Phoma spp, Phomopsis viticola, Phytophthora spp. including P. infestans, Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp, Pyrenophora spp, Pyricularia spp. including P. oryzae, Pythium spp. including P. ultimum, Ramularia spp, Rhizoctonia spp, Rhizomucor pusillus, Rhizopus arrhizus, Rhynchosporium spp, Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi, Sclerotinia spp, Sclerotium spp, Septoria spp, including S. nodorum, S. tritici, Sphaerotheca macularis, Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp, Stagonospora nodorum, Stemphylium spp,. Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola, Tilletia spp, Trichoderma spp. including T. harzianum, T. pseudokoningii, T. viride, Trichophyton spp, Typhula spp, Uncinula necator, Urocystis spp, Ustilago spp, Venturia spp. including V. inaequalis, Verticillium spp, and Xanthomonas spp. The compounds of formula (I) may be used for example on turf, ornamentals, such as flowers, shrubs, broad-leaved trees or evergreens, for example conifers, as well as for tree injection, pest management and the like. Within the scope of present invention, target crops and/or useful plants to be protected typically comprise perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St. Augustine grass and Zoysia grass; herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes. The term "useful plants" is to be understood as also including useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol-pyrovyl- shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola). Examples of crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I ^ and LibertyLink®. The term "useful plants" is to be understood as also including useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus. Examples of such plants are: YieldGard ^ (maize variety that expresses a CryIA(b) toxin); YieldGard Rootworm ^ (maize variety that expresses a CryIIIB(b1) toxin); YieldGard Plus ^ (maize variety that expresses a CryIA(b) and a CryIIIB(b1) toxin); Starlink ^ (maize variety that expresses a Cry9(c) toxin); Herculex I ^ (maize variety that expresses a CryIF(a2) toxin and the enzyme phosphinothricine N- acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B ^ (cotton variety that expresses a CryIA(c) toxin); Bollgard I ^ (cotton variety that expresses a CryIA(c) toxin); Bollgard II® (cotton variety that expresses a CryIA(c) and a CryIIA(b) toxin); VIPCOT ^ (cotton variety that expresses a VIP toxin); NewLeaf ^ (potato variety that expresses a CryIIIA toxin); Nature- Gard ^ Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait), Agrisure® RW (corn rootworm trait) and Protecta ^. The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus. Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as ^- endotoxins, e.g. Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1, Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ribosome- inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases. Further, in the context of the present invention there are to be understood by ^-endotoxins, for example Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1, Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701). Truncated toxins, for example a truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G- recognition sequence is inserted into a Cry3A toxin (see WO 03/018810). Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0374753, WO93/07278, WO95/34656, EP-A-0427529, EP-A-451878 and WO 03/052073. The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. CryI-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0367 474, EP-A-0401979 and WO 90/13651. The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera). Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard ^ (maize variety that expresses a Cry1Ab toxin); YieldGard Rootworm ^ (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus ^ (maize variety that expresses a Cry1Ab and a Cry3Bb1 toxin); Starlink ^ (maize variety that expresses a Cry9C toxin); Herculex I ^ (maize variety that expresses a Cry1Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B ^ (cotton variety that expresses a Cry1Ac toxin); Bollgard I ^ (cotton variety that expresses a Cry1Ac toxin); Bollgard II® (cotton variety that expresses a Cry1Ac and a Cry2Ab toxin); VipCot ^ (cotton variety that expresses a Vip3A and a Cry1Ab toxin); NewLeaf ^ (potato variety that expresses a Cry3A toxin); NatureGard ^, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait) and Protecta ^. Further examples of such transgenic crops are: 1. Bt11 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1Ab toxin. Bt11 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 2. Bt176 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a Cry1Ab toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 3. MIR604 Maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810. 4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects. 5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/ES/96/02. 6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cry1F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium. 7. NK603 × MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603 × MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a Cry1Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer. The compounds of formula (I) (including any one of compounds 1.1 to 1.6) or fungicidal compositions according to the present invention comprising a compound of formula (I) may be used in controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi (such as Phakopsora pachyrhizi) on soy bean plants. In particular, transgenic soybean plants expressing toxins, for example insecticidal proteins such as delta-endotoxins, e.g. Cry1Ac (Cry1Ac Bt protein). Accordingly, this may include transgenic soybean plants comprising event MON87701 (see U.S. Patent No. 8,049,071 and related applications and patents, as well as WO 2014/170327 A1 (eg, see paragraph [008] reference to Intacta RR2 PROTM soybean)), event MON87751 (US. Patent Application Publication No. 2014/0373191) or event DAS- 81419 (U.S. Patent No.8632978 and related applications and patents). Other transgenic soybean plants may comprise event SYHT0H2 - HPPD tolerance (U.S. Patent Application Publication No. 2014/0201860 and related applications and patents), event MON89788 - glyphosate tolerance (U.S. Pat. No.7,632,985 and related applications and patents), event MON87708 - dicamba tolerance (U.S. Patent Application Publication No. US 2011/0067134 and related applications and patents), event DP-356043-5 - glyphosate and ALS tolerance (U.S. Patent Application Publication No. US 2010/0184079 and related applications and patents), event A2704-12 - glufosinate tolerance (U.S. Patent Application Publication No. US 2008/0320616 and related applications and patents), event DP-305423-1 - ALS tolerance (U.S. Patent Application Publication No. US 2008/0312082 and related applications and patents), event A5547-127 - glufosinate tolerance (U.S. Patent Application Publication No. US 2008/0196127 and related applications and patents), event DAS-40278-9 - tolerance to 2,4- dichlorophenoxyacetic acid and aryloxyphenoxypropionate (see WO 2011/022469, WO 2011/022470, WO 2011/022471, and related applications and patents), event 127 - ALS tolerance (WO 2010/080829 and related applications and patents), event GTS 40-3-2 - glyphosate tolerance, event DAS-68416-4- 2,4-dichlorophenoxyacetic acid and glufosinate tolerance, event FG72 - glyphosate and isoxaflutole tolerance, event BPS-CV127-9 - ALS tolerance and GU262 - glufosinate tolerance or event SYHT04R - HPPD tolerance. The compounds of formula (I) (including any one of compounds 1.1 to 1.6) or fungicidal compositions according to the present invention comprising a compound of formula (I) may be used in controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi (such as Phakopsora pachyrhizi) on soy bean plants. In particular, there are known in the scientific literature certain Elite soybean plant varieties where R-gene stacks, conferring a degree of immunity or resistance to specific Phakopsora pachyrhizi, have been been introgressed in the plant genome, see for example: “Fighting Asian Soybean Rust”, Langenbach C, et al, Front Plant Science 7(797) 2016). An elite plant is any plant from an elite line, such that an elite plant is a representative plant from an elite variety. Non-limiting examples of elite soybean varieties that are commercially available to farmers or soybean breeders include: AG00802, A0868, AG0902, A1923, AG2403, A2824, A3704, A4324, A5404, AG5903, AG6202 AG0934; AG1435; AG2031; AG2035; AG2433; AG2733; AG2933; AG3334; AG3832; AG4135; AG4632; AG4934; AG5831; AG6534; and AG7231 (Asgrow Seeds, Des Moines, Iowa, USA); BPR0144RR, BPR 4077NRR and BPR 4390NRR (Bio Plant Research, Camp Point, Ill., USA); DKB17- 51 and DKB37-51 (DeKalb Genetics, DeKalb, Ill., USA); DP 4546 RR, and DP 7870 RR (Delta & Pine Land Company, Lubbock, Tex., USA); JG 03R501, JG 32R606C ADD and JG 55R503C (JGL Inc., Greencastle, Ind., USA); NKS 13-K2 (NK Division of Syngenta Seeds, Golden Valley, Minnesota, USA); 90M01, 91M30, 92M33, 93M11, 94M30, 95M30, 97B52, P008T22R2; P16T17R2; P22T69R; P25T51R; P34T07R2; P35T58R; P39T67R; P47T36R; P46T21R; and P56T03R2 (Pioneer Hi-Bred International, Johnston, Iowa, USA); SG4771NRR and SG5161NRR/STS (Soygenetics, LLC, Lafayette, Ind., USA); S00-K5, S11-L2, S28-Y2, S43-B1, S53-A1, S76-L9, S78-G6, S0009-M2; S007-Y4; S04-D3; S14-A6; S20-T6; S21-M7; S26-P3; S28-N6; S30-V6; S35-C3; S36-Y6; S39-C4; S47-K5; S48-D9; S52-Y2; S58- Z4; S67-R6; S73-S8; and S78-G6 (Syngenta Seeds, Henderson, Ky., USA); Richer (Northstar Seed Ltd. Alberta, CA); 14RD62 (Stine Seed Co. Ia., USA); or Armor 4744 (Armor Seed, LLC, Ar., USA). Thus, in a further preferred embodiment, the compounds of formula (I) (including any one of compounds 1.1 to 1.6), or fungicidal compositions according to the present invention comprising a compound of formula (I), are used to control Phakopsora pachyrhizi, (including fungicidally-resistant strains thereof, as outlined herein) on Elite soybean plant varieties where R-gene stacks, conferring a degree of immunity or resistance to specific Phakopsora pachyrhizi, have been been introgressed in the plant genome. Numerous benefits may be expected to ensue from said use, e.g. improved biological activity, an advantageous or broader spectrum of activity (inc. sensitive and resistant strains of Phakopsora pachyrhizi), an increased safety profile, improved crop tolerance, synergistic interactions or potentiating properties, improved onset of action or a longer lasting residual activity, a reduction in the number of applications and/or a reduction in the application rate of the compounds and compositions required for effective control of the phytopathogen (Phakopsora pachyrhizi), thereby enabling beneficial resistance- management practices, reduced environmental impact and reduced operator exposure. Fungicidal-resistant strains of Phakopsora pachyrhizi have been reported in the scientific literature, with strains resistant to one or more fungicides from at least each of the following fungicidal mode of action classes being observed: sterol demethylation-inhibitors (DMI), quinone-outside-inhibitors (QoI) and succinate dehydrogenase inhibitors (SDHI). See for example: “Sensitivity of Phakopsora pachyrhizi towards quinone-outside-inhibitors and demethylation-inhibitors, and corresponding resistance mechanisms.” Schmitz HK et al, Pest Manag Sci (2014) 70: 378-388; “First detection of a SDH variant with reduced SDHI sensitivity in Phakopsora pachyrhizi” Simões K et al, J Plant Dis Prot (2018) 125: 21-2; “Competitive fitness of Phakopsora pachyrhizi isolates with mutations in the CYP51 and CYTB genes.” Klosowski AC et al, Phytopathology (2016) 106: 1278-1284; “Detection of the F129L mutation in the cytochrome b gene in Phakopsora pachyrhizi.” Klosowski AC et al, Pest Manag Sci (2016) 72: 1211-1215. Thus, in a preferred embodiment, the compounds of formula (I) (including any one of compounds 1.1 to 1.6), or fungicidal compositions according to the present invention comprising a compound of formula (I), are used to control Phakopsora pachyrhizi which are resistant to one or more fungicides from any of the following fungicidal MoA classes: sterol demethylation-inhibitors (DMI), quinone-outside-inhibitors (QoI) and succinate dehydrogenase inhibitors (SDHI). The term “locus” as used herein means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation. The term “plants” refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits. The term “plant propagation material” is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes. There can be mentioned for example seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and parts of plants. Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants can be protected before transplantation by a total or partial treatment by immersion. Preferably “plant propagation material” is understood to denote seeds. The compounds of formula (I) may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently Formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects. Suitable carriers and adjuvants, e.g. for agricultural use, can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO 97/33890. Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended. Such formulations include anti-settling agents and dispersing agents and may further include a wetting agent to enhance activity as well an anti-foam and a crystal growth inhibitor. In use, these concentrates are diluted in water and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate. Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers. The particles contain the active ingredient retained in a solid matrix. Typical solid matrices include fuller’s earth, kaolin clays, silicas and other readily wet organic or inorganic solids. Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent. Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other non-volatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate. Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required. Typical carriers for granular Formulations include sand, fuller’s earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound. Granular Formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins. Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers. Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates. Encapsulated droplets are typically 1 to 50 microns in diameter. The enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound. Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores. Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter. Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring. Examples of such materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust and granular carbon. Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene-butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates. Other useful formulations for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents. Pressurised sprayers, wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used. Suitable agricultural adjuvants and carriers that are useful in formulating the compositions of the invention in the formulation types described above are well known to those skilled in the art. Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl formamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkyl pyrrolidinone, ethyl acetate, 2-ethyl hexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, alpha pinene, d-limonene, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol diacetate, glycerol monoacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropyl benzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy-propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octyl amine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monomethyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, isopropanol, and higher molecular weight alcohols such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc., ethylene glycol, propylene glycol, glycerine and N-methyl-2-pyrrolidinone. Water is generally the carrier of choice for the dilution of concentrates. Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller’s earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin. A broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application. These agents, when used, normally comprise from 0.1% to 15% by weight of the formulation. They can be anionic, cationic, non-ionic or polymeric in character and can be employed as emulsifying agents, wetting agents, suspending agents or for other purposes. Typical surface active agents include salts of alkyl sulfates, such as diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub.18 ethoxylate; alcohol-alkylene oxide addition products, such as tridecyl alcohol-C.sub. 16 ethoxylate; soaps, such as sodium stearate; alkylnaphthalenesulfonate salts, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl) sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryl trimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono and dialkyl phosphate esters. Other adjuvants commonly utilized in agricultural compositions include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti- foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents. In addition, further, other biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention. When applied simultaneously, these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank. These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides and/or plant growth regulators. Pesticidal agents are referred to herein using their common name are known, for example, from "The Pesticide Manual", 15th Ed., British Crop Protection Council 2009. In addition, the compositions of the invention may also be applied with one or more systemically acquired resistance inducers (“SAR” inducer). SAR inducers are known and described in, for example, United States Patent No. US 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl. The compounds of formula (I) are normally used in the form of agrochemical compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds. These further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants. They can also be selective herbicides or non-selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation. The compounds of formula (I) may be used in the form of (fungicidal) compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of formula (I) or of at least one preferred individual compound as defined herein, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants. The invention therefore provides a composition, preferably a fungicidal composition, comprising at least one compound formula (I) an agriculturally acceptable carrier and optionally an adjuvant. An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use. Agricultural carriers are well known in the art. Preferably said composition may comprise at least one or more pesticidally-active compounds, for example an additional fungicidal active ingredient in addition to the compound of formula (I). The compound of formula (I) may be the sole active ingredient of a composition or it may be admixed with one or more additional active ingredients such as a pesticide, fungicide, synergist, herbicide or plant growth regulator where appropriate. An additional active ingredient may, in some cases, result in unexpected synergistic activities. Examples of suitable additional active ingredients include the following: acycloamino acid fungicides, aliphatic nitrogen fungicides, amide fungicides, anilide fungicides, antibiotic fungicides, aromatic fungicides, arsenical fungicides, aryl phenyl ketone fungicides, benzamide fungicides, benzanilide fungicides, benzimidazole fungicides, benzothiazole fungicides, botanical fungicides, bridged diphenyl fungicides, carbamate fungicides, carbanilate fungicides, conazole fungicides, copper fungicides, dicarboximide fungicides, dinitrophenol fungicides, dithiocarbamate fungicides, dithiolane fungicides, furamide fungicides, furanilide fungicides, hydrazide fungicides, imidazole fungicides, mercury fungicides, morpholine fungicides, organophosphorous fungicides, organotin fungicides, oxathiin fungicides, oxazole fungicides, phenylsulfamide fungicides, polysulfide fungicides, pyrazole fungicides, pyridine fungicides, pyrimidine fungicides, pyrrole fungicides, quaternary ammonium fungicides, quinoline fungicides, quinone fungicides, quinoxaline fungicides, strobilurin fungicides, sulfonanilide fungicides, thiadiazole fungicides, thiazole fungicides, thiazolidine fungicides, thiocarbamate fungicides, thiophene fungicides, triazine fungicides, triazole fungicides, triazolopyrimidine fungicides, urea fungicides, valinamide fungicides, and zinc fungicides. Examples of suitable additional active ingredients also include the following: 3-difluoromethyl-1-methyl- 1H-pyrazole-4-carboxylic acid (9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)- amide , 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid methoxy-[1-methyl-2-(2,4,6- trichlorophenyl)-ethyl]-amide , 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid (2- dichloromethylene-3-ethyl-1-methyl-indan-4-yl)-amide (1072957-71-1), 1-methyl-3-difluoromethyl-1H- pyrazole-4-carboxylic acid (4'-methylsulfanyl-biphenyl-2-yl)-amide, 1-methyl-3-difluoromethyl-4H- pyrazole-4-carboxylic acid [2-(2,4-dichloro-phenyl)-2-methoxy-1-methyl-ethyl]-amide, (5-Chloro-2,4- dimethyl-pyridin-3-yl)-(2,3,4-trimethoxy-6-methyl-phenyl)-methanone, (5-Bromo-4-chloro-2-methoxy- pyridin-3-yl)-(2,3,4-trimethoxy-6-methyl-phenyl)-methanone, 2-{2-[(E)-3-(2,6-Dichloro-phenyl)-1- methyl-prop-2-en-(E)-ylideneaminooxymethyl]-phenyl}-2-[(Z)-methoxyimino]-N-methyl-acetamide, 3-[5- (4-Chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, (E)-N-methyl-2- [2- (2, 5- dimethylphenoxymethyl) phenyl]-2-methoxy-iminoacetamide, 4-bromo-2-cyano-N, N-dimethyl-6- trifluoromethylbenzimidazole-1-sulphonamide, a- [N-(3-chloro-2, 6-xylyl)-2-methoxyacetamido]-y- butyrolactone, 4-chloro-2-cyano-N,N - dimethyl-5-p-tolylimidazole-1-sulfonamide, N-allyl-4, 5,-dimethyl- 2-trimethylsilylthiophene-3-carboxamide, N- (l-cyano-1, 2-dimethylpropyl)-2- (2, 4-dichlorophenoxy) propionamide, N- (2-methoxy-5-pyridyl)-cyclopropane carboxamide, (.+-.)-cis-1-(4-chlorophenyl)-2-(1H- 1,2,4-triazol-1-yl)-cycloheptanol, 2-(1-tert-butyl)-1-(2-chlorophenyl)-3-(1,2,4-triazol-1-yl)-propan-2-ol, 2',6'-dibromo-2-methyl-4-trifluoromethoxy-4'-trifluoromethyl-1,3-thiazole- 5-carboxanilide, 1-imidazolyl- 1-(4'-chlorophenoxy)-3,3-dimethylbutan-2-one, methyl (E)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4- yloxy]phenyl]3-methoxyacrylate, methyl (E)-2-[2-[6-(2-thioamidophenoxy)pyrimidin-4-yloxy]phenyl]-3- methoxyacrylate, methyl (E)-2-[2-[6-(2-fluorophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[6-(2,6-difluorophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacryla te, methyl (E)-2-[2- [3-(pyrimidin-2-yloxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[3-(5-methylpyrimidin-2- yloxy)-phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[3-(phenyl-sulphonyloxy)phenoxy]phenyl-3- methoxyacrylate, methyl (E)-2-[2-[3-(4-nitrophenoxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2- [2-phenoxyphenyl]-3-methoxyacrylate, methyl (E)-2-[2-(3,5-dimethyl-benzoyl)pyrrol-1-yl]-3- methoxyacrylate, methyl (E)-2-[2-(3-methoxyphenoxy)phenyl]-3-methoxyacrylate, methyl (E)-2[2-(2- phenylethen-1-yl)-phenyl]-3-methoxyacrylate, methyl (E)-2-[2-(3,5-dichlorophenoxy)pyridin-3-yl]-3- methoxyacrylate, methyl (E)-2-(2-(3-(1,1,2,2-tetrafluoroethoxy)phenoxy)phenyl)-3-methoxyacrylate, methyl (E)-2-(2-[3-(alpha-hydroxybenzyl)phenoxy]phenyl)-3-methoxyacrylate, methyl (E)-2-(2-(4- phenoxypyridin-2-yloxy)phenyl)-3-methoxyacrylate, methyl (E)-2-[2-(3-n-propyloxy-phenoxy)phenyl]3- methoxyacrylate, methyl (E)-2-[2-(3-isopropyloxyphenoxy)phenyl]-3-methoxyacrylate, methyl (E)-2-[2- [3-(2-fluorophenoxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-(3-ethoxyphenoxy)phenyl]-3- methoxyacrylate, methyl (E)-2-[2-(4-tert-butyl-pyridin-2-yloxy)phenyl]-3-methoxyacrylate, methyl (E)-2- [2-[3-(3-cyanophenoxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[(3-methyl-pyridin-2- yloxymethyl)phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[6-(2-methyl-phenoxy)pyrimidin-4- yloxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-(5-bromo-pyridin-2-yloxymethyl)phenyl]-3- methoxyacrylate, methyl (E)-2-[2-(3-(3-iodopyridin-2-yloxy)phenoxy)phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[6-(2-chloropyridin-3-yloxy)pyrimidin-4-yloxy]phenyl]-3-methoxyac rylate, methyl (E),(E)-2-[2- (5,6-dimethylpyrazin-2-ylmethyloximinomethyl)phenyl]-3-methox yacrylate, methyl (E)-2-{2-[6-(6- methylpyridin-2-yloxy)pyrimidin-4-yloxy]phenyl}-3-methoxy-a crylate, methyl (E),(E)-2-{ 2-(3- methoxyphenyl)methyloximinomethyl]-phenyl}-3-methoxyacrylate, methyl (E)-2-{2-(6-(2- azidophenoxy)-pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate, methyl (E),(E)-2-{2-[6-phenylpyrimidin-4- yl)-methyloximinomethyl]phenyl}-3-methox yacrylate, methyl (E),(E)-2-{2-[(4-chlorophenyl)- methyloximinomethyl]-phenyl}-3-methoxyacryl ate, methyl (E)-2-{2-[6-(2-n-propylphenoxy)-1,3,5- triazin-4-yloxy]phenyl}-3-methoxyacr ylate, methyl (E),(E)-2-{2-[(3- nitrophenyl)methyloximinomethyl]phenyl}-3-methoxyacrylate, 3-chloro-7-(2-aza-2,7,7-trimethyl-oct-3- en-5-ine), 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, 3-iodo-2-propinyl alcohol, 4- chlorophenyl-3-iodopropargyl formal, 3-bromo-2,3-diiodo-2-propenyl ethylcarbamate, 2,3,3-triiodoallyl alcohol, 3-bromo-2,3-diiodo-2-propenyl alcohol, 3-iodo-2-propinyl n-butylcarbamate, 3-iodo-2-propinyl n-hexylcarbamate, 3-iodo-2-propinyl cyclohexyl-carbamate, 3-iodo-2-propinyl phenylcarbamate; phenol derivatives, such as tribromophenol, tetrachlorophenol, 3-methyl-4-chlorophenol, 3,5-dimethyl-4- chlorophenol, phenoxyethanol, dichlorophene, o-phenylphenol, m-phenylphenol, p-phenylphenol, 2- benzyl-4-chlorophenol, 5-hydroxy-2(5H)-furanone; 4,5-dichlorodithiazolinone, 4,5-benzodithiazolinone, 4,5-trimethylenedithiazolinone, 4,5-dichloro-(3H)-1,2-dithiol-3-one, 3,5-dimethyl-tetrahydro-1,3,5- thiadiazine-2-thione, N-(2-p-chlorobenzoylethyl)-hexaminium chloride, acibenzolar, acypetacs, alanycarb, albendazole, aldimorph, allicin, allyl alcohol, ametoctradin, amisulbrom, amobam, ampropylfos, anilazine, asomate, aureofungin, azaconazole, azafendin, azithiram, azoxystrobin, barium polysulfide, benalaxyl, benalaxyl-M, benodanil, benomyl, benquinox, bentaluron, benthiavalicarb, benthiazole, benzalkonium chloride, benzamacril, benzamorf, benzohydroxamic acid, benzovindiflupyr, berberine, bethoxazin, biloxazol, binapacryl, biphenyl, bitertanol, bithionol, bixafen, blasticidin-S, boscalid, bromothalonil, bromuconazole, bupirimate, buthiobate, butylamine calcium polysulfide, captafol, captan, carbamorph, carbendazim, carbendazim chlorhydrate, carboxin, carpropamid, carvone, CGA41396, CGA41397, chinomethionate, chitosan, chlobenthiazone, chloraniformethan, chloranil, chlorfenazole, chloroneb, chloropicrin, chlorothalonil, chlorozolinate, chlozolinate, climbazole, clotrimazole, clozylacon, copper containing compounds such as copper acetate, copper carbonate, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper oxyquinolate, copper silicate, copper sulphate, copper tallate, copper zinc chromate and Bordeaux mixture, cresol, cufraneb, cuprobam, cuprous oxide, cyazofamid, cyclafuramid, cycloheximide, cyflufenamid, cymoxanil, cypendazole, cyproconazole, cyprodinil, dazomet, debacarb, decafentin, dehydroacetic acid, di-2- pyridyl disulphide 1, 1'-dioxide, dichlofluanid, diclomezine, dichlone, dicloran, dichlorophen, dichlozoline, diclobutrazol, diclocymet, diethofencarb, difenoconazole, difenzoquat, diflumetorim, O, O-di-iso-propyl- S-benzyl thiophosphate, dimefluazole, dimetachlone, dimetconazole, dimethomorph, dimethirimol, diniconazole, diniconazole-M, dinobuton, dinocap, dinocton, dinopenton, dinosulfon, dinoterbon, diphenylamine, dipyrithione, disulfiram, ditalimfos, dithianon, dithioether, dodecyl dimethyl ammonium chloride, dodemorph, dodicin, dodine, doguadine, drazoxolon, edifenphos, enestroburin, epoxiconazole, etaconazole, etem, ethaboxam, ethirimol, ethoxyquin, ethilicin, ethyl (Z)-N-benzyl-N ([methyl (methyl- thioethylideneamino- oxycarbonyl) amino] thio)-ß-alaninate, etridiazole, famoxadone, fenamidone, fenaminosulf, fenapanil, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenitropan, fenoxanil, fenpiclonil, fenpicoxamid, fenpropidin, fenpropimorph, fenpyrazamine, fentin acetate, fentin hydroxide, ferbam, ferimzone, fluazinam, fludioxonil, flumetover, flumorph, flupicolide, fluopyram, fluoroimide, fluotrimazole, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutanil, flutolanil, flutriafol, fluxapyroxad, folpet, formaldehyde, fosetyl, fuberidazole, furalaxyl, furametpyr, furcarbanil, furconazole, furfural, furmecyclox, furophanate, glyodin, griseofulvin, guazatine, halacrinate, hexa chlorobenzene, hexachlorobutadiene, hexachlorophene, hexaconazole, hexylthiofos, hydrargaphen, hydroxyisoxazole, hymexazole, imazalil, imazalil sulphate, imibenconazole, iminoctadine, iminoctadine triacetate, inezin, iodocarb, ipconazole, ipfentrifluconazole, iprobenfos, iprodione, iprovalicarb, isopropanyl butyl carbamate, isoprothiolane, isopyrazam, isotianil, isovaledione, izopamfos, kasugamycin, kresoxim- methyl, LY186054, LY211795, LY248908, mancozeb, mandipropamid, maneb, mebenil, mecarbinzid, mefenoxam, mefentrifluconazole, mepanipyrim, mepronil, mercuric chloride, mercurous chloride, meptyldinocap, metalaxyl, metalaxyl-M, metam, metazoxolon, metconazole, methasulfocarb, methfuroxam, methyl bromide, methyl iodide, methyl isothiocyanate, metiram, metiram-zinc, metominostrobin, metrafenone, metsulfovax, milneb, moroxydine, myclobutanil, myclozolin, nabam, natamycin, neoasozin, nickel dimethyldithiocarbamate, nitrostyrene, nitrothal-iso- propyl, nuarimol, octhilinone, ofurace, organomercury compounds, orysastrobin, osthol, oxadixyl, oxasulfuron, oxathiapiprolin, oxine-copper, oxolinic acid, oxpoconazole, oxycarboxin, paclobutrazol, parinol, pefurazoate, penconazole, pencycuron, penflufen, pentachlorophenol, penthiopyrad, phenamacril, phenazin oxide, phosdiphen, phosetyl-Al, phosphorus acids, phthalide, picoxystrobin, piperalin, polycarbamate, polyoxin D, polyoxrim, polyram, probenazole, prochloraz, procymidone, propamidine, propamocarb, propiconazole, propineb, propionic acid, proquinazid, prothiocarb, prothioconazole, pydiflumetofen, pyracarbolid, pyraclostrobin, pyrametrostrobin, pyraoxystrobin, pyrazophos, pyribencarb, pyridinitril, pyrifenox, pyrimethanil, pyriofenone, pyroquilon, pyroxychlor, pyroxyfur, pyrrolnitrin, quaternary ammonium compounds, quinacetol, quinazamid, quinconazole, quinomethionate, quinoxyfen, quintozene, rabenzazole, santonin, sedaxane, silthiofam, simeconazole, sipconazole, sodium pentachlorophenate, spiroxamine, streptomycin, sulphur, sultropen, tebuconazole, tebfloquin, tecloftalam, tecnazene, tecoram, tetraconazole, thiabendazole, thiadifluor, thicyofen, thifluzamide, 2- (thiocyanomethylthio) benzothiazole, thiophanate-methyl, thioquinox, thiram, tiadinil, timibenconazole, tioxymid, tolclofos-methyl, tolylfluanid, triadimefon, triadimenol, triamiphos, triarimol, triazbutil, triazoxide, tricyclazole, tridemorph, trifloxystrobin, triflumazole, triforine, triflumizole, triticonazole, uniconazole, urbacide, validamycin, valifenalate, vapam, vinclozolin, zarilamid, zineb, ziram, and zoxamide. The compounds of the invention may also be used in combination with anthelmintic agents. Such anthelmintic agents include, compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives as described in EP- 357460, EP-444964 and EP- 594291. Additional anthelmintic agents include semisynthetic and biosynthetic avermectin/milbemycin derivatives such as those described in US-5015630, WO-9415944 and WO-9522552. Additional anthelmintic agents include the benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, parbendazole, and other members of the class. Additional anthelmintic agents include imidazothiazoles and tetrahydropyrimidines such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel. Additional anthelmintic agents include flukicides, such as triclabendazole and clorsulon and the cestocides, such as praziquantel and epsiprantel. The compounds of the invention may be used in combination with derivatives and analogues of the paraherquamide/marcfortine class of anthelmintic agents, as well as the antiparasitic oxazolines such as those disclosed in US-5478855, US- 4639771 and DE-19520936. The compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents as described in WO 96/15121 and also with anthelmintic active cyclic depsipeptides such as those described in WO 96/11945, WO 93/19053, WO 93/25543, EP 0626375, EP 0382173, WO 94/19334, EP 0382173, and EP 0503538. The compounds of the invention may be used in combination with other ectoparasiticides; for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like; neonicotinoids such as imidacloprid and the like. The compounds of the invention may be used in combination with terpene alkaloids, for example those described in International Patent Application Publication Numbers WO 95/19363 or WO 04/72086, particularly the compounds disclosed therein. Other examples of such biologically active compounds that the compounds of the invention may be used in combination with include but are not restricted to the following: Organophosphates: acephate, azamethiphos, azinphos-ethyl, azinphos- methyl, bromophos, bromophos-ethyl, cadusafos, chlorethoxyphos, chlorpyrifos, chlorfenvinphos, chlormephos, demeton, demeton-S-methyl, demeton-S-methyl sulphone, dialifos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosthiazate, heptenophos, isazophos, isothioate, isoxathion, malathion, methacriphos, methamidophos, methidathion, methyl- parathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, paraoxon, parathion, parathion-methyl, phenthoate, phosalone, phosfolan, phosphocarb, phosmet, phosphamidon, phorate, phoxim, pirimiphos, pirimiphos- methyl, profenofos, propaphos, proetamphos, prothiofos, pyraclofos, pyridapenthion, quinalphos, sulprophos, temephos, terbufos, tebupirimfos, tetrachlorvinphos, thimeton, triazophos, trichlorfon, vamidothion. Carbamates: alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801, isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m-cumenylbutyryl(methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717. Pyrethroids: acrinathin, allethrin, alphametrin, 5-benzyl-3-furylmethyl (E) -(1 R)-cis-2,2-dimethyl-3-(2- oxothiolan-3-ylidenemethyl)cyclopropanecarboxylate, bifenthrin, beta -cyfluthrin, cyfluthrin, a- cypermethrin, beta -cypermethrin, bioallethrin, bioallethrin((S)-cyclopentylisomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, cyhalothrin, cythithrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, ethofenprox, fenfluthrin, fenpropathrin, fenvalerate, flucythrinate, flumethrin, fluvalinate (D isomer), imiprothrin, cyhalothrin, lambda-cyhalothrin, permethrin, phenothrin, prallethrin, pyrethrins (natural products), resmethrin, tetramethrin, transfluthrin, theta-cypermethrin, silafluofen, t-fluvalinate, tefluthrin, tralomethrin, Zeta-cypermethrin. Arthropod growth regulators: a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron, buprofezin, diofenolan, hexythiazox, etoxazole, chlorfentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide; c) juvenoids: pyriproxyfen, methoprene (including S-methoprene), fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen. Other antiparasitics: acequinocyl, amitraz, AKD-1022, ANS-118, azadirachtin, Bacillus thuringiensis, bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG-505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloden, diafenthiuron, DBI-3204, dinactin, dihydroxymethyldihydroxypyrrolidine, dinobuton, dinocap, endosulfan, ethiprole, ethofenprox, fenazaquin, flumite, MTI- 800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, flufenzine, flufenprox, fluproxyfen, halofenprox, hydramethylnon, IKI-220, kanemite, NC-196, neem guard, nidinorterfuran, nitenpyram, SD-35651, WL-108477, pirydaryl, propargite, protrifenbute, pymethrozine, pyridaben, pyrimidifen, NC-1111, R-195,RH-0345, RH-2485, RYI-210, S-1283, S-1833, SI-8601, silafluofen, silomadine, spinosad, tebufenpyrad, tetradifon, tetranactin, thiacloprid, thiocyclam, thiamethoxam, tolfenpyrad, triazamate, triethoxyspinosyn, trinactin, verbutin, vertalec, YI-5301. Biological agents: Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, virus and fungi. Bactericides: chlortetracycline, oxytetracycline, streptomycin. Other biological agents: enrofloxacin, febantel, penethamate, moloxicam, cefalexin, kanamycin, pimobendan, clenbuterol, omeprazole, tiamulin, benazepril, pyriprole, cefquinome, florfenicol, buserelin, cefovecin, tulathromycin, ceftiour, carprofen, metaflumizone, praziquarantel, triclabendazole. Thus, compounds of formula (I) can be used in combination with one or more other active ingeredients to provide various fungicidal mixtures. Specific examples of such mixtures include (wherein “I” represents a compound of formula (I)): a compound selected from the group of substances consisting of petroleum oils + I, 1,1-bis(4-chloro-phenyl)-2-ethoxyethanol + I, 2,4-dichlorophenyl benzenesulfonate + I, 2-fluoro-N-methyl-N-1-naphthylacetamide + I, 4-chlorophenyl phenyl sulfone + I, acetoprole + I, aldoxycarb + I, amidithion + I, amidothioate + I, amiton + I, amiton hydrogen oxalate + I, amitraz + I, aramite + I, arsenous oxide + I, azobenzene + I, azothoate + I, benomyl + I, benoxa-fos + I, benzyl benzoate + I, bixafen + I, brofenvalerate + I, bromo-cyclen + I, bromophos + I, bromopropylate + I, buprofezin + I, butocarboxim + I, butoxycarboxim + I, butylpyridaben + I, calcium polysulfide + I, camphechlor + I, carbanolate + I, carbophenothion + I, cymiazole + I, chino-methionat + I, chlorbenside + I, chlordimeform + I, chlordimeform hydrochloride + I, chlorfenethol + I, chlorfenson + I, chlorfensulfide + I, chlorobenzilate + I, chloromebuform + I, chloromethiuron + I, chloropropylate + I, chlorthiophos + I, cinerin I + I, cinerin II + I, cinerins + I, closantel + I, coumaphos + I, crotamiton + I, crotoxyphos + I, cufraneb + I, cyanthoate + I, DCPM + I, DDT + I, demephion + I, demephion-O + I, demephion-S + I, demeton-methyl + I, demeton-O + I, demeton-O-methyl + I, demeton-S + I, demeton-S-methyl + I, demeton-S-methylsulfon + I, dichlofluanid + I, dichlorvos + I, dicliphos + I, dienochlor + I, dimefox + I, dinex + I, dinex-diclexine + I, dinocap-4 + I, dinocap-6 + I, dinocton + I, dino-penton + I, dinosulfon + I, dinoterbon + I, dioxathion + I, diphenyl sulfone + I, disulfiram + I, DNOC + I, dofenapyn + I, doramectin + I, endothion + I, eprinomectin + I, ethoate-methyl + I, etrimfos + I, fenazaflor + I, fenbutatin oxide + I, fenothiocarb + I, fenpyrad + I, fen-pyroximate + I, fenpyrazamine + I, fenson + I, fentrifanil + I, flubenzimine + I, flucycloxuron + I, fluenetil + I, fluorbenside + I, FMC 1137 + I, formetanate + I, formetanate hydrochloride + I, formparanate + I, gamma-HCH + I, glyodin + I, halfenprox + I, hexadecyl cyclopropanecarboxylate + I, isocarbophos + I, jasmolin I + I, jasmolin II + I, jodfenphos + I, lindane + I, malonoben + I, mecarbam + I, mephosfolan + I, mesulfen + I, methacrifos + I, methyl bromide + I, metolcarb + I, mexacarbate + I, milbemycin oxime + I, mipafox + I, monocrotophos + I, morphothion + I, moxidectin + I, naled + I, 4-chloro-2-(2-chloro-2-methyl-propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazin- 3-one + I, nifluridide + I, nikkomycins + I, nitrilacarb + I, nitrilacarb 1:1 zinc chloride complex + I, omethoate + I, oxydeprofos + I, oxydisulfoton + I, pp'-DDT + I, parathion + I, permethrin + I, phenkapton + I, phosalone + I, phosfolan + I, phosphamidon + I, polychloroterpenes + I, polynactins + I, proclonol + I, promacyl + I, propoxur + I, prothidathion + I, prothoate + I, pyrethrin I + I, pyrethrin II + I, pyrethrins + I, pyridaphenthion + I, pyrimitate + I, quinalphos + I, quintiofos + I, R-1492 + I, phosglycin + I, rotenone + I, schradan + I, sebufos + I, selamectin + I, sophamide + I, SSI-121 + I, sulfiram + I, sulfluramid + I, sulfotep + I, sulfur + I, diflovidazin + I, tau-fluvalinate + I, TEPP + I, terbam + I, tetradifon + I, tetrasul + I, thiafenox + I, thiocarboxime + I, thiofanox + I, thiometon + I, thioquinox + I, thuringiensin + I, triamiphos + I, triarathene + I, triazophos + I, triazuron + I, trifenofos + I, trinactin + I, vamidothion + I, vaniliprole + I, bethoxazin + I, copper dioctanoate + I, copper sulfate + I, cybutryne + I, dichlone + I, dichlorophen + I, endothal + I, fentin + I, hydrated lime + I, nabam + I, quinoclamine + I, quinonamid + I, simazine + I, triphenyltin acetate + I, triphenyltin hydroxide + I, crufomate + I, piperazine + I, thiophanate + I, chloralose + I, fenthion + I, pyridin-4-amine + I, strychnine + I, 1-hydroxy-1H-pyridine-2-thione + I, 4- (quinoxalin-2-ylamino)benzenesulfonamide + I, 8-hydroxyquinoline sulfate + I, bronopol + I, copper hydroxide + I, cresol + I, dipyrithione + I, dodicin + I, fenaminosulf + I, formaldehyde + I, hydrargaphen + I, kasugamycin + I, kasugamycin hydrochloride hydrate + I, nickel bis(dimethyldithiocarbamate) + I, nitrapyrin + I, octhilinone + I, oxolinic acid + I, oxytetracycline + I, potassium hydroxyquinoline sulfate + I, probenazole + I, streptomycin + I, streptomycin sesquisulfate + I, tecloftalam + I, thiomersal + I, Adoxophyes orana GV + I, Agrobacterium radiobacter + I, Amblyseius spp. + I, Anagrapha falcifera NPV + I, Anagrus atomus + I, Aphelinus abdominalis + I, Aphidius colemani + I, Aphidoletes aphidimyza + I, Autographa californica NPV + I, Bacillus sphaericus Neide + I, Beauveria brongniartii + I, Chrysoperla carnea + I, Cryptolaemus montrouzieri + I, Cydia pomonella GV + I, Dacnusa sibirica + I, Diglyphus isaea + I, Encarsia formosa + I, Eretmocerus eremicus + I, Heterorhabditis bacteriophora and H. megidis + I, Hippodamia convergens + I, Leptomastix dactylopii + I, Macrolophus caliginosus + I, Mamestra brassicae NPV + I, Metaphycus helvolus + I, Metarhizium anisopliae var. acridum + I, Metarhizium anisopliae var. anisopliae + I, Neodiprion sertifer NPV and N. lecontei NPV + I, Orius spp. + I, Paecilomyces fumosoroseus + I, Phytoseiulus persimilis + I, Steinernema bibionis + I, Steinernema carpocapsae + I, Steinernema feltiae + I, Steinernema glaseri + I, Steinernema riobrave + I, Steinernema riobravis + I, Steinernema scapterisci + I, Steinernema spp. + I, Trichogramma spp. + I, Typhlodromus occidentalis + I , Verticillium lecanii + I, apholate + I, bisazir + I, busulfan + I, dimatif + I, hemel + I, hempa + I, metepa + I, methiotepa + I, methyl apholate + I, morzid + I, penfluron + I, tepa + I, thiohempa + I, thiotepa + I, tretamine + I, uredepa + I, (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol + I, (E)- tridec-4-en-1-yl acetate + I, (E)-6-methylhept-2-en-4-ol + I, (E,Z)-tetradeca-4,10-dien-1-yl acetate + I, (Z)-dodec-7-en-1-yl acetate + I, (Z)-hexadec-11-enal + I, (Z)-hexadec-11-en-1-yl acetate + I, (Z)- hexadec-13-en-11-yn-1-yl acetate + I, (Z)-icos-13-en-10-one + I, (Z)-tetradec-7-en-1-al + I, (Z)-tetradec- 9-en-1-ol + I, (Z)-tetradec-9-en-1-yl acetate + I, (7E,9Z)-dodeca-7,9-dien-1-yl acetate + I, (9Z,11E)- tetradeca-9,11-dien-1-yl acetate + I, (9Z,12E)-tetradeca-9,12-dien-1-yl acetate + I, 14-methyloctadec-1- ene + I, 4-methylnonan-5-ol with 4-methylnonan-5-one + I, alpha-multistriatin + I, brevicomin + I, codlelure + I, codlemone + I, cuelure + I, disparlure + I, dodec-8-en-1-yl acetate + I, dodec-9-en-1-yl acetate + I, dodeca-8 + I, 10-dien-1-yl acetate + I, dominicalure + I, ethyl 4-methyloctanoate + I, eugenol + I, frontalin + I, grandlure + I, grandlure I + I, grandlure II + I, grandlure III + I, grandlure IV + I, hexalure + I, ipsdienol + I, ipsenol + I, japonilure + I, lineatin + I, litlure + I, looplure + I, medlure + I, megatomoic acid + I, methyl eugenol + I, muscalure + I, octadeca-2,13-dien-1-yl acetate + I, octadeca-3,13-dien-1- yl acetate + I, orfralure + I, oryctalure + I, ostramone + I, siglure + I, sordidin + I, sulcatol + I, tetradec- 11-en-1-yl acetate + I, trimedlure + I, trimedlure A + I, trimedlure B1 + I, trimedlure B2 + I, trimedlure C + I, trunc-call + I, 2-(octylthio)-ethanol + I, butopyronoxyl + I, butoxy(polypropylene glycol) + I, dibutyl adipate + I, dibutyl phthalate + I, dibutyl succinate + I, diethyltoluamide + I, dimethyl carbate + I, dimethyl phthalate + I, ethyl hexanediol + I, hexamide + I, methoquin-butyl + I, methylneodecanamide + I, oxamate + I, picaridin + I, 1-dichloro-1-nitroethane + I, 1,1-dichloro-2,2-bis(4-ethylphenyl)-ethane + I, 1,2-dichloropropane with 1,3-dichloropropene + I, 1-bromo-2-chloroethane + I, 2,2,2-trichloro-1-(3,4- dichloro-phenyl)ethyl acetate + I, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate + I, 2-(1,3- dithiolan-2-yl)phenyl dimethylcarbamate + I, 2-(2-butoxyethoxy)ethyl thiocyanate + I, 2-(4,5-dimethyl- 1,3-dioxolan-2-yl)phenyl methylcarbamate + I, 2-(4-chloro-3,5-xylyloxy)ethanol + I, 2-chlorovinyl diethyl phosphate + I, 2-imidazolidone + I, 2-isovalerylindan-1,3-dione + I, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate + I, 2-thiocyanatoethyl laurate + I, 3-bromo-1-chloroprop-1-ene + I, 3-methyl-1- phenylpyrazol-5-yl dimethyl-carbamate + I, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate + I, 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate + I, acethion + I, acrylonitrile + I, aldrin + I, allosamidin + I, allyxycarb + I, alpha-ecdysone + I, aluminium phosphide + I, aminocarb + I, anabasine + I, athidathion + I, azamethiphos + I, Bacillus thuringiensis delta endotoxins + I, barium hexafluorosilicate + I, barium polysulfide + I, barthrin + I, Bayer 22/190 + I, Bayer 22408 + I, beta- cyfluthrin + I, beta-cypermethrin + I, bioethanomethrin + I, biopermethrin + I, bis(2-chloroethyl) ether + I, borax + I, bromfenvinfos + I, bromo-DDT + I, bufencarb + I, butacarb + I, butathiofos + I, butonate + I, calcium arsenate + I, calcium cyanide + I, carbon disulfide + I, carbon tetrachloride + I, cartap hydrochloride + I, cevadine + I, chlorbicyclen + I, chlordane + I, chlordecone + I, chloroform + I, chloropicrin + I, chlorphoxim + I, chlorprazophos + I, cis-resmethrin + I, cismethrin + I, clocythrin + I, copper acetoarsenite + I, copper arsenate + I, copper oleate + I, coumithoate + I, cryolite + I, CS 708 + I, cyanofenphos + I, cyanophos + I, cyclethrin + I, cythioate + I, d-tetramethrin + I, DAEP + I, dazomet + I, decarbofuran + I, diamidafos + I, dicapthon + I, dichlofenthion + I, dicresyl + I, dicyclanil + I, dieldrin + I, diethyl 5-methylpyrazol-3-yl phosphate + I, dilor + I, dimefluthrin + I, dimetan + I, dimethrin + I, dimethylvinphos + I, dimetilan + I, dinoprop + I, dinosam + I, dinoseb + I, diofenolan + I, dioxabenzofos + I, dithicrofos + I, DSP + I, ecdysterone + I, EI 1642 + I, EMPC + I, EPBP + I, etaphos + I, ethiofencarb + I, ethyl formate + I, ethylene dibromide + I, ethylene dichloride + I, ethylene oxide + I, EXD + I, fenchlorphos + I, fenethacarb + I, fenitrothion + I, fenoxacrim + I, fenpirithrin + I, fensulfothion + I, fenthion-ethyl + I, flucofuron + I, fosmethilan + I, fospirate + I, fosthietan + I, furathiocarb + I, furethrin + I, guazatine + I, guazatine acetates + I, sodium tetrathiocarbonate + I, halfenprox + I, HCH + I, HEOD + I, heptachlor + I, heterophos + I, HHDN + I, hydrogen cyanide + I, hyquincarb + I, IPSP + I, isazofos + I, isobenzan + I, isodrin + I, isofenphos + I, isolane + I, isoprothiolane + I, isoxathion + I, juvenile hormone I + I, juvenile hormone II + I, juvenile hormone III + I, kelevan + I, kinoprene + I, lead arsenate + I, leptophos + I, lirimfos + I, lythidathion + I, m-cumenyl methylcarbamate + I, magnesium phosphide + I, mazidox + I, mecarphon + I, menazon + I, mercurous chloride + I, mesulfenfos + I, metam + I, metam- potassium + I, metam-sodium + I, methanesulfonyl fluoride + I, methocrotophos + I, methoprene + I, methothrin + I, methoxychlor + I, methyl isothiocyanate + I, methylchloroform + I, methylene chloride + I, metoxadiazone + I, mirex + I, naftalofos + I, naphthalene + I, NC-170 + I, nicotine + I, nicotine sulfate + I, nithiazine + I, nornicotine + I, O-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate + I, O,O- diethyl O-4-methyl-2-oxo-2H-chromen-7-yl phosphorothioate + I, O,O-diethyl O-6-methyl-2- propylpyrimidin-4-yl phosphorothioate + I, O,O,O',O'-tetrapropyl dithiopyrophosphate + I, oleic acid + I, para-dichlorobenzene + I, parathion-methyl + I, pentachlorophenol + I, pentachlorophenyl laurate + I, PH 60-38 + I, phenkapton + I, phosnichlor + I, phosphine + I, phoxim-methyl + I, pirimetaphos + I, polychlorodicyclopentadiene isomers + I, potassium arsenite + I, potassium thiocyanate + I, precocene I + I, precocene II + I, precocene III + I, primidophos + I, profluthrin + I, promecarb + I, prothiofos + I, pyrazophos + I, pyresmethrin + I, quassia + I, quinalphos-methyl + I, quinothion + I, rafoxanide + I, resmethrin + I, rotenone + I, kadethrin + I, ryania + I, ryanodine + I, sabadilla + I, schradan + I, sebufos + I, SI-0009 + I, thiapronil + I, sodium arsenite + I, sodium cyanide + I, sodium fluoride + I, sodium hexafluorosilicate + I, sodium pentachlorophenoxide + I, sodium selenate + I, sodium thiocyanate + I, sulcofuron + I, sulcofuron-sodium + I, sulfuryl fluoride + I, sulprofos + I, tar oils + I, tazimcarb + I, TDE + I, tebupirimfos + I, temephos + I, terallethrin + I, tetrachloroethane + I, thicrofos + I, thiocyclam + I, thiocyclam hydrogen oxalate + I, thionazin + I, thiosultap + I, thiosultap-sodium + I, tralomethrin + I, transpermethrin + I, triazamate + I, trichlormetaphos-3 + I, trichloronat + I, trimethacarb + I, tolprocarb + I, triclopyricarb + I, triprene + I, veratridine + I, veratrine + I, XMC + I, zetamethrin + I, zinc phosphide + I, zolaprofos + I, meperfluthrin + I, tetramethylfluthrin + I, bis(tributyltin) oxide + I, bromoacetamide + I, ferric phosphate + I, niclosamide-olamine + I, tributyltin oxide + I, pyrimorph + I, trifenmorph + I, 1,2- dibromo-3-chloropropane + I, 1,3-dichloropropene + I, 3,4-dichlorotetrahydrothio-phene 1,1-dioxide + I, 3-(4-chlorophenyl)-5-methylrhodanine + I, 5-methyl-6-thioxo-1,3,5-thiadiazinan-3-ylacetic acid + I, 6- isopentenylaminopurine + I, anisiflupurin + I, benclothiaz + I, cytokinins + I, DCIP + I, furfural + I, isamidofos + I, kinetin + I, Myrothecium verrucaria composition + I, tetrachlorothiophene + I, xylenols + I, zeatin + I, potassium ethylxanthate + I ,acibenzolar + I, acibenzolar-S-methyl + I, Reynoutria sachalinensis extract + I, alpha-chlorohydrin + I, antu + I, barium carbonate + I, bisthiosemi + I, brodifacoum + I, bromadiolone + I, bromethalin + I, chlorophacinone + I, cholecalciferol + I, coumachlor + I, coumafuryl + I, coumatetralyl + I, crimidine + I, difenacoum + I, difethialone + I, diphacinone + I, ergocalciferol + I, flocoumafen + I, fluoroacetamide + I, flupropadine + I, flupropadine hydrochloride + I, norbormide + I, phosacetim + I, phosphorus + I, pindone + I, pyrinuron + I, scilliroside + I, -sodium fluoroacetate + I, thallium sulfate + I, warfarin + I, -2-(2-butoxyethoxy)ethyl piperonylate + I, 5-(1,3- benzodioxol-5-yl)-3-hexylcyclohex-2-enone + I, farnesol with nerolidol + I, verbutin + I, MGK 264 + I, piperonyl butoxide + I, piprotal + I, propyl isomer + I, S421 + I, sesamex + I, sesasmolin + I, sulfoxide + I, anthraquinone + I, copper naphthenate + I, copper oxychloride + I, dicyclopentadiene + I, thiram + I, zinc naphthenate + I, ziram + I, imanin + I, ribavirin + I, chloroinconazide + I, mercuric oxide + I, thiophanate-methyl + I, azaconazole + I, bitertanol + I, bromuconazole + I, cyproconazole + I, difenoconazole + I, diniconazole -+ I, epoxiconazole + I, fenbuconazole + I, fluquinconazole + I, flusilazole + I, flutriafol + I, furametpyr + I, hexaconazole + I, imazalil- + I, imiben-conazole + I, ipconazole + I, metconazole + I, myclobutanil + I, paclobutrazole + I, pefurazoate + I, penconazole + I, prothioconazole + I, pyrifenox + I, prochloraz + I, propiconazole + I, pyrisoxazole + I, -simeconazole + I, tebucon-azole + I, tetraconazole + I, triadimefon + I, triadimenol + I, triflumizole + I, triticonazole + I, ancymidol + I, fenarimol + I, nuarimol + I, bupirimate + I, dimethirimol + I, ethirimol + I, dodemorph + I, fenpropidin + I, fenpropimorph + I, spiroxamine + I, tridemorph + I, cyprodinil + I, mepanipyrim + I, pyrimethanil + I, fenpiclonil + I, fludioxonil + I, benalaxyl + I, furalaxyl + I, -metalaxyl -+ I, Rmetalaxyl + I, ofurace + I, oxadixyl + I, carbendazim + I, debacarb + I, fuberidazole -+ I, thiabendazole + I, chlozolinate + I, dichlozoline + I, myclozoline- + I, procymidone + I, vinclozoline + I, boscalid + I, carboxin + I, fenfuram + I, flutolanil + I, mepronil + I, oxycarboxin + I, penthiopyrad + I, thifluzamide + I, dodine + I, iminoctadine + I, azoxystrobin + I, dimoxystrobin + I, enestroburin + I, fenaminstrobin + I, flufenoxystrobin + I, fluoxastrobin + I, kresoxim--methyl + I, metominostrobin + I, trifloxystrobin + I, orysastrobin + I, picoxystrobin + I, pyraclostrobin + I, pyrametostrobin + I, pyraoxystrobin + I, ferbam + I, mancozeb + I, maneb + I, metiram + I, propineb + I, zineb + I, captafol + I, captan + I, fluoroimide + I, folpet + I, tolylfluanid + I, bordeaux mixture + I, copper oxide + I, mancopper + I, oxine-copper + I, nitrothal- isopropyl + I, edifenphos + I, iprobenphos + I, phosdiphen + I, tolclofos-methyl + I, anilazine + I, benthiavalicarb + I, blasticidin-S + I, chloroneb -+ I, chloro-tha-lonil + I, cyflufenamid + I, cymoxanil + I, cyclobutrifluram + I, diclocymet + I, diclomezine -+ I, dicloran + I, diethofencarb + I, dimethomorph -+ I, flumorph + I, dithianon + I, ethaboxam + I, etridiazole + I, famoxadone + I, fenamidone + I, fenoxanil + I, ferimzone + I, fluazinam + I, flumetylsulforim + I, fluopicolide + I, fluoxytioconazole + I, flusulfamide + I, fluxapyroxad + I, -fenhexamid + I, fosetyl-aluminium -+ I, hymexazol + I, iprovalicarb + I, cyazofamid + I, methasulfocarb + I, metrafenone + I, pencycuron + I, phthalide + I, polyoxins + I, propamocarb + I, pyribencarb + I, proquinazid + I, pyroquilon + I, pyriofenone + I, quinoxyfen + I, quintozene + I, tiadinil + I, triazoxide + I, tricyclazole + I, triforine + I, validamycin + I, valifenalate + I, zoxamide + I, mandipropamid + I, flubeneteram + I, isopyrazam + I, sedaxane + I, benzovindiflupyr + I, pydiflumetofen + I, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide + I, isoflucypram + I, isotianil + I, dipymetitrone + I, 6-ethyl-5,7-dioxo-pyrrolo[4,5][1,4]dithiino[1,2- c]isothiazole-3-carbonitrile + I, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3- carboxamide + I, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine-3-carbonitrile + I, (R)-3- (difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + I, 4-(2-bromo-4-fluoro- phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine + I, 4- (2- bromo- 4- fluorophenyl) - N- (2- chloro- 6- fluorophenyl) - 1, 3- dimethyl- 1H- pyrazol- 5- amine + I, fluindapyr + I, coumethoxystrobin (jiaxiangjunzhi) + I, lvbenmixianan + I, dichlobentiazox + I, mandestrobin + I, 3-(4,4- difluoro-3,4-dihydro-3,3-dimethylisoquinolin-1-yl)quinolone + I, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3- quinolyl)oxy]phenyl]propan-2-ol + I, oxathiapiprolin + I, tert-butyl N-[6-[[[(1-methyltetrazol-5-yl)-phenyl- methylene]amino]oxymethyl]-2-pyridyl]carbamate + I, pyraziflumid + I, inpyrfluxam + I, trolprocarb + I, mefentrifluconazole + I, ipfentrifluconazole+ I, 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4- yl]pyridine-3-carboxamide + I, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + I, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine + I, [2-[3-[2-[1-[2- [3,5-bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]-3-chloro- phenyl] methanesulfonate + I, but-3-ynyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl- methylene]amino]oxymethyl]-2-pyridyl]carbamate + I, methyl N-[[5-[4-(2,4-dimethylphenyl)triazol-2-yl]- 2-methyl-phenyl]methyl]carbamate + I, 3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine + I, pyridachlometyl + I, 3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + I, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one + I, 1- methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1-yl)phenoxy]methyl]phenyl]tetrazol-5-one + I, aminopyrifen + I, ametoctradin + I, amisulbrom + I, penflufen + I, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol- 3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide + I, florylpicoxamid + I, fenpicoxamid + I, metarylpicoxamid + I, tebufloquin + I, ipflufenoquin + I, quinofumelin + I, isofetamid + I, N-[2-[2,4- dichloro-phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + I, N-[2-[2-chloro-4- (trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + I, benzothiostrobin + I, phenamacril + I, 5-amino-1,3,4-thiadiazole-2-thiol zinc salt (2:1) + I, fluopyram + I, flufenoxadiazam + I, flutianil + I, fluopimomide + I, pyrapropoyne + I, picarbutrazox + I, 2- (difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan-4-yl)pyridine-3-carboxamide + I, 2- (difluoromethyl) - N- ((3R) - 1, 1, 3- trimethylindan- 4- yl) pyridine- 3- carboxamide + I, 4-[[6-[2-(2,4-difluorophenyl)-1,1- difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + I, metyltetraprole + I, 2- (difluoromethyl) - N- ((3R) - 1, 1, 3- trimethylindan- 4- yl) pyridine- 3- carboxamide + I, α- (1, 1- dimethylethyl) - α- [4'- (trifluoromethoxy) [1, 1'- biphenyl] - 4- yl] -5- pyrimidinemethanol + I, fluoxapiprolin + I, enoxastrobin + I, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3- pyridyl]oxy] benzonitrile + I, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-sulfanyl-1,2,4- triazol-1-yl)propyl]-3-pyridyl]oxy] benzonitrile + I, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3- (5-thioxo-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + I, trinexapac + I, coumoxystrobin + I, zhongshengmycin + I, thiodiazole copper + I, zinc thiazole + I, amectotractin + I, iprodione + I, seboctylamine + I; N'-[5-bromo-2-methyl-6-[(1S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N- methyl-formamidine + I, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N- methyl-formamidine + I, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N- methyl-formamidine + I, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N- methyl-formamidine + I, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N- methyl-formamidine + I (these compounds may be prepared from the methods described in WO2015/155075); N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methyl- formamidine + I (this compound may be prepared from the methods described in IPCOM000249876D); N-isopropyl-N’-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl- formamidine+ I, N’-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N- isopropyl-N-methyl-formamidine + I (these compounds may be prepared from the methods described in WO2018/228896); N-ethyl-N’-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl- formamidine + I, N-ethyl-N’-[5-methoxy-2-methyl-4-[(2-trifuoromethyl)tetrahydrofuran-2-yl]phenyl]-N- methyl-formamidine + I (these compounds may be prepared from the methods described in WO2019/110427); N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + I, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + I, N-[(1R)-1- benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + I, N-[(1S)-1-benzyl-3,3,3- trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + I, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]- 7,8-difluoro-quinoline-3-carboxamide + I, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3- carboxamide + I, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3- carboxamide + I, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3- carboxamide + I, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + I, N-[(1S)-1- benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + I, N-((1R)-1-benzyl-3-chloro-1-methyl- but-3-enyl)-8-fluoro-quinoline-3-carboxamide + I, N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8- fluoro-quinoline-3-carboxamide + I (these compounds may be prepared from the methods described in WO2017/153380); 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + I, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline + I, 4,4-difluoro- 3,3-dimethyl-1-(6-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline + I, 4,4-difluoro-3,3-dimethyl-1-(7- methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline + I, 1-(6-chloro-7-methyl-pyrazolo[1,5-a]pyridin-3-yl)-4,4- difluoro-3,3-dimethyl-isoquinoline + I (these compounds may be prepared from the methods described in WO2017/025510); 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + I, 1- (4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline + I, 6-chloro-4,4-difluoro-3,3- dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline + I, 4,4-difluoro-1-(5-fluoro-4-methyl-benzimidazol- 1-yl)-3,3-dimethyl-isoquinoline + I, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6H- cyclopenta[e]benzimidazole + I (these compounds may be prepared from the methods described in WO2016/156085); N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide + I, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]propanamide + I, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]propanamide + I, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]urea + I, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]urea + I, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]urea + I, N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide + I, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one + I, 5,5- dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one + I, ethyl 1-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate + I, N,N-dimethyl-1-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine + I. The compounds in this paragraph may be prepared from the methods described in WO 2017/055473, WO 2017/055469, WO 2017/093348 and WO 2017/118689; 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4- triazol-1-yl)propan-2-ol + I (this compound may be prepared from the methods described in WO 2017/029179); 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol + I (this compound may be prepared from the methods described in WO 2017/029179); 3-[2-(1- chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile + I (this compound may be prepared from the methods described in WO 2016/156290); 3-[2-(1-chlorocyclopropyl)-3-(3-chloro- 2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile + I (this compound may be prepared from the methods described in WO 2016/156290); (4-phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3- carboxylate + I (this compound may be prepared from the methods described in WO 2014/006945); 2,6- Dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetrone + I (this compound may be prepared from the methods described in WO 2011/138281); N-methyl-4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]benzenecarbothioamide + I; N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]benzamide + I; (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent- 3-enamide + I (this compound may be prepared from the methods described in WO 2018/153707); N'- (2-chloro-5-methyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + I; N'-[2-chloro-4-(2- fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine + I (this compound may be prepared from the methods described in WO 2016/202742); 2-(difluoromethyl)-N-[(3S)-3-ethyl-1,1-dimethyl- indan-4-yl]pyridine-3-carboxamide + I (this compound may be prepared from the methods described in WO 2014/095675); (5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone + I, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone + I (these compounds may be prepared from the methods described in WO 2017/220485); 2-oxo-N-propyl-2-[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide + I (this compound may be prepared from the methods described in WO 2018/065414); ethyl 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2- thienyl]methyl]pyrazole-4-carboxylate + I (this compound may be prepared from the methods described in WO 2018/158365); 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]acetamide + I, N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]benzamide + I, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + I, N-[N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + I (these compounds may be prepared from the methods described in WO 2018/202428). The above described mixing partners are known. Where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound "abamectin" is described under entry number (1). Where "[CCN]" is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright © 1995- 2004]; for example, the compound "acetoprole" is described under the internet address http://www.alanwood.net/pesticides/acetoprole.html. Most of the active ingredients described above are referred to hereinabove by a so-called "common name", the relevant "ISO common name" or another "common name" being used in individual cases. If the designation is not a "common name", the nature of the designation used instead is given in round brackets for the particular compound; in that case, the IUPAC name, the IUPAC/Chemical Abstracts name, a "chemical name", a "traditional name", a "compound name" or a "develoment code" is used or, if neither one of those designations nor a "common name" is used, an "alternative name" is employed. “CAS Reg. No” means the Chemical Abstracts Registry Number. The active ingredient mixture of the compounds of formula (I) and an active ingredient as described above are preferably in a mixing ratio of from 100:1 to 1:6000, especially from 50:1 to 1:50, more especially in a ratio of from 20:1 to 1:20, even more especially from 10:1 to 1:10, very especially from 5:1 and 1:5, special preference being given to a ratio of from 2:1 to 1:2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1:1, or 5:1, or 5:2, or 5:3, or 5:4, or 4:1, or 4:2, or 4:3, or 3:1, or 3:2, or 2:1, or 1:5, or 2:5, or 3:5, or 4:5, or 1:4, or 2:4, or 3:4, or 1:3, or 2:3, or 1:2, or 1:600, or 1:300, or 1:150, or 1:35, or 2:35, or 4:35, or 1:75, or 2:75, or 4:75, or 1:6000, or 1:3000, or 1:1500, or 1:350, or 2:350, or 4:350, or 1:750, or 2:750, or 4:750. Those mixing ratios are by weight. The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body. The mixtures comprising a compound of formula (I) and one or more active ingredients as described above can be applied, for example, in a single “ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a “tank-mix”, and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the compounds of formula (I) and the active ingredient(s) as described above, is not essential for working the present invention. The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides. The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds of formula (I) for the preparation of these compositions are also a subject of the invention. Another aspect of the invention is related to the use of a compound of formula (I) or of a preferred individual compound as defined herein, of a composition comprising at least one compound of formula (I) or at least one preferred individual compound as above-defined, or of a fungicidal or insecticidal mixture comprising at least one compound of formula (I) or at least one preferred individual compound as above-defined, in admixture with other fungicides or insecticides as described above, for controlling or preventing infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms. A further aspect of the invention is related to a method of controlling or preventing an infestation of plants, e.g., useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g., harvested food crops, or of non-living materials by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials. Controlling or preventing means reducing infestation by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated. A preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, or insects which comprises the application of a compound of formula (I), or an agrochemical composition which contains at least one of said compounds, is foliar application. The frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen or insect. However, the compounds of formula (I) can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field. The compounds of formula I may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation. A formulation, e.g. a composition containing the compound of formula (I), and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of formula (I), may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants). Advantageous rates of application are normally from 5g to 2kg of active ingredient (a.i.) per hectare (ha), preferably from 10g to 1kg a.i./ha, most preferably from 20g to 600g a.i./ha. When used as seed drenching agent, convenient dosages are from 10mg to 1g of active substance per kg of seeds. When the combinations of the present invention are used for treating seed, rates of 0.001 to 50 g of a compound of formula I per kg of seed, preferably from 0.01 to 10g per kg of seed are generally sufficient. Suitably, a composition comprising a compound of formula (I) according to the present invention is applied either preventative, meaning prior to disease development or curative, meaning after disease development. The compositions of the invention may be employed in any conventional form, for example in the form of a twin pack, a powder for dry seed treatment (DS), an emulsion for seed treatment (ES), a flowable concentrate for seed treatment (FS), a solution for seed treatment (LS), a water dispersible powder for seed treatment (WS), a capsule suspension for seed treatment (CF), a gel for seed treatment (GF), an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP) or any technically feasible formulation in combination with agriculturally acceptable adjuvants. Such compositions may be produced in conventional manner, e.g. by mixing the active ingredients with appropriate formulation inerts (diluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects). Also conventional slow release formulations may be employed where long lasting efficacy is intended. Particularly formulations to be applied in spraying forms, such as water dispersible concentrates (e.g. EC, SC, DC, OD, SE, EW, EO and the like), wettable powders and granules, may contain surfactants such as wetting and dispersing agents and other compounds that provide adjuvancy effects, e.g. the ondensation product of formaldehyde with naphthalene sulphonate, an alkylarylsulphonate, a lignin sulphonate, a fatty alkyl sulphate, and ethoxylated alkylphenol and an ethoxylated fatty alcohol. A seed dressing formulation is applied in a manner known per se to the seeds employing the combination of the invention and a diluent in suitable seed dressing formulation form, e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds. Such seed dressing formulations are known in the art. Seed dressing formulations may contain the single active ingredients or the combination of active ingredients in encapsulated form, e.g. as slow release capsules or microcapsules. In general, the formulations include from 0.01 to 90% by weight of active agent, from 0 to 20% agriculturally acceptable surfactant and 10 to 99.99% solid or liquid formulation inerts and adjuvant(s), the active agent consisting of at least the compound of formula (I) optionally together with other active agents, particularly microbiocides or conservatives or the like. Concentrated forms of compositions generally contain in between about 2 and 80%, preferably between about 5 and 70% by weight of active agent. Application forms of formulation may for example contain from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight of active agent. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ diluted formulations. Whereas it is preferred to formulate commercial products as concentrates, the end user will normally use dilute formulations. The compounds in Tables 1.1 to 1.7 below illustrate the compounds of the invention. The skilled person would understand that the compounds of formula (I) may exist as E and/or Z isomers as described herein before. Where mentioned the specific geometric configuration is not considered to be limiting. Table 1.1: This table discloses 61 specific compounds of formula (I):
Figure imgf000049_0001
wherein A1, A2, are CH2, X is O, Y is CH, R1 is hydrogen, and R2 is as defined below in the Table 1. Each of Tables 1.2 to 1.7 (which follow Table 1.1) discloses 61 individual compounds of the formula (I) in which A1, A2, X, Y, and R1 are as specifically defined in Tables 1.2 to 1.7, which refer to Table 1 wherein R2 is specifically defined. Table 1
Figure imgf000049_0002
Figure imgf000050_0001
Table 1.2: This table discloses 61 specific compounds of the formula (I) wherein A1and A2 are CH2, X is O, Y is CH, R1 is methyl, and R2 is as defined above in the Table 1. Table 1.3: This table discloses 61 specific compounds of the formula (I) wherein A1 and A2 are CH2, X is O, Y is CH, R1 is fluoro, and R2 is as defined above in the Table 1. Table 1.4: This table discloses 61 specific compounds of the formula (I) wherein A1 is CH2, A2 is CH2CH2, X is O, Y is CH, R1 is hydrogen, and R2 is as defined above in the Table 1. Table 1.5: This table discloses 61 specific compounds of the formula (I) wherein A1 and A2 are CH2, X is O, Y is CH, R1 is methoxy, and R2 is as defined above in the Table 1. Table 1.6: This table discloses 61 specific compounds of the formula (I) wherein A1 and A2 are CH2, X is O, Y is N, R1 is hydrogen, and R2 is as defined above in the Table 1. Table 1.7: This table discloses 61 specific compounds of the formula (I) wherein A1 and A2 are CH2, X is NH, Y is N, R1 is hydrogen, and R2 is as defined above in the Table 1. EXAMPLES The Examples which follow serve to illustrate the invention. The compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm, 0.8 ppm or 0.2 ppm. Compounds of formula (I) may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against diseases that are caused by fungi or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile (including improved crop tolerance), improved physico- chemical properties, or increased biodegradability). Throughout this description, temperatures are given in degrees Celsius (°C) and “mp.” means melting point. LC/MS means Liquid Chromatography Mass Spectrometry and the description of the apparatus and the methods is as follows: Method A: Spectra were recorded on a Mass Spectrometer from Waters Corporation (SQD, SQDII or QDA Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive and negative ions), Capillary: 0.8-3.00 kV, Cone: 5-30 V, Source Temperature: 120-150°C, Desolvation Temperature: 350-600°C, Cone Gas Flow: 50-150 l/h, Desolvation Gas Flow: 650-1000 l/h, Mass range: 50 to 900 Da and an Acquity UPLC from Waters Corporation: Binary pump, heated column compartment , diode-array detector and ELSD. Column: Waters UPLC HSS T3, 1.8 µm, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 400, Runtime: 1.5 min; Solvents: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05 % HCOOH; Flow (ml/min) 0.85, Gradient: 10% B isocratic for 0.2 min, then 10-100% B in 1.0 min, 100% B isocratic for 0.2min, 100-10% B in 0.05min, 10% B isocratic for 0.05 min. Where necessary, enantiomerically pure final compounds may be obtained from racemic materials as appropriate via standard physical separation techniques, such as reverse phase chiral chromatography, or through stereoselective synthetic techniques, eg, by using chiral starting materials. Formulation Examples Wettable powders a) b) c) Active ingredient [compound of Formula (I)] 25 % 50 % 75 % sodium lignosulfonate 5 % 5 % - sodium lauryl sulfate 3 % - 5 % sodium diisobutylnaphthalenesulfonate - 6 % 10 % phenol polyethylene glycol ether - 2 % - (7-8 mol of ethylene oxide) highly dispersed silicic acid 5 % 10 % 10 % Kaolin 62 % 27 % - The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration. Powders for dry seed treatment a) b) c) Active ingredient [compound of Formula (I)] 25 % 50 % 75 % light mineral oil 5 % 5 % 5 % highly dispersed silicic acid 5 % 5 % - Kaolin 65 % 40 % - Talcum - - 20 % The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment. Emulsifiable concentrate active ingredient [compound of Formula (I)] 10 % octylphenol polyethylene glycol ether 3 % (4-5 mol of ethylene oxide) calcium dodecylbenzenesulfonate 3 % castor oil polyglycol ether (35 mol of ethylene oxide) 4 % Cyclohexanone 30 % xylene mixture 50 % Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water. Dusts a) b) c) Active ingredient [compound of Formula (I)] 5 % 6 % 4 % Talcum 95 % - - Kaolin - 94 % - mineral filler - - 96 % Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed. Extruder granules Active ingredient [compound of Formula (I)] 15 % sodium lignosulfonate 2 % Carboxymethylcellulose 1 % Kaolin 82 % The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air. Coated granules Active ingredient [compound of Formula (I)] 8 % polyethylene glycol (mol. wt.200) 3 % Kaolin 89 % The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner. Suspension concentrate Active ingredient [compound of Formula (I)] 40 % propylene glycol 10 % nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6 % Sodium lignosulfonate 10 % Carboxymethylcellulose 1 % Silicone oil (in the form of a 75 % emulsion in water) 1 % Water 32 % The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion. Flowable concentrate for seed treatment Active ingredient [compound of Formula (I)] 40 % propylene glycol 5 % copolymer butanol PO/EO 2 % tristyrenephenole with 10-20 moles EO 2 % 1,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 % monoazo-pigment calcium salt 5 % Silicone oil (in the form of a 75 % emulsion in water) 0.2 % Water 45.3 % The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion. Slow-Release Capsule Suspension 28 parts of a combination of the compound of Formula (I) are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8:1). This mixture is emulsified in a mixture of 1.2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed. The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension Formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns. The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose. List of Abbreviations: Aq. = aqueous Ac = Acetyl br s = broad singlet °C = degrees Celsius CO = carbon monoxide DCM = dichloromethane DMSO-d6 = deuterated dimethyl sulfoxide d = doublet dd = doublet of doublets DMF = dimethylformamide EtOAc = ethyl acetate EtOH = ethanol equiv. = equivalent h = hour(s) M = molar m = mulitplet min = minutes MHz = mega hertz mp = melting point PEPPSI-IPr catalyst =[1,3-Bis(2,6-Diisopropylphenyl)imidazol-2-ylidene](3- chloropyridyl)palladium(II) dichloride ppm = parts per million RT = room temperature Rt = retention time s = singlet t = triplet THF = tetrahydrofuran LC/MS = Liquid Chromatography Mass Spectrometry (description of the apparatus and the methods used for LC/MS analysis are given above) Preparation Examples Example 1: Preparation of methyl (E)-2-(3-ethoxyiminotetralin-5-yl)-3-methoxy-prop-2-enoate (Compound 1.5 and Compound 1:6)
Figure imgf000055_0001
Step 1: Preparation of methyl (Z)-2-iodo-3-methoxy-prop-2-enoate
Figure imgf000055_0002
To a solution of methyl trans-3-methoxyacrylate (20.0 g, 18.7 mL, 172 mmol, 1.00 equiv.) in dichloromethane (350 mL) was added N-iodo succinimide (43.9 g, 189 mmol, 1.10 equiv.) in small portions. Acetic acid (19.9 mL, 344 mmol, 2.00 equiv.) was then introduced dropwise at room temperature and the resulting suspension was stirred for 22 hours. Triethyl amine (72.2 mL, 516 mmol, 3.00 equiv.) was then added dropwise while keeping the temperature constant with a water bath. The brown solution was stirred for 3 hours. A mixture of saturated aqueous Na2S2O3 and saturated aqueous NaHCO3 was then added, the layers were separated, and the aqueous layer was extracted with dichloromethane. The total combined organic fraction was washed sequentially with aqueous NaHCO3, aqueous Na2S2O3 and brine, then dried over Na2SO4, filtered and concentrated under reduced pressure. The resultant crude residue was purified by flash chromatography (cyclohexane:EtOAc) to give methyl (Z)-2-iodo-3-methoxy-prop-2-enoate as a brown solid. LC-MS (Method A), Rt = 0.76 min, MS: (M+H) = 243; NMR: 1H NMR (400 MHz, CDCl3) δ ppm 3.80 (s, 3 H) 4.02 (s, 3 H) 7.67 - 7.75 (m, 1 H). Step 2: Preparation of 8-bromo-N-ethoxy-tetralin-2-imine
Figure imgf000056_0001
To a mixture of 8-bromotetralin-2-one (3.00 g, 13.3 mmol, 1.00 equiv.) in ethanol (20 mL) was added O- ethylhydroxylamine hydrochloride (4.02 g, 40.0 mmol, 3.00 equiv.) followed by sodium acetate (3.31 g, 40.0 mmol, 3.00 equiv.). The resulting reaction mixture was stirred at room temperature for 18 hours, then diluted with EtOAc and water, and extracted with EtOAc. The total combined organic fraction was washed with water and brine, dried with Na2SO4, filtered, and concentrated under reduced pressure. The resultant crude residue was purified by flash chromatography (cyclohexane:EtOAc) to give 8- bromo-N-ethoxy-tetralin-2-imine as an oil. LC-MS (Method A), Rt = 1.18 min, MS: (M+H) = 268 - 270; 1H NMR (400 MHz, CDCl3) δ ppm: 7.46 (m, 1H), 7.08-7.12 (m, 1H), 6.99-7.06 (m, 1H), 4.17 (m, 2H), 3.77 (s, 2H), 2.89-2.96 (m, 2H), 2.52-2.59 (m, 2H), 1.32 (m, 3H). Step 3: Preparation of methyl N-ethoxy-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) tetralin-2-imine
Figure imgf000056_0002
To a solution of 8-bromo-N-ethoxy-tetralin-2-imine (0.75 g, 2.80 mmol, 1.00 equiv.) in dioxane (5.60 mL) was added potassium acetate (0.55 g, 5.60 mmol, 2.00 equiv.) and bis(pinacolato)diboron (1.43 g, 5.60 mmol, 2.00 equiv.). The solution was degassed with argon for 5 min and PdCl2(dppf)2 (0.21 g, 0.28 mmol, 0.10 equiv.) was then introduced. The reddish solution obtained was stirred at 100°C for 1h. After allowing to reach RT, the reaction mixture was diluted with EtOAc and water then extracted with EtOAc. The total combined organic fraction was washed with water and brine, dried with Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash chromatography (cyclohexane:EtOAc) to give N-ethoxy-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)tetralin-2-imine as a brown gum. LC-MS (Method A), Rt = 1.27 min, MS: (M+H) = 316; 1H NMR (400 MHz, CDCl3) δ ppm : 7.66 (m, 1H), 7.19-7.23 (m, 1H), 7.14-7.17 (m, 1H), 4.12-4.18 (m, 2H), 4.11 (s, 2H), 2.86-2.93 (m, 2H), 2.52-2.57 (m, 2H), 1.37 (s, 12H), 1.31 (m, 3H). Step 4: Preparation of methyl (E)-2-(3-ethoxyiminotetralin-5-yl)-3-methoxy-prop-2-enoate To a solution of N-ethoxy-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)tetralin-2-imine (400 mg, 1.27 mmol, 1.00 equiv.) in dioxane (12.7 mL) and water (0.63 mL) was added methyl (Z)-2-iodo-3-methoxy- prop-2-enoate (460 mg, 1.90 mmol, 1.50 equiv.), cesium carbonate (831 mg, 2.54 mmol, 2.00 equiv.) followed by addition of cataCXium-A-Pd-G3 (195 mg, 0.25 mmol, 0.20 equiv.). The solution was degassed with argon for 5 min and then stirred at 80°C for 4 hours. The reaction mixture was diluted with EtOAc and water then extracted with EtOAc. The total combined organic fraction was washed with water and brine, dried with Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography (cyclohexane:EtOAc) to give methyl (E)-2-(3-ethoxyiminotetralin- 5-yl)-3-methoxy-prop-2-enoate as 2 separate oxime isomers that were isolated as orange oils. (Z)-isomer Compound 1.6 LC-MS (Method A), Rt = 0.99 min, MS: (M+H) = 305; 1H NMR (400 MHz, CDCl3) δ ppm: 7.61 (s, 1H), 7.11-7.20 (m, 2H), 7.04 (m, 1H), 4.13 (m, 2H), 3.85 (s, 3H), 3.73 (s, 3H), 3.58 (s, 2H), 2.91-2.97 (m, 2H), 2.54-2.60 (m, 2H), 1.29 (m, 3H). (E)-isomer Compound 1.5 LC-MS (Method A), Rt = 1.02 min, MS: (M+H) = 305; 1H NMR (400 MHz, CDCl3) δ ppm: 7.60 (s, 1H), 7.14-7.22 (m, 2H), 7.08 (m, 1H), 4.07 (m, 2H), 3.83 (s, 3H), 3.70 (s, 3H), 3.37 (s, 2H), 2.83-2.88 (m, 2H), 2.64-2.70 (m, 2H), 1.24 (m, 3H). Example 2 Preparation of methyl (E)-3-methoxy-2-(3-prop-2-ynoxyiminotetralin-5-yl)prop-2-enoate (Compound 1.3 and Compound 1:4)
Figure imgf000057_0001
Step 1: Preparation of 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)tetralin-2-one
Figure imgf000058_0001
To a mixture of 8-bromotetralin-2-one (7.00 g, 31.1 mmol, 1.00 equiv.) in dioxane (62.2 mL) was added potassium carbonate (6.17 g, 62.2 mmol, 2.00 equiv.) and bis(pinacolato)diboron (16.0 g, 62.2 mmol, 2.00 equiv.). The solution was degassed with argon for 5 min and PdCl2(dppf)2 (2.40 g, 3.11 mmol, 0.10 equiv.) was introduced. The resultant reddish solution obtained was stirred at 100°C for 1h. The reaction mixture was diluted with EtOAc and water and then extracted with EtOAc. The total combined organic fraction was washed with water and brine, dried with Na2SO4, filtered, and concentrated under reduced pressure. The resultant crude residue was purified by flash chromatography (cyclohexane:EtOAc) to give 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)tetralin-2-one. LC-MS (Method A), Rt = 1.10 min, MS: (M+H) = 273; 1H NMR (400 MHz, CDCl3) δ ppm: 7.76 (m, 1H), 7.33 (d, 1H), 7.21-7.26 (m, 1H), 4.02 (s, 2H), 3.08 (m, 2H), 2.54-2.60 (m, 2H), 1.28 (s, 12H). Step 2: Preparation of methyl (E)-3-methoxy-2-(3-oxotetralin-5-yl)prop-2-enoate
Figure imgf000058_0002
To a solution of 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)tetralin-2-one (1.00 g, 3.67 mmol, 1.00 equiv.) in dioxane (36.7 mL) and water (1.84 mL) was added methyl (Z)-2-iodo-3-methoxy-prop-2- enoate (1.33 g, 5.51 mmol, 1.50 equiv.), cesium carbonate (2.41 g, 7.35 mmol, 2.00 equiv.), followed by cataCXium-A-Pd-G3 (563 mg, 0.73 mmol, 0.20 equiv.). The resultant solution was degassed with argon for 5 min, then stirred at 90°C for 30 min. The reaction mixture was allowed to reach RT, diluted with EtOAc and water, and extracted with EtOAc. The total combined organic fraction was washed with water and brine, dried with Na2SO4, filtered, and concentrated under reduced pressure. The resultant crude residue was purified by flash chromatography (cyclohexane:EtOAc) to give methyl (E)-3-methoxy- 2-(3-oxotetralin-5-yl)prop-2-enoate as an orange oil. LC-MS (Method A), Rt = 0.83 min, MS: (M+H) = 261; 1H NMR (400 MHz, CDCl3) δ ppm: 7.60 (s, 1H), 7.21-7.25 (m, 2H), 7.10 (m, 1H), 3.84 (s, 3H), 3.71 (s, 3H), 3.44 (s, 2H), 3.11 (m, 2H), 2.57 (m, 2H). Step 3: Preparation of methyl (E)-3-methoxy-2-(3-prop-2-ynoxyiminotetralin-5-yl)prop-2-enoate To a solution of methyl (E)-3-methoxy-2-(3-oxotetralin-5-yl)prop-2-enoate (100 mg, 0.31 mmol, 1.00 equiv.) in methanol (4.00 mL) was added O-prop-2-ynylhydroxylamine hydrochloride (100 mg, 0.92 mmol, 3.00 equiv.) followed by sodium acetate (76.4 mg, 0.92 mmol, 3.00 equiv.). The resulting reaction mixture was stirred at room temperature for 15 min, diluted with TBME and water, and then extracted with TBME. The total combined organic fraction was washed with water and brine, dried with Na2SO4, filtered, and concentrated under reduced pressure. The resultant crude residue was purified by flash chromatography (cyclohexane:EtOAc) to give methyl (E)-3-methoxy-2-(3-prop-2-ynoxyiminotetralin-5- yl)prop-2-enoate as 2 separate oxime isomers that were isolated as orange oils. (Z)-isomer Compound 1.3 LCMS (Method A), Rt: 0.97 min, M+H: 314,1H NMR (CDCl3) δ: 7.62 (s, 1H), 7.17-7.23 (m, 1H), 7.11-7.15 (m, 1H), 7.04 (m, 1H), 4.68 (d, 2H), 3.86 (s, 3H), 3.73 (s, 3H), 3.60 (s, 2H), 2.92-2.97 (m, 2H), 2.58-2.63 (m, 2H), 2.48 (m, 1H) (E)-isomer Compound 1.4 LCMS (Method A), Rt: 0.99 min, M+H: 314, 1H NMR (CDCl3) δ: 7.61 (s, 1H), 7.15-7.24 (m, 2H), 7.10 (m, 1H), 4.64 (d, 2H), 3.85 (s, 3H), 3.72 (s, 3H), 3.41 (s, 2H), 2.85-2.90 (m, 2H), 2.69-2.74 (m, 2H), 2.45 (m, 1H) Table T1: Melting point (mp) data and/or retention times (Rt) for compounds according to formula (I):
Figure imgf000059_0001
Figure imgf000060_0001
Example B: Biological examples/test methods: Glomerella lagenarium syn. Colletotrichum lagenarium (anthracnose of cucurbits): Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 °C and the inhibition of growth was determined photometrically after 72 hrs at 620nm. The following compounds gave at least 80% control of Glomerella lagenarium at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.2, 1.3, 1.4 Erysiphe graminis f.sp. tritici (Wheat powdery mildew): Wheat leaf segments are placed on agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf disks are inoculated with spores of the fungus. After appropriate incubation the activity of a compound is assessed 7 dpi (days post inoculation) as preventive fungicidal activity. The following compounds gave at least 80% control of Erysiphe graminis f. sp. tritici at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.2, 1.3, 1.4 Mycosphaerella arachidis syn. Cercospora arachidicola (Brown leaf spot of peanut): Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24°C and the inhibition of growth was determined photometrically after approximately 5-6 days at 620nm. The following compounds gave at least 80% control of Mycosphaerella arachidis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.2, 1.3, 1.4 Phakopsora pachyrhizi (Soybean rust): Soybean leaf disks are placed on agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf disks are inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound is assessed approx.12 dpi (days after inoculation) as preventive fungicidal activity. The following compounds gave at least 70% control of Phakopsora pachyrhizi at 60 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.2, 1.3, 1.4, 1.5, 1.6 Phytophthora infestans (late blight of potato/tomato): Tomato leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf disks are inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound is assessed 4 dpi (days after inoculation) as preventive fungicidal activity. The following compounds gave at least 80% control of Phytophthora infestans at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.4 Plasmopara viticola (downy mildew of grapevine): Grape vine leaf disks are placed on agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf disks are inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound is assessed 7 dpi (days after inoculation) as preventive fungicidal activity. The following compounds gave at least 80% control of Plasmopara viticola at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.2, 1.3, 1.4 Puccinia recondita (Brown rust), curative: Wheat leaf segments are placed on agar in multiwell plates (24-well format). The leaf segments are inoculated with a spore suspension of the fungus and sprayed with test solutions 1 day after inoculation. After appropriate incubation the activity of a compound is assessed 8 dpi (days after inoculation) as curative fungicidal activity. The following compounds gave at least 80% control of Puccinia recondita f. sp. tritici at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.2, 1.3, 1.4 Puccinia recondita (Brown rust), preventative: Wheat leaf segments are placed on agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf segments are inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound is assessed 8 dpi (days after inoculation) as preventative fungicidal activity. The following compounds gave at least 80% control of Puccinia recondita f. sp. tritici at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.2, 1.3, 1.4 Mycosphaerella graminicola (Septoria tritici) / (Septoria blotch): Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 4-5 days after application. The following compounds gave at least 80% control of Mycosphaerella graminicola at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: (Compounds of Table T1): 1.1, 1.2, 1.3, 1.4

Claims

CLAIMS: 1. A compound of formula (I)
Figure imgf000063_0001
Wherein Y is CH or N; X is O or NH; R1 is selected from the group consisting of hydrogen, halogen, C1-C4alkyl and C1-C4alkoxy; R2 is selected from the group consisting of hydrogen, C1-C8alkyl, C3-C6alkenyl, C3-C6alkynyl, cyanoC1-C6alkyl-, C1-C6haloalkyl, C3-C6haloalkenyl, hydroxyC2-C6alkyl-, C1-C4alkoxyC2- C6alkyl-, C1-C4haloalkoxyC2-C6alkyl-, C1-C4alkoxyC2-C4alkoxyC2-C6alkyl-, C2-C6alkenyloxyC2- C6alkyl-, C2-C6alkynyloxyC2-C6alkyl-, aminoC2-C6alkyl-, N-C1-C4alkylaminoC2-C6alkyl-, N,N- diC1-C4alkylaminoC2-C6alkyl-, C1-C6alkylcarbonylC1-C6alkyl-, C1-C6alkoxycarbonylC1-C6alkyl-, C1-C6alkylcarbonyloxyC2-C6alkyl-, N-C1-C4alkylaminocarbonylC1-C6alkyl-, N,N-diC1- C4alkylaminocarbonylC1-C6alkyl-, C1-C6alkylsulfanylC1-C6alkyl-, C1-C6alkylsulfinylC1-C6alkyl-, C1-C6alkylsulfonylC1-C6alkyl-, C1-C4alkoxyiminoC2-C4alkyl-, C3-C6cycloalkyl, C3-C6cycloalkylC1- C3alkyl-, phenyl, heterocyclyl, heteroaryl, phenylC1-C3alkyl-, heterocyclylC1-C3alkyl- and heteroarylC1-C3alkyl-, wherein said C3-C6cycloalkyl, C3-C6cycloalkylC1-C3alkyl-, phenyl, heterocyclyl, heteroaryl, phenylC1-C3alkyl-, heterocyclylC1-C3alkyl- or heteroarylC1-C3alkyl- are optionally substituted where feasible by 1 or 2 R3 substituents, which may be the same or different, and wherein said heterocyclyl is a 3- to 6- membered non-aromatic ring which comprises 1 or 2 heteroatoms individually selected from nitrogen, oxygen and sulfur, and said heteroaryl is a 5-or 6-membered monocyclic aromatic ring which comprises 1, 2, 3 or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur; R3 is selected from the group consisting of methyl, ethyl, propyl, iso-propyl, chloro, fluoro, cyano, difluoromethyl, trifluoromethyl, oxo, hydroxy, methoxy, ethoxy, difluoromethoxy, and cyclopropyl; A1 is CH2 or O; A2 is a direct bond, CH2, or CH2CH2; or an agronomically acceptable salt thereof; or an N-oxide thereof.
2. The compound according to claim 1, wherein Y is CH.
3. The compound according to claim 1 or claim 2, wherein X is O.
4. The compound according to any one of claims 1 to 3, wherein R1 is selected from the group consisting of hydrogen, fluoro and methyl.
5. The compound according to any one of claims 1 to 4, wherein R1 is hydrogen.
6. The compound according to any one of claims 1 to 5, wherein R2 is selected from the group consisting of C1-C8alkyl, C3-C6alkenyl, C3-C6alkynyl, cyanoC1-C6alkyl-, C1-C6haloalkyl, hydroxyC2-C6alkyl-, C1-C4alkoxyC2-C6alkyl-, C1-C4haloalkoxyC2-C6alkyl-, C1- C6alkylcarbonyloxyC2-C6alkyl-, C1-C4alkoxyiminoC2-C4alkyl-, C3-C6cycloalkyl and C3- C6cycloalkylC1-C3alkyl-, wherein said C3-C6cycloalkyl or C3-C6cycloalkylC1-C3alkyl- are optionally substituted where feasible by 1 or 2 R3 substituents, which may be the same or different.
7. The compound according to any one of claims 1 to 6, wherein R2 is selected from the group consisting of C1-C8alkyl and C3-C6alkynyl.
8. The compound according to any one of claims 1 to 7, wherein R2 is selected from the group consisting of methyl, ethyl and propargyl.
9. The compound according to any one of claims 1 to 8, wherein A1 is CH2.
10. The compound according to any one of claims 1 to 9, wherein A2 is CH2.
11. The compound according to any one of claims 1 to 10, wherein A1 and A2 are CH2.
12. An agrochemical composition comprising a fungicidally effective amount of a compound of formula (I) according to any one of claims 1 to 11 and an agrochemically-acceptable diluent or carrier.
13. The composition according to claim 12, further comprising at least one additional active ingredient.
14. A method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a fungicidally effective amount of a compound of formula (I) according to any of claims 1 to 11, or a composition comprising this compound as active ingredient, is applied to the plants, to parts thereof or the locus thereof.
15. Use of a compound of formula (I) according to any one of claims 1 to 11 as a fungicide.
PCT/EP2021/075770 2020-09-21 2021-09-20 Microbiocidal compounds WO2022058580A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR112023004833A BR112023004833A2 (en) 2020-09-21 2021-09-20 MICROBIOCIDAL COMPOUNDS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2014840.9 2020-09-21
GBGB2014840.9A GB202014840D0 (en) 2020-09-21 2020-09-21 Microbiocidal compounds

Publications (1)

Publication Number Publication Date
WO2022058580A1 true WO2022058580A1 (en) 2022-03-24

Family

ID=73196688

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2021/075770 WO2022058580A1 (en) 2020-09-21 2021-09-20 Microbiocidal compounds

Country Status (3)

Country Link
BR (1) BR112023004833A2 (en)
GB (1) GB202014840D0 (en)
WO (1) WO2022058580A1 (en)

Citations (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2176186A (en) * 1985-06-04 1986-12-17 Egyt Gyogyszervegyeszeti Gyar Fungicidal phenanthrene derivatives
US4639771A (en) 1984-10-31 1987-01-27 Kabushiki Kaisha Toshiba Image processing system
EP0357460A2 (en) 1988-09-02 1990-03-07 Sankyo Company Limited 13-Substituted milbemycin derivatives, their preparation and use
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0382173A2 (en) 1989-02-07 1990-08-16 Meiji Seika Kaisha Ltd. PF 1022 substance, method of producing same and anthelmintic composition containing same
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0414153A1 (en) * 1989-08-22 1991-02-27 Nihon Nohyaku Co., Ltd. N-(substituted benzyloxy)imine derivatives, process for the production thereof, use thereof, and method of use thereof
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0444964A1 (en) 1990-03-01 1991-09-04 Sankyo Company Limited Milbemycin ether derivatives, their preparation and their anthelmintic uses
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
EP0503538A1 (en) 1991-03-08 1992-09-16 Meiji Seika Kaisha Ltd. Medicinal composition containing an anthelmintic cyclic depsipeptide
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1993019053A1 (en) 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
WO1993025543A2 (en) 1992-06-11 1993-12-23 Bayer Aktiengesellschaft Enniatines and enniatine derivates used to control endoparasites
EP0594291A1 (en) 1992-09-01 1994-04-27 Sankyo Company Limited Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
WO1994015944A1 (en) 1993-01-18 1994-07-21 Pfizer Limited New antiparasitic agents related to the milbemycins and avermectins
WO1994019334A1 (en) 1993-02-19 1994-09-01 Meiji Seika Kaisha, Ltd. Pf1022 derivative, cyclic depsipeptide
EP0626375A1 (en) 1993-05-26 1994-11-30 Bayer Ag Octacyclodepsipeptides having endoparasiticidal activity
WO1995019363A1 (en) 1994-01-14 1995-07-20 Pfizer Inc. Antiparasitic pyrrolobenzoxazine compounds
WO1995022552A1 (en) 1994-02-16 1995-08-24 Pfizer Limited Antiparasitic agents
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
US5478855A (en) 1992-04-28 1995-12-26 Yashima Chemical Industry Co., Ltd. 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-oxazoline
WO1996011945A2 (en) 1994-10-18 1996-04-25 Bayer Aktiengesellschaft Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
WO1996015121A1 (en) 1994-11-10 1996-05-23 Bayer Aktiengesellschaft Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production
DE19520936A1 (en) 1995-06-08 1996-12-12 Bayer Ag Ectoparasiticides means
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
WO1998017631A2 (en) * 1996-10-23 1998-04-30 Novartis Ag Substituted oxime-ethers and their use as pesticides
US5856573A (en) 1994-12-26 1999-01-05 Shionogi & Co., Ltd Process for producing 2-(2-hydroxymethylphenyl)acetamide derivative and intermediate for the production thereof
WO2001012585A1 (en) 1999-08-16 2001-02-22 Korea Research Institute Of Chemical Technology Fungicidal compounds having a fluorovinyl- or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2004072086A2 (en) 2003-02-14 2004-08-26 Pfizer Limited Antiparasitic terpene alkaloids
US6919298B2 (en) 2002-04-04 2005-07-19 Valent Biosciences Corporation Enhanced herbicide composition
WO2006044293A2 (en) 2004-10-12 2006-04-27 Pharmacopeia Drug Discovery, Inc. Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
US20080196127A1 (en) 2005-04-11 2008-08-14 Bayer Bioscience N.V. Elite Event A5547-127 and Methods and Kits For Identifying Such Event in Biological Samples
US20080312082A1 (en) 2006-10-31 2008-12-18 Kinney Anthony J Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof
US20080320616A1 (en) 2005-04-08 2008-12-25 Bayer Bioscience N.V. Elite Event A2407-12 and Methods and Kits for Identifying Such Event in Biological Samples
WO2009064031A1 (en) 2007-11-16 2009-05-22 Sumitomo Chemical Company, Limited Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same
WO2009112275A1 (en) * 2008-03-14 2009-09-17 Bayer Cropscience Ag Pesticidal condensed - ring aryl compounds
US7632985B2 (en) 2005-05-27 2009-12-15 Monsanto Technology Llc Soybean event MON89788 and methods for detection thereof
WO2010080829A1 (en) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Soybean event 127 and methods related thereto
US20100184079A1 (en) 2006-06-28 2010-07-22 Pioneer Hi-Bred International, Inc. Soybean event 3560.4.3.5 and compositions and methods for the identification and detection thereof
WO2011022471A1 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Detection of aad-1 event das-40278-9
WO2011022470A1 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Control of aad-1 monocot volunteers in fields of dicot crops
WO2011022469A2 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
US20110067134A1 (en) 2009-09-17 2011-03-17 Brinker Ronald J Soybean transgenic event mon 87708 and methods of use thereof
WO2011046082A1 (en) * 2009-10-13 2011-04-21 日本曹達株式会社 Oxime ether derivative or salt thereof, and agricultural/horticultural germicide
US8049071B2 (en) 2007-11-15 2011-11-01 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event MON87701 and methods for detection thereof
WO2011138281A2 (en) 2010-05-06 2011-11-10 Bayer Cropscience Ag Process for the preparation of dithiine tetracarboxydiimides
WO2014006945A1 (en) 2012-07-04 2014-01-09 アグロカネショウ株式会社 2-aminonicotinic acid ester derivative and bactericide containing same as active ingredient
US8632978B2 (en) 2011-07-26 2014-01-21 Dow Agrosciences, Llc. Soybean event pDAB9582.814.19.1 detection method
WO2014075873A1 (en) * 2012-11-13 2014-05-22 Syngenta Participations Ag Microbiocidal pyrazole derivatives
WO2014095675A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
US20140201860A1 (en) 2010-12-15 2014-07-17 Syngenta Participations Ag Soybean event syht0h2 and compositions and methods for detection thereof
WO2014170327A1 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Method for combating pests
US20140373191A1 (en) 2013-06-14 2014-12-18 Monsanto Technology, Llc Soybean transgenic event mon87751 and methods for detection and use thereof
WO2015155075A1 (en) 2014-04-11 2015-10-15 Syngenta Participations Ag Fungicidal n'-[2-methyl-6-[2-alkoxy-ethoxy]-3-pyridyl]-n-alkyl-formamidine derivatives for use in agriculture
WO2016055404A1 (en) 2014-10-10 2016-04-14 Basf Se Stereoselective process to obtain (z)-5-cyclyloxy-2-[(e)-methoxyimino]-3-methyl-pent-3-enic acid methyl amides using e,z-isomer mixture of and intermediates thereof
WO2016156290A1 (en) 2015-04-02 2016-10-06 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazole derivatives
WO2016156085A1 (en) 2015-03-27 2016-10-06 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2016202742A1 (en) 2015-06-15 2016-12-22 Bayer Cropscience Aktiengesellschaft Halogen-substituted phenoxyphenylamidines and the use thereof as fungicides
WO2017025510A1 (en) 2015-08-12 2017-02-16 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2017029179A1 (en) 2015-08-14 2017-02-23 Bayer Cropscience Aktiengesellschaft Triazole derivatives, intermediates thereof and their use as fungicides
WO2017055469A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017055473A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017093348A1 (en) 2015-12-02 2017-06-08 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017118689A1 (en) 2016-01-08 2017-07-13 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017153380A1 (en) 2016-03-10 2017-09-14 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
WO2017220485A1 (en) 2016-06-21 2017-12-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018065414A1 (en) 2016-10-06 2018-04-12 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018153707A1 (en) 2017-02-22 2018-08-30 Basf Se Crystalline forms of a strobilurin type compound for combating phytopathogenic fungi
WO2018158365A1 (en) 2017-03-03 2018-09-07 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018202428A1 (en) 2017-05-02 2018-11-08 Basf Se Fungicidal mixture comprising substituted 3-phenyl-5-(trifluoromethyl)-1,2,4-oxadiazoles
WO2018228896A1 (en) 2017-06-14 2018-12-20 Syngenta Participations Ag Fungicidal compositions
WO2019110427A1 (en) 2017-12-04 2019-06-13 Syngenta Participations Ag Microbiocidal phenylamidine derivatives

Patent Citations (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639771A (en) 1984-10-31 1987-01-27 Kabushiki Kaisha Toshiba Image processing system
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
GB2176186A (en) * 1985-06-04 1986-12-17 Egyt Gyogyszervegyeszeti Gyar Fungicidal phenanthrene derivatives
EP0357460A2 (en) 1988-09-02 1990-03-07 Sankyo Company Limited 13-Substituted milbemycin derivatives, their preparation and use
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
EP0382173A2 (en) 1989-02-07 1990-08-16 Meiji Seika Kaisha Ltd. PF 1022 substance, method of producing same and anthelmintic composition containing same
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0414153A1 (en) * 1989-08-22 1991-02-27 Nihon Nohyaku Co., Ltd. N-(substituted benzyloxy)imine derivatives, process for the production thereof, use thereof, and method of use thereof
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0444964A1 (en) 1990-03-01 1991-09-04 Sankyo Company Limited Milbemycin ether derivatives, their preparation and their anthelmintic uses
EP0503538A1 (en) 1991-03-08 1992-09-16 Meiji Seika Kaisha Ltd. Medicinal composition containing an anthelmintic cyclic depsipeptide
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1993019053A1 (en) 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
US5478855A (en) 1992-04-28 1995-12-26 Yashima Chemical Industry Co., Ltd. 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-oxazoline
WO1993025543A2 (en) 1992-06-11 1993-12-23 Bayer Aktiengesellschaft Enniatines and enniatine derivates used to control endoparasites
EP0594291A1 (en) 1992-09-01 1994-04-27 Sankyo Company Limited Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
WO1994015944A1 (en) 1993-01-18 1994-07-21 Pfizer Limited New antiparasitic agents related to the milbemycins and avermectins
WO1994019334A1 (en) 1993-02-19 1994-09-01 Meiji Seika Kaisha, Ltd. Pf1022 derivative, cyclic depsipeptide
EP0626375A1 (en) 1993-05-26 1994-11-30 Bayer Ag Octacyclodepsipeptides having endoparasiticidal activity
WO1995019363A1 (en) 1994-01-14 1995-07-20 Pfizer Inc. Antiparasitic pyrrolobenzoxazine compounds
WO1995022552A1 (en) 1994-02-16 1995-08-24 Pfizer Limited Antiparasitic agents
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
WO1996011945A2 (en) 1994-10-18 1996-04-25 Bayer Aktiengesellschaft Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
WO1996015121A1 (en) 1994-11-10 1996-05-23 Bayer Aktiengesellschaft Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production
US5856573A (en) 1994-12-26 1999-01-05 Shionogi & Co., Ltd Process for producing 2-(2-hydroxymethylphenyl)acetamide derivative and intermediate for the production thereof
DE19520936A1 (en) 1995-06-08 1996-12-12 Bayer Ag Ectoparasiticides means
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
WO1998017631A2 (en) * 1996-10-23 1998-04-30 Novartis Ag Substituted oxime-ethers and their use as pesticides
WO2001012585A1 (en) 1999-08-16 2001-02-22 Korea Research Institute Of Chemical Technology Fungicidal compounds having a fluorovinyl- or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
US6919298B2 (en) 2002-04-04 2005-07-19 Valent Biosciences Corporation Enhanced herbicide composition
WO2004072086A2 (en) 2003-02-14 2004-08-26 Pfizer Limited Antiparasitic terpene alkaloids
WO2006044293A2 (en) 2004-10-12 2006-04-27 Pharmacopeia Drug Discovery, Inc. Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
US20080320616A1 (en) 2005-04-08 2008-12-25 Bayer Bioscience N.V. Elite Event A2407-12 and Methods and Kits for Identifying Such Event in Biological Samples
US20080196127A1 (en) 2005-04-11 2008-08-14 Bayer Bioscience N.V. Elite Event A5547-127 and Methods and Kits For Identifying Such Event in Biological Samples
US7632985B2 (en) 2005-05-27 2009-12-15 Monsanto Technology Llc Soybean event MON89788 and methods for detection thereof
US20100184079A1 (en) 2006-06-28 2010-07-22 Pioneer Hi-Bred International, Inc. Soybean event 3560.4.3.5 and compositions and methods for the identification and detection thereof
US20080312082A1 (en) 2006-10-31 2008-12-18 Kinney Anthony J Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof
US8049071B2 (en) 2007-11-15 2011-11-01 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event MON87701 and methods for detection thereof
WO2009064031A1 (en) 2007-11-16 2009-05-22 Sumitomo Chemical Company, Limited Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same
WO2009112275A1 (en) * 2008-03-14 2009-09-17 Bayer Cropscience Ag Pesticidal condensed - ring aryl compounds
WO2010080829A1 (en) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Soybean event 127 and methods related thereto
WO2011022469A2 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
WO2011022470A1 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Control of aad-1 monocot volunteers in fields of dicot crops
WO2011022471A1 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Detection of aad-1 event das-40278-9
US20110067134A1 (en) 2009-09-17 2011-03-17 Brinker Ronald J Soybean transgenic event mon 87708 and methods of use thereof
WO2011046082A1 (en) * 2009-10-13 2011-04-21 日本曹達株式会社 Oxime ether derivative or salt thereof, and agricultural/horticultural germicide
WO2011138281A2 (en) 2010-05-06 2011-11-10 Bayer Cropscience Ag Process for the preparation of dithiine tetracarboxydiimides
US20140201860A1 (en) 2010-12-15 2014-07-17 Syngenta Participations Ag Soybean event syht0h2 and compositions and methods for detection thereof
US8632978B2 (en) 2011-07-26 2014-01-21 Dow Agrosciences, Llc. Soybean event pDAB9582.814.19.1 detection method
WO2014006945A1 (en) 2012-07-04 2014-01-09 アグロカネショウ株式会社 2-aminonicotinic acid ester derivative and bactericide containing same as active ingredient
WO2014075873A1 (en) * 2012-11-13 2014-05-22 Syngenta Participations Ag Microbiocidal pyrazole derivatives
WO2014095675A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
WO2014170327A1 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Method for combating pests
US20140373191A1 (en) 2013-06-14 2014-12-18 Monsanto Technology, Llc Soybean transgenic event mon87751 and methods for detection and use thereof
WO2015155075A1 (en) 2014-04-11 2015-10-15 Syngenta Participations Ag Fungicidal n'-[2-methyl-6-[2-alkoxy-ethoxy]-3-pyridyl]-n-alkyl-formamidine derivatives for use in agriculture
WO2016055404A1 (en) 2014-10-10 2016-04-14 Basf Se Stereoselective process to obtain (z)-5-cyclyloxy-2-[(e)-methoxyimino]-3-methyl-pent-3-enic acid methyl amides using e,z-isomer mixture of and intermediates thereof
WO2016156085A1 (en) 2015-03-27 2016-10-06 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2016156290A1 (en) 2015-04-02 2016-10-06 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazole derivatives
WO2016202742A1 (en) 2015-06-15 2016-12-22 Bayer Cropscience Aktiengesellschaft Halogen-substituted phenoxyphenylamidines and the use thereof as fungicides
WO2017025510A1 (en) 2015-08-12 2017-02-16 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2017029179A1 (en) 2015-08-14 2017-02-23 Bayer Cropscience Aktiengesellschaft Triazole derivatives, intermediates thereof and their use as fungicides
WO2017055469A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017055473A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017093348A1 (en) 2015-12-02 2017-06-08 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017118689A1 (en) 2016-01-08 2017-07-13 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017153380A1 (en) 2016-03-10 2017-09-14 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
WO2017220485A1 (en) 2016-06-21 2017-12-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018065414A1 (en) 2016-10-06 2018-04-12 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018153707A1 (en) 2017-02-22 2018-08-30 Basf Se Crystalline forms of a strobilurin type compound for combating phytopathogenic fungi
WO2018158365A1 (en) 2017-03-03 2018-09-07 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018202428A1 (en) 2017-05-02 2018-11-08 Basf Se Fungicidal mixture comprising substituted 3-phenyl-5-(trifluoromethyl)-1,2,4-oxadiazoles
WO2018228896A1 (en) 2017-06-14 2018-12-20 Syngenta Participations Ag Fungicidal compositions
WO2019110427A1 (en) 2017-12-04 2019-06-13 Syngenta Participations Ag Microbiocidal phenylamidine derivatives

Non-Patent Citations (25)

* Cited by examiner, † Cited by third party
Title
"The Pesticide Manual'' [The Pesticide Manual - A World Compendium", THE BRITISH CROP PROTECTION COUNCIL
"The Pesticide Manual", 2009, BRITISH CROP PROTECTION COUNCIL
ADVANCED SYNTHESIS AND CATALYSIS, vol. 359, 2017, pages 3865 - 3879
BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 18, 2010, pages 8642 - 8659
CHEM., INT. ED., vol. 56, 2017, pages 12770
CURRENT ORGANOCATALYSIS, vol. 5, 2018, pages 196 - 200
J. MED. CHEM., vol. 36, 1993, pages 2485 - 2493
JOURNAL OF MEDICINAL CHEMISTRY, vol. 43, 2000, pages 560 - 568
JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, 2013, pages 5514 - 5540
JOURNAL OF MEDICINAL CHEMISTRY, vol. 61, 2018, pages 5623 - 5642
JOURNAL OF ORGANIC CHEMISTRY, vol. 71, 2006, pages 4956 - 4964
KLOSOWSKI AC ET AL.: "Competitive fitness of Phakopsora pachyrhizi isolates with mutations in the CYP51 and CYTB genes", PHYTOPATHOLOGY, vol. 106, 2016, pages 1278 - 1284
KLOSOWSKI AC ET AL.: "Detection of the F129L mutation in the cytochrome b gene in Phakopsora pachyrhizi", PEST MANAG SCI, vol. 72, 2016, pages 1211 - 1215, XP055720325, DOI: 10.1002/ps.4099
LANGENBACH C ET AL.: "Fighting Asian Soybean Rust", FRONT PLANT SCIENCE, vol. 7, no. 797, 2016
LEROUX, F. ET AL.: "The Preparation of Organolithium Reagents and Intermediates", 2004, WILEY
ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 9, 2011, pages 6895 - 6898
ORGANIC LETTERS, vol. 11, 2009, pages 1321 - 1324
ORGANIC LETTERS, vol. 13, 2011, pages 540 - 542
ORGANIC LETTERS, vol. 14, 2013, pages 272 - 275
ORGANIC LETTERS, vol. 18, 2016, pages 6344 - 6347
RSC ADVANCES, vol. 4, 2014, pages 48177 - 48190
SCHMITZ HK: "Sensitivity of Phakopsora pachyrhizi towards quinone-outside-inhibitors and demethylation-inhibitors, and corresponding resistance mechanisms", PEST MANAG SCI, vol. 70, 2014, pages 378 - 388, XP055521613, DOI: 10.1002/ps.3562
SIMÕES K ET AL.: "First detection of a SDH variant with reduced SDHI sensitivity in Phakopsora pachyrhizf", J PLANT DIS PROT, vol. 125, 2018, pages 21 - 2
TETRAHEDRON, vol. 67, 2011, pages 624 - 635
TETRAHEDRON, vol. 68, 2012, pages 2113 - 2120

Also Published As

Publication number Publication date
GB202014840D0 (en) 2020-11-04
BR112023004833A2 (en) 2023-04-18

Similar Documents

Publication Publication Date Title
EP3941898B1 (en) Fungicidal compounds
WO2020079111A1 (en) Microbiocidal compounds
US20220183295A1 (en) Microbiocidal 2-acylamino-thiazole-4-carboxamide derivatives
US20220017501A1 (en) Microbiocidal thiazole derivatives
WO2021224102A1 (en) Microbiocidal compounds
WO2020208095A1 (en) Microbiocidal picolinamide derivatives
US11629129B2 (en) Microbiocidal picolinamide derivatives
WO2020165403A1 (en) Phenyl substituted thiazole derivatives as microbiocidal compounds
WO2021219780A1 (en) Microbiocidal compounds
WO2021219778A1 (en) Microbiocidal compounds
WO2021219775A1 (en) Microbiocidal compounds
CA3213300A1 (en) Microbiocidal quinoline/quinoxaline benzothiazine derivatives
WO2022223376A1 (en) Microbiocidal quinoline/quinoxaline isoquinoline derivatives
WO2020025807A1 (en) Microbiocidal 1,2,5-oxadiazol-3(2h)-one derivatives
WO2020078732A1 (en) Microbiocidal oxadiazole derivatives
RU2817796C2 (en) Fungicidal compounds
WO2022058580A1 (en) Microbiocidal compounds
WO2021009026A1 (en) Methyl 2-[(4-methoxyimino-tetralin-6-yl]prop-2-enoate derivatives, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1h-isobenzofurane and indane analogues thereof, and similar compounds, as agrochemical fungicides
WO2023118011A1 (en) Microbiocidal aza-heterobiaryl derivatives
WO2023148206A1 (en) Microbiocidal n-amide derivatives
WO2023094303A1 (en) Microbiocidal heterobiaryl amide derivatives
EP4313949A1 (en) Microbiocidal isonicotinic amide derivatives
WO2021204855A1 (en) Microbiocidal quinoline dihydropyrrolopyrazine derivatives
WO2024100069A1 (en) Microbiocidal pyridine derivatives
WO2023166067A1 (en) Microbiocidal pyridazinone amide derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21778461

Country of ref document: EP

Kind code of ref document: A1

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112023004833

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112023004833

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20230315

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21778461

Country of ref document: EP

Kind code of ref document: A1